AptarGroup (ATR) 10-K24 Feb 202019 FY Annual reportFinancial data

Company Profile

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
Document and Entity Information - USD ($)	Dec. 31, 2019	Feb. 18, 2020	Jun. 28, 2019
Document and Entity Information
Document Type	10-K
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Dec. 31, 2019
Entity File Number	1-11846
Entity Registrant Name	APTARGROUP INC
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	36-3853103
Entity Address, Address Line One	DELAWARE
Entity Address, City or Town	CRYSTAL LAKE
Entity Address, State or Province	IL
Entity Address, Postal Zip Code	60014
City Area Code	815
Local Phone Number	477-0424
Title of 12(b) Security	Common Stock, $.01 par value
Trading Symbol	ATR
Security Exchange Name	NYSE
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		64,054,138
Entity Public Float			$ 7,975,902,822
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	FY
Entity Central Index Key	0000896622
Amendment Flag	false

CONSOLIDATED STATEMENTS OF INCO

CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
Net sales	$ 2,859,732	$ 2,764,761	$ 2,469,283
Operating Expenses:
Cost of sales (exclusive of depreciation and amortization shown below)	1,818,398	1,812,961	1,603,070
Selling, research & development and administrative	454,617	429,955	387,424
Depreciation and amortization	194,552	171,747	153,094
Restructuring initiatives	20,472	63,829	2,208
Total Operating Expenses	2,488,039	2,478,492	2,145,796
Operating Income	371,693	286,269	323,487
Other (Expense) Income:
Interest expense	(35,489)	(32,626)	(40,597)
Interest income	4,174	7,056	5,470
Equity in results of affiliates	135	(229)	(229)
Miscellaneous, net	1,556	5,550	6,694
Total Other Income (Expense)	(29,624)	(20,249)	(28,662)
Income before Income Taxes	342,069	266,020	294,825
Provision for Income Taxes	99,842	71,254	74,796
Net Income	242,227	194,766	220,029
Net (Income) Loss Attributable to Noncontrolling Interests	(25)	(21)	1
Net Income Attributable to AptarGroup, Inc.	$ 242,202	$ 194,745	$ 220,030
Net Income Attributable to AptarGroup, Inc. Per Common Share:
Basic (in dollars per share)	$ 3.81	$ 3.12	$ 3.52
Diluted (in dollars per share)	$ 3.66	$ 3	$ 3.41
Average number of shares outstanding:
Basic (in shares)	63,574	62,437	62,435
Diluted (in shares)	66,150	64,958	64,596

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
Net Income	$ 242,227	$ 194,766	$ 220,029
Other Comprehensive Income (Loss):
Foreign currency translation adjustments	(8,727)	(62,914)	74,404
Changes in treasury locks, net of tax		17	28
Gain (loss) on derivatives, net of tax	(37)	1,547	(3,186)
Defined benefit pension plan, net of tax
Actuarial gain / (loss), net of tax	(25,877)	5,292	(7,906)
Prior service cost, net of tax	320	(26)	(1,038)
Amortization of prior service cost included in net income, net of tax	2,541	533	296
Amortization of net loss included in net income, net of tax	332	4,991	3,828
Total defined benefit pension plan, net of tax	(22,684)	10,790	(4,820)
Total other comprehensive income (loss)	(31,448)	(50,560)	66,426
Comprehensive Income	210,779	144,206	286,455
Comprehensive (Income) Loss Attributable to Noncontrolling Interests	21	16	(18)
Comprehensive Income Attributable to AptarGroup, Inc.	$ 210,800	$ 144,222	$ 286,437

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Current Assets:
Cash and equivalents	$ 241,970	$ 261,823
Accounts and notes receivable, less allowance for doubtful accounts of $3,626 in 2019 and $3,541 in 2018	558,428	569,630
Inventories	375,795	381,110
Prepaid and other	115,048	118,245
Total Current Assets	1,291,241	1,330,808
Property, Plant and Equipment:
Buildings and improvements	504,328	453,572
Machinery and equipment	2,521,737	2,368,332
Property, Plant and Equipment, Gross	3,026,065	2,821,904
Less: Accumulated depreciation	(1,963,520)	(1,855,810)
Property, Plant and Equipment, Net	1,062,545	966,094
Land	25,133	25,519
Total Property, Plant and Equipment	1,087,678	991,613
Other Assets:
Investments in equity securities	8,396	25,448
Goodwill	763,461	712,095
Intangible assets	291,084	254,904
Operating lease right-of-use assets	72,377
Miscellaneous	47,882	62,867
Total Other Assets	1,183,200	1,055,314
Total Assets	3,562,119	3,377,735
Current Liabilities:
Notes payable, revolving credit facility and overdrafts	44,259	101,293
Current maturities of long-term obligations, net of unamortized debt issuance costs	65,988	62,678
Accounts payable, accrued and other liabilities	573,028	525,199
Total Current Liabilities	683,275	689,170
Long-term obligations, net of unamortized debt issuance costs	1,085,453	1,125,993
Deferred Liabilities and Other:
Deferred income taxes	41,388	53,917
Retirement and deferred compensation plans	101,225	62,319
Operating lease liabilities	55,276
Deferred and other non-current liabilities	23,250	23,465
Commitments and contingencies
Total Deferred Liabilities and Other	221,139	139,701
AptarGroup, Inc. stockholders' equity
Common stock, $.01 par value, 199 million shares authorized, 68.6 and 67.3 million shares issued as of December 31, 2019 and 2018, respectively	686	673
Capital in excess of par value	770,596	678,769
Retained earnings	1,523,820	1,371,826
Accumulated other comprehensive (loss)	(341,948)	(310,504)
Less treasury stock at cost, 4.8 and 4.4 million shares as of December 31, 2019 and 2018, respectively	(381,238)	(318,208)
Total AptarGroup, Inc. Stockholders' Equity	1,571,916	1,422,556
Noncontrolling interests in subsidiaries	336	315
Total Stockholders' Equity	1,572,252	1,422,871
Total Liabilities and Stockholders' Equity	$ 3,562,119	$ 3,377,735

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands, shares in Millions	Dec. 31, 2019	Dec. 31, 2018
CONDENSED CONSOLIDATED BALANCE SHEETS
Accounts and notes receivable, allowance for doubtful accounts (in dollars)	$ 3,626	$ 3,541
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	199	199
Common stock, shares issued	68.6	67.3
Treasury stock, shares	4.8	4.4

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($) $ in Thousands	Retained Earnings	Accumulated Other Comprehensive Income/(Loss)	Common Stock Par Value	Treasury Stock	Capital in Excess of Par Value	Non-Controlling Interest	Total
Balance at Dec. 31, 2016	$ 1,197,234	$ (319,709)	$ 660	$ (250,917)	$ 546,682	$ 292	$ 1,174,242
Increase (Decrease) in Stockholders' Equity
Net Income	220,030					(1)	220,029
Foreign currency translation adjustments		74,385				19	74,404
Changes in unrecognized pension gains (losses) and related amortization, net of tax		(4,820)					(4,820)
Changes in treasury locks, net of tax		28					28
Changes in derivative gains (losses), net of tax		(3,186)					(3,186)
Stock awards and option exercises			12	25,212	67,605		92,829
Cash dividends declared on common stock	(79,944)						(79,944)
Treasury stock purchased				(120,540)			(120,540)
Common stock repurchased and retired	(36,173)		(5)		(4,816)		(40,994)
Balance at Dec. 31, 2017	1,301,147	(253,302)	667	(346,245)	609,471	310	1,312,048
Increase (Decrease) in Stockholders' Equity
Net Income	194,745					21	194,766
Adoption of accounting standards \| Accounting Standards Update 2014-09	2,937						2,937
Adoption of accounting standards \| Accounting Standards Update 2018-02	6,658	(6,658)
Foreign currency translation adjustments		(62,898)				(16)	(62,914)
Changes in unrecognized pension gains (losses) and related amortization, net of tax		10,790					10,790
Changes in treasury locks, net of tax		17					17
Changes in derivative gains (losses), net of tax		1,547					1,547
Stock awards and option exercises			12	31,942	75,763		107,717
Cash dividends declared on common stock	(82,346)						(82,346)
Treasury stock purchased				(3,905)			(3,905)
Common stock repurchased and retired	(51,315)		(6)		(6,465)		(57,786)
Balance at Dec. 31, 2018	1,371,826	(310,504)	673	(318,208)	678,769	315	1,422,871
Increase (Decrease) in Stockholders' Equity
Net Income	242,202					25	242,227
Foreign currency translation adjustments		(8,723)				(4)	(8,727)
Changes in unrecognized pension gains (losses) and related amortization, net of tax		(22,684)					(22,684)
Changes in derivative gains (losses), net of tax		(37)					(37)
Stock awards and option exercises			13	23,467	91,827		115,307
Cash dividends declared on common stock	(90,208)						(90,208)
Treasury stock purchased				(86,497)			(86,497)
Balance at Dec. 31, 2019	$ 1,523,820	$ (341,948)	$ 686	$ (381,238)	$ 770,596	$ 336	$ 1,572,252

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Cash Flows from Operating Activities:
Net income	$ 242,227	$ 194,766	$ 220,029
Adjustments to reconcile net income to net cash provided by operations:
Depreciation	166,944	156,292	142,755
Amortization	27,608	15,455	10,339
Stock based compensation	23,893	19,561	18,924
Provision for (recovery of) doubtful accounts	782	923	235
(Gain) loss on disposition of fixed assets	344	(770)	387
Gain on remeasurement of equity securities		(6,500)
Debt prepayment costs			4,710
Deferred income taxes	8,746	(23,352)	2,238
Defined benefit plan expense	15,342	19,501	17,200
Equity in results of affiliates	(135)	229	229
Changes in balance sheet items, excluding effects from acquisitions and foreign currency adjustments:
Accounts receivables	8,811	(66,968)	(44,658)
Inventories	605	(25,183)	(12,989)
Prepaid and other current assets	6,596	(9,437)	(33,959)
Accounts payable, accrued and other liabilities	(779)	37,155	58,245
Income taxes payable	5,658	(3,155)	(8,753)
Retirement and deferred compensation plan liabilities	(3,956)	(22,762)	(41,004)
Other changes, net	11,771	27,873	(9,199)
Net Cash Provided by Operations	514,457	313,628	324,729
Cash Flows from Investing Activities:
Capital expenditures	(242,276)	(211,252)	(156,624)
Proceeds from sale of property, plant and equipment	4,301	4,466	2,036
Insurance proceeds		10,631	709
Settlement for derivative			(66,155)
Acquisition of business, net of cash acquired	(106,328)	(527,916)
Acquisition of intangible assets	(4,806)	(611)
Investment in equity securities	(3,530)	(10,000)	(5,000)
Proceeds from sale of investment in equity securities	16,487
Notes receivable, net	(116)	(779)	234
Net Cash Used by Investing Activities	(336,268)	(735,461)	(224,800)
Cash Flows from Financing Activities:
Proceeds from notes payable and overdrafts	50,854	49,069
Repayments of notes payable and overdrafts	(53,269)	(29,994)
Proceeds and repayments of short term credit facility, net	(52,096)	81,063	(169,213)
Proceeds from long-term obligations	10,523	13,161	625,628
Repayments of long-term obligations	(67,276)	(72,290)	(165,798)
Dividends paid	(90,208)	(82,346)	(79,944)
Credit facility costs			(3,542)
Debt prepayment costs			(4,710)
Proceeds from stock option exercises	90,834	88,156	73,905
Purchase of treasury stock	(86,497)	(3,905)	(120,540)
Common stock repurchased and retired		(57,786)	(40,994)
Net Cash Provided (Used) by Financing Activities	(197,135)	(14,872)	114,792
Effect of Exchange Rate Changes on Cash	(904)	(9,112)	31,632
Net Increase (Decrease) in Cash and Equivalents and Restricted Cash	(19,850)	(445,817)	246,353
Cash and Equivalents and Restricted Cash at Beginning of Period	266,823	712,640	466,287
Cash and Equivalents and Restricted Cash at End of Period	246,973	266,823	712,640
Supplemental Cash Flow Disclosure:
Interest paid	34,422	32,005	38,838
Income taxes paid	$ 86,097	$ 96,048	$ 77,349

CONSOLIDATED STATEMENTS OF CA_2

CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Restricted cash included in the line item prepaid and other on the Condensed Consolidated Balance Sheets as shown below represents amounts held in escrow.
Cash and equivalents	$ 241,970	$ 261,823	$ 712,640
Restricted cash included in prepaid and other	5,003	5,000
Total Cash and Equivalents and Restricted Cash shown in the Statement of Cash Flows	$ 246,973	$ 266,823	$ 712,640	$ 466,287

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Dec. 31, 2019
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES BASIS OF PRESENTATION The accompanying consolidated financial statements include the accounts of AptarGroup, Inc. and our subsidiaries. The terms “AptarGroup”, “Aptar”, “Company”, “we”, “us” or “our” as used herein refer to AptarGroup, Inc. and our subsidiaries. All significant intercompany accounts and transactions have been eliminated. Certain previously reported amounts have been reclassified to conform to the current period presentation. AptarGroup’s organizational structure consists of three market-focused business segments which are Beauty + Home, Pharma and Food + Beverage. This is a strategic structure which allows us to be more closely aligned with our customers and the markets in which they operate. In late 2017, Aptar began a business transformation plan to drive profitable sales growth, increase operational excellence, enhance our approach to innovation and improve organizational effectiveness (see Note 21 – Restructuring Initiatives for further details). The primary focus of the plan is the Beauty + Home segment; however, certain global general and administrative functions are also addressed. During 2019, 2018 and 2017, we recognized approximately $20.5 million, $63.8 million and $2.2 million, respectively, of restructuring costs related to this plan. During the quarter ended June 30, 2018, primarily based on published estimates which indicate that Argentina's three-year cumulative inflation rate has exceeded 100%, we concluded that Argentina has become a highly inflationary economy. Beginning July 1, 2018, we have applied highly inflationary accounting for our Argentinian subsidiaries. We have changed the functional currency from the Argentinian peso to the U.S. dollar. Local currency monetary assets and liabilities were remeasured into U.S. dollars using exchange rates as of the latest balance sheet date, with remeasurement adjustments and other transaction gains and losses recognized in net earnings. During the last half of 2018, we recognized approximately $0.8 million of currency gains due to these changes. Our Argentinian operations contributed approximately less than 2.0% of consolidated net assets and revenues at and for the year ended December 31, 2019. ACCOUNTING ESTIMATES The financial statements are prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). This process requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. CASH AND CASH EQUIVALENTS We consider all investments that are readily convertible to known amounts of cash with an original maturity of three months or less when purchased to be cash equivalents. INVENTORIES Inventories are stated at lower of cost or net realizable value. Costs included in inventories are raw materials, direct labor and manufacturing overhead. INVESTMENTS IN EQUITY SECURITIES We account for our 20% to 50% owned investments using the equity method. Equity investments that do not result in consolidation and are not accounted for under the equity method are measured at fair value. Any related changes in fair value is recognized in net income unless the investments qualify for a practicality exception. In May 2018, we invested $10.0 million in preferred equity stock of Reciprocal Labs Corporation, doing business as Propeller Health. During 2018, we increased the value of this investment by approximately $6.5 million due to fair value inputs. This investment was ultimately sold during January 2019 for an amount of $16.5 million (see Note 20 – Acquisitions for further details). During August 2019, we also invested an aggregate amount of $3.5 million in two preferred equity investments that are accounted for at cost less impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer. There were no indications of impairment nor were there any changes from observable price changes noted for the year ended December 31, 2019. There were no dividends received from affiliated companies in 2019, 2018 and 2017. PROPERTY AND DEPRECIATION Properties are stated at cost. Depreciation is determined on a straight-line basis over the estimated useful lives for financial reporting purposes and accelerated methods for income tax reporting. Generally, the estimated useful lives are 10 to 40 years for buildings and improvements and 3 to 15 years for machinery and equipment. FINITE-LIVED INTANGIBLE ASSETS Finite-lived intangibles, consisting of patents, acquired technology, customer relationships, trademarks and trade names and license agreements acquired in purchase transactions, are capitalized and amortized over their useful lives which range from 1 to 20 years. GOODWILL The Company has historically evaluated the excess of purchase price over the fair value of the net assets acquired (“goodwill”) for impairment annually as of December 31 or more frequently if impairment indicators arose in accordance with Accounting Standards Codification (“ASC”) Topic 350, “Intangibles - Goodwill and Other.” In the fourth quarter of 2019, the Company changed the date of its annual assessment of goodwill to October 1 for all reporting units. The change in testing date for goodwill is a change in accounting principle, which management believes is preferable as the new date of the assessment better aligns with the Company’s budgeting process and will create a more efficient and timely process surrounding the impairment tests. The change in the assessment date does not delay, accelerate or avoid a potential impairment charge. The Company has determined that it is impracticable to objectively determine projected cash flows and related valuation estimates that would have been used as of each October 1 of prior reporting periods without the use of hindsight. As such, the Company prospectively applied the change in annual goodwill impairment testing date from October 1, 2019. We believe that the accounting estimates related to determining the fair value of our reporting units is a critical accounting estimate because: (1) it is highly susceptible to change from period to period because it requires management to make assumptions about the future cash flows for each reporting unit over several years, and (2) the impact that recognizing an impairment would have on the assets reported on our balance sheet as well as our results of operations could be material. Management’s determination of the fair value of our reporting units, based on future cash flows for the reporting units, requires significant judgment and the use of estimates and assumptions related to projected revenue growth rates, the terminal growth factor, as well as the discount rate. Actual cash flows in the future may differ significantly from those forecasted today. The estimates and assumptions for future cash flows and its impact on the impairment testing of goodwill is a critical accounting estimate. Management believes goodwill in purchase transactions has continuing value. Goodwill is not amortized and must be tested annually, or more frequently as circumstances dictate, for impairment. The annual goodwill impairment test may first consider qualitative factors to determine whether it is more likely than not (i.e., greater than 50 percent chance) that the fair value of a reporting unit is less than its book value. This is sometimes referred to as the “step zero” approach and is an optional step in the annual goodwill impairment analysis. Management has performed this qualitative assessment as of October 1, 2019 for each of our reporting units. Based on our review of macroeconomic, industry, and market events and circumstances as well as the overall financial performance of the reporting units, we determined that it was more likely than not that the fair value of these reporting units was greater than their carrying amounts. During the third quarter of 2019, we performed a separate quantitative impairment assessment using a discounted cash flow analysis of the Active Packaging reporting unit, which was formed as a result of the CSP Technologies Acquisition in the third quarter of 2018. We calculated the fair value of the Active Packaging reporting unit and compared it with the associated carrying value (the “step one” approach) as of July 1, 2019. Based on this quantitative analysis, the fair value of the reporting unit exceeded the carrying value and therefore no impairment loss was recognized. IMPAIRMENT OF LONG-LIVED ASSETS Long-lived assets, such as property, plant and equipment and finite-lived intangibles, are evaluated for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. An impairment loss is recognized when estimated undiscounted future cash flows expected to result from the use of the asset plus net proceeds expected from disposition of the asset (if any) are less than the carrying value of the asset. DERIVATIVES INSTRUMENTS AND HEDGING ACTIVITIES Derivative financial instruments are recorded in the Consolidated Balance Sheets at fair value as either assets or liabilities. Changes in the fair value of derivatives are recorded in each period in earnings or other comprehensive income, depending on whether a derivative is designated and effective as part of a hedge transaction. RETIREMENT OF COMMON STOCK During 2019, we repurchased 779 thousand shares of common stock, all of which were returned to treasury stock. During 2018, we repurchased 668 thousand shares of common stock, of which 623 thousand shares were immediately retired. Common stock was reduced by the number of shares retired at $0.01 par value per share. We allocate the excess purchase price over par value between additional paid-in capital and retained earnings. RESEARCH & DEVELOPMENT EXPENSES Research and development costs, net of any customer funded research and development or government research and development credits, are expensed as incurred. These costs amounted to $82.8 million, $75.3 million and $68.2 million in 2019, 2018 and 2017, respectively. INCOME TAXES We compute taxes on income in accordance with the tax rules and regulations of the many taxing authorities where the income is earned. The income tax rates imposed by these taxing authorities may vary substantially. Taxable income may differ from pre-tax income for financial accounting purposes. To the extent that these differences create timing differences between the tax basis of an asset or liability and its reported amount in the financial statements, an appropriate provision for deferred income taxes is made. All of our non-U.S. earnings are subject to U.S. taxation, either from the transition tax enacted in the U.S. by the Tax Cuts and Jobs Act (“TCJA”) on accumulated non-U.S. earnings as of the end of 2017 or the global intangible low-taxed income (“GILTI”) provisions on non-U.S. earnings thereafter. We maintain our assertion that the cash and distributable reserves at our non-U.S. affiliates are indefinitely reinvested. We will provide for the necessary withholding and local income taxes when management decides that an affiliate should make a distribution. These decisions are made taking into consideration the financial requirements of the non-U.S. affiliates and the global cash management goals of the Company. We provide a liability for the amount of unrecognized tax benefits from uncertain tax positions. This liability is provided whenever we determine that a tax benefit will not meet a more-likely-than-not threshold for recognition. See Note 6 – Income Taxes for more information. TRANSLATION OF FOREIGN CURRENCIES The functional currencies of the majority of our foreign operations are the local currencies. Assets and liabilities of our foreign operations are translated into U.S. dollars at the rates of exchange on the balance sheet date. Sales and expenses are translated at the average rates of exchange prevailing during the year. The related translation adjustments are accumulated in a separate section of Stockholders’ Equity. Realized and unrealized foreign currency transaction gains and losses are reflected in income, as a component of miscellaneous income and expense, and represented losses of $1.7 million, $1.7 million and $5.0 million in 2019, 2018 and 2017, respectively. STOCK-BASED COMPENSATION Accounting standards require the application of the non-substantive vesting approach which means that an award is fully vested when the employee’s retention of the award is no longer contingent on providing future service. Under this approach, compensation costs are recognized over the requisite service period of the award instead of ratably over the vesting period stated in the grant. As such, costs are recognized immediately if the employee is retirement eligible on the date of grant or over the period from the date of grant until retirement eligibility if retirement eligibility is reached before the end of the vesting period stated in the grant. See Note 16 – Stock-Based Compensation for more information. REVENUE RECOGNITION At inception of customer contracts, we assess the goods and services promised in order to identify a performance obligation for each promise to transfer a good or service (or bundle of goods or services) that is distinct. To identify the performance obligations, we consider all the goods or services promised in the contract, whether explicitly stated or implied based on customary business practices. For a contract that has more than one performance obligation, we allocate the total contract consideration to each distinct performance obligation on a relative standalone selling price basis. Revenue is recognized when (or as) the performance obligations are satisfied (i.e., when the customer obtains control of the good or service). The majority of our revenues are derived from product and tooling sales; however, we also receive revenues from service, license, exclusivity and royalty arrangements, which are considered insignificant. See specific discussions about methods of accounting for control transfers of product and tooling sales in Note 2 – Revenue. LEASES We determine if an arrangement is a lease at inception. Operating lease assets are included in operating lease right-of-use (“ROU”) assets and operating lease liabilities are included in accounts payable accrued and other liabilities in our Consolidated Balance Sheets. Finance leases are included in property, plant and equipment, current maturities of long-term obligations and long-term obligations in our Consolidated Balance Sheets. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. We use the implicit rate when readily determinable. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at the commencement date of the lease in determining the present value of lease payments. The operating lease ROU asset includes any lease payments made as well as initial direct costs incurred and excludes lease incentives. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term. We have lease agreements with lease and non-lease components, which are generally accounted for separately. For certain equipment leases, we account for the lease and non-lease components as a single lease component. We have elected not to recognize right-of-use assets and lease liabilities that arise from short-term leases (a lease whose term is 12 months or less and does not include a purchase option that we are reasonably certain to exercise). Certain vehicle lease contracts include guaranteed residual value that is considered in the determination of lease classification. The probability of having to satisfy a residual value guarantee is not considered for the purpose of lease classification, but is considered when measuring a lease liability. ADOPTION OF RECENT ACCOUNTING PRONOUNCEMENTS Changes to U.S. GAAP are established by the Financial Accounting Standards Board (“FASB”) in the form of Accounting Standards Updates (“ASUs”) to the FASB’s Accounting Standards Codification. In February 2016, the FASB issued a new standard related to leases to increase transparency and comparability among organizations. Most prominent among the changes in the standard is the recognition of ROU assets and lease liabilities by lessees for those leases classified as operating leases, as our accounting for finance leases remained substantially unchanged. Under the new standard, disclosures are required to meet the objective of enabling users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases. We adopted the standard on January 1, 2019 using a modified retrospective transition, with the effective date method. Under this method, financial results reported in periods prior to 2019 are not recast. We elected the package of practical expedients permitted under the transition guidance within the new standard, which among other things, allows companies to carry forward their historical lease classification. We also implemented internal controls and key system functionality to enable the preparation of financial information on adoption. The impact of adoption of the standard to previously reported results is shown below. Balance at Balance at December 31, January 1, 2018 Adjustments 2019 Consolidated Balance Sheets Operating lease right-of-use assets $ — $ 83,222 $ 83,222 Prepaid and other 118,245 (1,383) 116,862 Property, plant and equipment 991,613 5,876 997,489 Current maturities of long-term obligations, net of unamortized debt issuance costs 62,678 2,631 65,309 Accounts payable, accrued and other liabilities 525,199 20,508 545,707 Operating lease liabilities — 61,331 61,331 Long-term obligations, net of unamortized debt issuance costs 1,125,993 3,245 1,129,238 In May 2014, the FASB issued ASU 2014-09, which amended the guidance for recognition of revenue from customer contracts. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in the amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. On January 1, 2018, we adopted this standard and all the related amendments (the “new revenue standard”) for all contracts. This adoption was accounted for using the modified retrospective method. We recognized the cumulative effect of initially applying the new revenue standard as an adjustment to the January 1, 2018 opening balance of retained earnings. Comparative information for the prior periods has not been restated and continues to be reported under the accounting standards in effect prior to January 1, 2018. Balance at Balance at December 31, 2017 Adjustment January 1, 2018 Consolidated Balance Sheets Assets Inventories $ 337,216 $ (7,064) $ 330,152 Prepaid and other 109,791 6,411 116,202 Liabilities Accounts payable, accrued and other liabilities 461,579 (5,706) 455,873 Deferred income taxes 20,995 1,292 22,287 Deferred and other non-current liabilities 5,608 824 6,432 Stockholders’ Equity Retained earnings 1,301,147 2,937 1,304,084 A majority of our sales revenue continues to be recognized when products are shipped from our manufacturing facilities. For certain custom product and tooling sales where revenue was previously recognized when the products were shipped, we now recognize revenue over the time required to manufacture the product or build the tool in accordance with the new revenue standard. We also have certain extended warranty contracts, which under the new standard are considered a separate performance obligation and are required to be deferred and recognized into revenue over the life of the agreement. In accordance with the new revenue standard requirements, the disclosure of the impact of adoption on our consolidated statements of income and balance sheets is as follows: For the Year Ended December 31, 2018 Balances Without Effect of As Adoption of Change Reported ASC 606 Higher/(Lower) Consolidated Statements of Income Net Sales Beauty + Home $ 1,426,382 $ 1,424,701 $ 1,681 Pharma 954,652 954,497 155 Food + Beverage 383,727 385,001 (1,274) Costs and Expenses Cost of sales (exclusive of depreciation and amortization) 1,812,961 1,811,290 1,671 Provision for income taxes 71,254 71,541 (287) Net income 194,766 195,588 (822) December 31, 2018 Balances Without Effect of As Adoption of Change Reported ASC 606 Higher/(Lower) Consolidated Balance Sheets Assets Inventories $ 381,110 $ 391,315 $ (10,205) Prepaid and other 118,245 108,490 9,755 Liabilities Accounts payable, accrued and other liabilities 525,199 529,168 (3,969) Deferred income taxes 53,917 52,912 1,005 Deferred and other non-current liabilities 23,465 23,066 399 Stockholders’ Equity Retained earnings 1,371,826 1,369,711 2,115 In January 2016, the FASB issued ASU 2016-01, which provides guidance on the classification and measurement of financial assets and liabilities (equity securities and financial liabilities) under the fair value option and the presentation and disclosure requirements for financial instruments. In February 2018, ASU 2018-03 was issued to clarify certain aspects of the guidance issued in January 2016. The guidance modifies how entities measure equity investments and present changes in the fair value of financial liabilities. Under the new guidance, entities measure equity investments that do not result in consolidation and are not accounted for under the equity method at fair value and recognize any related changes in fair value in net income unless the investments qualify for the new practicality exception. A measurement alternative exists for those equity investments that do not have a readily determinable fair value. These investments may be measured at cost less impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer. The standard also includes a new impairment model for equity investments without readily determinable fair values. The new model is a single-step model under which we are required to perform a qualitative assessment each reporting period to identify impairment. When a qualitative assessment indicates that an impairment exists, we will estimate the fair value of the investment and recognize in current earnings an impairment loss equal to the difference between the fair value and the carrying amount of the equity investment. The new standard is effective for fiscal years and interim periods beginning after December 15, 2017. We adopted the requirements of this standard during the first quarter of 2018. In November 2016, the FASB issued ASU 2016-18, which provides guidance to address the diversity in the classification and presentation of changes in restricted cash on the statement of cash flows. The amendments in this standard require that a statement of cash flows explain the change during the period in the total cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. The new standard is effective for fiscal years and interim periods beginning after December 15, 2017. We adopted the requirements of this standard during the first quarter of 2018 and appropriate disclosures are included on the statement of cash flows to the extent applicable. In February 2018, the FASB issued ASU 2018-02, which provides guidance on the reclassification of certain tax effects from accumulated other comprehensive income. This guidance allows for the reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the TCJA. The new standard is effective for fiscal years and interim periods beginning after December 15, 2018. We elected to early adopt this standard in the fourth quarter of 2018. As part of this adoption, we elected to reclassify $6.7 million of stranded income tax effects of the TCJA from accumulated other comprehensive income to retained earnings at the beginning of the fourth quarter of 2018. Other accounting standards that have been issued by the FASB or other standards-setting bodies did not have a material impact on our consolidated financial statements.

REVENUE

REVENUE	12 Months Ended
REVENUE	Dec. 31, 2019
REVENUE.
REVENUE	NOTE 2 REVENUE Revenue by segment and geography for the years ended December 31, 2019 and 2018 is as follows: For the Year Ended December 31, 2019 Latin Segment Europe Domestic America Asia Total Beauty + Home $ 792,255 $ 310,411 $ 160,048 $ 90,000 $ 1,352,714 Pharma 729,882 297,871 26,344 36,954 1,091,051 Food + Beverage 116,332 228,486 33,996 37,153 415,967 Total $ 1,638,469 $ 836,768 $ 220,388 $ 164,107 $ 2,859,732 For the Year Ended December 31, 2018 Latin Segment Europe Domestic America Asia Total Beauty + Home $ 816,359 $ 334,881 $ 178,392 $ 96,750 $ 1,426,382 Pharma 696,079 196,928 25,485 36,160 954,652 Food + Beverage 115,040 194,527 31,742 42,418 383,727 Total $ 1,627,478 $ 726,336 $ 235,619 $ 175,328 $ 2,764,761 Aptar performs its obligations under a contract with a customer by transferring goods and/or services in exchange for consideration from the customer. The timing of performance will sometimes differ from the timing of the receipt of the associated consideration from the customer, thus resulting in the recognition of a contract asset or a contract liability. Aptar recognizes a contract asset when it transfers control of goods or services to a customer prior to invoicing for the related performance obligation. The contract asset is transferred to accounts receivable when the product is shipped and invoiced to the customer. Aptar recognizes a contract liability if the customer's payment of consideration precedes the entity's performance. The opening and closing balances of Aptar’s contract asset and contract liabilities are as follows: Balance as of Balance as of Increase/ December 31, 2018 December 31, 2019 (Decrease) (opening) (closing) Contract asset (current) $ 15,858 $ 16,245 $ 387 Contract asset (long-term) $ — $ — $ — Contract liability (current) $ 68,134 $ 79,305 $ 11,171 Contract liability (long-term) $ 11,261 $ 9,779 $ (1,482) The differences in the opening and closing balances of our contract asset and contract liabilities are primarily the result of acquisitions and timing differences between our performance and the customer’s payment. The total amount of revenue recognized during the current year against contract liabilities is $61.3 million, including $32.6 million relating to contract liabilities at the beginning of the year. Determining the Transaction Price In most cases, the transaction price for each performance obligation is stated in the contract. In determining the variable amounts of consideration within the transaction price (such as volume-based customer rebates), Aptar includes an estimate of the expected amount of consideration as revenue. Aptar applies the expected value method based on all of the information (historical, current and forecast) that is reasonably available and identifies reasonable estimates based on this information. We apply the method consistently throughout the contract when estimating the effect of an uncertainty on the amount of variable consideration to which it will be entitled. Point in Time Performance Obligations For product and tooling sales considered to be point in time, Aptar typically assesses, among other things, the shipping terms of the contract, shipping being one of the indicators of transfer of control. For free on board (“FOB”) shipping point terms, revenue is recognized at the time of shipment. The performance obligation with respect to the sale of goods is satisfied at the time of shipment because the customer gains control at that time. Once the goods are shipped, we are precluded from redirecting the shipment to another customer. With respect to FOB destination sales, shipping and/or handling costs that occur before the customer obtains control of the goods are deemed to be fulfilment activities and are accounted for as fulfilment costs and revenue is recorded upon final delivery to the customer location. Over Time Performance Obligations For performance obligations related to manufacturing of highly customized products that have no alternative use for us and for which we have an enforceable right to payment for performance completed to date, we transfer control and recognize revenue over time by measuring progress towards complete satisfaction using the Output Method based on the number of products produced. For similar performance obligations related to our tooling sales, we transfer control and recognize revenue over time by measuring progress towards complete satisfaction using the Input Method based on costs incurred relative to total estimated costs to completion. We believe these measurements provide a faithful depiction of the transfer of goods as the costs incurred reflect the value of the products produced. Product Sales Aptar primarily manufactures dispensing systems for our Beauty + Home, Pharma and Food + Beverage customers. The amount of consideration is typically fixed for such customers. At the time of delivery, the customer is invoiced the agreed-upon price. Revenue from product sales is typically recognized upon manufacture or shipment, when control of the goods transfers to the customer. To determine when the control transfers, Aptar typically assesses, among other things, the shipping terms of the contract, shipping being one of the indicators of transfer of control. A majority of product sales are sold FOB shipping point. For FOB shipping point shipments, control of the goods transfers to the customer at the time of shipment of the goods. Therefore, Aptar's performance obligation is satisfied at the time of shipment. Aptar has elected to account for shipping and handling costs that occur after the customer has obtained control of a good as fulfillment costs rather than as a promised service. Aptar does not have any material significant payment terms as payment is typically received shortly after the point of sale. There also exist instances where Aptar manufactures highly customized products that have no alternative use to Aptar and for which Aptar has an enforceable right to payment for performance completed to date. For these products, we transfer control and recognizes revenue over time by measuring progress towards completion using the Output Method based on the number of products produced. As we normally make our products to a customer’s order, the time between production and shipment of our products is typically within a few weeks. As a part of its customary business practice, Aptar offers a standard warranty that the products will materially comply with the technical specifications and will be free from material defects. Because such warranties are not sold separately, do not provide for any service beyond a guarantee of a product’s initial specifications, and are not required by law, there is no revenue deferral for these types of warranties. Tooling Sales Aptar also builds or contracts for molds and other tools (collectively defined as “tooling”) necessary to produce our products. As with product sales, Aptar recognizes revenue when control of the tool transfers to the customer. If the tooling is highly customized with no alternative use to Aptar and Aptar has an enforceable right to payment for performance completed to date, we transfer control and recognize revenue over time by measuring progress towards completion using the Input Method based on costs incurred relative to total estimated costs to completion. Otherwise, revenue for the tooling is recognized at the point in time when the customer approves the tool. Aptar does not have any material significant payment terms as payment is typically either received during the mold-build process or shortly after completion. In certain instances, Aptar offers extended warranties on our tools above and beyond the normal standard warranties. Aptar normally receives payment at the inception of the contract and recognizes revenue over the term of the contract. At December 31, 2018, $758 thousand of unearned revenue associated with outstanding contracts was reported in Accounts Payable, Accrued and Other Liabilities. At December 31, 2019, the unearned amount was $515 thousand. Aptar expects to recognize approximately $228 thousand of the unearned amount in 2020 and $287 thousand thereafter. Service Sales Aptar also provides services to its pharmaceutical customers. As with product sales, Aptar recognizes revenue based on completion of each performance obligation of the service contract. Contract Costs Aptar does not incur significant costs to obtain or fulfill revenue contracts. Practical Expedients Significant financing component: Aptar elected not to adjust the promised consideration for the time value of money for contracts where the difference between the time of payment and performance is one year or less. Remaining performance obligations: Aptar elected not to disclose the aggregate amount of the transaction price allocated to remaining performance obligations for its contracts that are one year or less, as the revenue is expected to be recognized within the next year. In addition, we have elected not to disclose the expected consideration related to performance obligations where we recognize revenue in the amount it has a right to invoice (e.g., usage-based pricing terms).

INVENTORIES

INVENTORIES	12 Months Ended
INVENTORIES	Dec. 31, 2019
INVENTORIES
INVENTORIES	NOTE 3 INVENTORIES Inventories, by component net of reserves, consisted of: 2019 2018 Raw materials $ 111,653 $ 110,720 Work in process 123,750 131,091 Finished goods 140,392 139,299 Total $ 375,795 $ 381,110

GOODWILL AND OTHER INTANGIBLE A

GOODWILL AND OTHER INTANGIBLE ASSETS	12 Months Ended
GOODWILL AND OTHER INTANGIBLE ASSETS	Dec. 31, 2019
GOODWILL AND OTHER INTANGIBLE ASSETS
GOODWILL AND OTHER INTANGIBLE ASSETS	N OTE 4 GOODWILL AND OTHER INTANGIBLE ASSETS The changes in the carrying amount of goodwill for the year ended December 31, 2019 are as follows by reporting segment: Beauty + Food + Corporate Home Pharma Beverage & Other Total Balance as of December 31, 2017 Goodwill $ 223,947 $ 203,069 $ 16,871 $ 1,615 $ 445,502 Accumulated impairment losses — — — (1,615) (1,615) $ 223,947 $ 203,069 $ 16,871 $ — $ 443,887 Acquisition 5,565 174,343 103,678 — 283,586 Reallocation, net — (8,048) 8,048 — — Foreign currency exchange effects (5,579) (9,481) (318) — (15,378) Balance as of December 31, 2018 Goodwill $ 223,933 $ 359,883 $ 128,279 $ 1,615 $ 713,710 Accumulated impairment losses — — — (1,615) (1,615) $ 223,933 $ 359,883 $ 128,279 $ — $ 712,095 Acquisition — 57,934 — — 57,934 Foreign currency exchange effects (2,275) (4,167) (126) — (6,568) Balance as of December 31, 2019 Goodwill $ 221,658 $ 413,650 $ 128,153 $ 1,615 $ 765,076 Accumulated impairment losses — — — (1,615) (1,615) $ 221,658 $ 413,650 $ 128,153 $ — $ 763,461 During the fourth quarter of 2018, certain CSP Technologies product lines were transferred from Pharma segment to the Food + Beverage segment affecting the Active Packaging and Food + Beverage reporting units to better align our customer needs. The changes resulted in the reassignment of the assets and liabilities to the reporting units affected. The goodwill was reallocated to the reporting units affected using the relative fair value approach. During the third quarter of 2019, we performed a separate quantitative impairment assessment using a discounted cash flow analysis of the Active Packaging reporting unit, which was formed as a result of the CSP Technologies Acquisition in the third quarter of 2018. We calculated the fair value of the Active Packaging reporting unit and compared it with the associated carrying value (the “step one” approach) as of July 1, 2019. Based on this quantitative analysis, the fair value of the reporting unit exceeded the carrying value and therefore no impairment loss was recognized. We have completed the annual impairment analysis of our reporting units as of October 1, 2019 using a qualitative analysis of goodwill commonly referred to as the “step zero” approach for each of our reporting units. Based on our review of macroeconomic, industry, and market events and circumstances as well as the overall financial performance of the reporting units, we determined that it was more likely than not that the fair value of these reporting units was greater than their carrying amounts. No impairment was recognized during the years ended December 31, 2019, 2018 or 2017. The table below shows a summary of intangible assets for the years ended December 31, 2019 and 2018. 2019 2018 Weighted Average Gross Gross Amortization Period Carrying Accumulated Net Carrying Accumulated Net (Years) Amount Amortization Value Amount Amortization Value Amortized intangible assets: Patents 7.2 $ 2,804 (1,318) $ 1,486 $ 5,427 $ (5,294) $ 133 Acquired technology 13.0 100,511 (25,430) 75,081 92,389 (18,304) 74,085 Customer relationships 13.6 217,934 (33,924) 184,010 179,597 (20,439) 159,158 Trademarks and trade names 7.0 35,015 (11,003) 24,012 21,243 (5,914) 15,329 License agreements and other 10.3 16,153 (9,658) 6,495 13,852 (7,653) 6,199 Total intangible assets 12.6 $ 372,417 $ (81,333) $ 291,084 $ 312,508 $ (57,604) $ 254,904 Aggregate amortization expense for the intangible assets above for the years ended December 31, 2019, 2018 and 2017 was $27,608, $15,455 and $10,339 , respectively. Estimated amortization expense for the years ending December 31 is as follows: 2020 $ 31,135 2021 29,582 2022 29,343 2023 29,171 2024 and thereafter 171,853 Future amortization expense may fluctuate depending on changes in foreign currency rates. The estimates for amortization expense noted above are based upon foreign exchange rates as of December 31, 2019.

ACCOUNTS PAYABLE AND ACCRUED LI

ACCOUNTS PAYABLE AND ACCRUED LIABILITIES	12 Months Ended
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES	Dec. 31, 2019
ACCOUNTS PAYABLE, ACCRUED AND OTHER LIABILITIES.
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES	NOTE 5 ACCOUNTS PAYABLE, ACCRUED AND OTHER LIABILITIES At December 31, 2019 and 2018, accounts payable, accrued and other liabilities consisted of the following: 2019 2018 Accounts payable, principally trade $ 192,739 $ 164,528 Accrued employee compensation costs 163,839 168,349 Customer deposits and other unearned income 86,820 67,775 Other accrued liabilities 129,630 124,547 Total $ 573,028 $ 525,199

INCOME TAXES

INCOME TAXES	12 Months Ended
INCOME TAXES	Dec. 31, 2019
INCOME TAXES
INCOME TAXES	NOTE 6 INCOME TAXES On December 22, 2017, the U.S. enacted the Tax Cuts and Jobs Act (“TCJA”), which significantly changed U.S. tax law. The TCJA lowered the Company’s U.S. statutory federal income tax rate from 35% to 21% effective January 1, 2018, while imposing a deemed repatriation tax on previously deferred foreign income. The Company completed its accounting for the income tax effects of the TCJA during 2018, in accordance with the U.S. Securities and Exchange Commission Staff Accounting Bulletin No. 118. Income before income taxes consists of: Years Ended December 31, 2019 2018 2017 United States $ 94,612 $ 34,404 $ 36,139 International 247,457 231,616 258,686 Total $ 342,069 $ 266,020 $ 294,825 The provision (benefit) for income taxes is composed of: Years Ended December 31, 2019 2018 2017 Current: U.S. Federal $ 2,129 $ 10,273 $ (342) State/Local 883 877 230 International 88,084 83,456 72,670 $ 91,096 $ 94,606 $ 72,558 Deferred: U.S. Federal/State $ 4,670 $ (17,019) $ 2,570 International 4,076 (6,333) (332) $ 8,746 $ (23,352) $ 2,238 Total $ 99,842 $ 71,254 $ 74,796 The difference between the actual income tax provision and the tax provision computed by applying the statutory federal income tax rate of 21.0% in 2019 and 2018, and 35.0% in 2017 to income before income taxes is as follows: Years Ended December 31, 2019 2018 2017 Income tax at statutory rate $ 71,835 $ 55,864 $ 103,189 State income taxes (benefits), net of federal (tax) benefit 2,622 (1,516) (2,620) Investment incentives (2,530) (1,900) (1,900) Tax resolutions (1,915) (3,400) (5,188) Excess tax benefits from share-based compensation (12,520) (10,800) (10,383) Deferred benefits from tax rate changes — (2,800) (5,055) U.S. GILTI and BEAT (1,485) 5,625 — U.S. tax reform - transition tax — (2,570) 31,575 Results of forward contract — — (23,883) Valuation allowance 10,623 3,170 1,344 Rate differential on earnings of foreign operations 29,807 26,424 (16,097) Other items, net 3,405 3,157 3,814 Actual income tax provision $ 99,842 $ 71,254 $ 74,796 Effective income tax rate 29.2 % 26.8 % 25.4 % The 2019 tax provision was favorably impacted by excess tax benefits on deductible share-based compensation. The tax provision for 2019 reflects a $12.5 million benefit from this item. The mix of pretax income has an unfavorable impact, because the majority of our income is earned in higher tax jurisdictions. Additionally, we have incurred losses in jurisdictions where we cannot tax effect the loss. We have elected to account for the tax on the U.S. GILTI as a period cost and not as a measure of deferred taxes. The 2018 tax provision was favorably impacted by excess tax benefits on deductible stock compensation. The tax provision for 2018 reflects a $10.8 million benefit from this item. The mix of pretax income has an unfavorable impact, reflecting that the majority of our income is earned in higher tax jurisdictions. The U.S. GILTI tax and Base Erosion Anti-Abuse Tax (“BEAT”) also had a $5.6 million unfavorable impact. The 2017 tax provision was favorably impacted by the mix of pretax income in various non-U.S. tax jurisdictions. The tax provision for 2017 reflects $10.4 million related to the excess tax benefits on deductible stock compensation, which is new for 2017. The deferred tax benefit of $5.1 million is net of a provisional benefit of $6.8 million recorded for the change in the U.S. tax rate and a charge of $1.7 million for tax rate changes in France and Argentina. The $5.2 million related to tax resolutions includes an amount of $3.2 million related to uncertain tax positions in Europe. The remaining $2.0 million is a refund from a distribution tax paid in France. Furthermore, the tax provision for 2017 reflects a provisional charge of $31.6 million from the transition tax enacted as part of the U.S. tax reform. This was partially offset by a benefit of $23.9 million from the forward contracts discussed in Note 11 – Derivative Instruments and Hedging Activities. Significant deferred tax assets and liabilities as of December 31, 2019 and 2018 are composed of the following temporary differences: 2019 2018 Deferred Tax Assets: Net operating loss carryforwards $ 24,941 $ 22,462 Operating and finance leases 25,440 — Pension liabilities 24,925 15,405 Share-based compensation 6,082 10,130 U.S. federal tax credits 8,575 12,045 U.S. state tax credits 7,881 10,186 Vacation and bonus 7,645 6,891 Research and development 7,539 6,945 Inventory 5,993 6,038 Workers compensation 3,835 3,373 Other 16,496 13,985 Total gross deferred tax assets 139,352 107,460 Less valuation allowance (23,320) (11,189) Net deferred tax assets 116,032 96,271 Deferred Tax Liabilities: Acquisition related intangibles 62,851 59,004 Depreciation and amortization 28,284 31,140 Operating and finance leases 27,555 2,034 Other 6,215 10,351 Total gross deferred tax liabilities 124,905 102,529 Net deferred tax (liabilities) assets $ (8,873) $ (6,258) The $12.1 million increase in our valuation allowance in 2019 is primarily due to losses in foreign jurisdictions where we cannot record the benefit of the losses. We evaluate the deferred tax assets and record a valuation allowance when it is believed it is more likely than not that the benefit will not be realized. We have established a valuation allowance for $20.2 million of the $24.9 million of tax effected net operating loss carryforwards. These losses are generally in locations that have not produced cumulative three year operating profit. A valuation allowance of $3.1 million has also been established against the $7.9 million of U.S. state tax credit carryforwards. The U.S. federal tax credits will expire in the years 2026 and 2027. There is no expiration date on $20.8 million of the tax-effected net operating loss carryforwards and $4.1 million (tax effected) will expire in the years 2020 to 2038. The U.S. state tax credit carryforwards of $7.9 million (tax effected) will expire in the years 2020 to 2034. As a result of U.S. tax reform and the U.S. GILTI provisions, none of the non-U.S. unremitted earnings will be subject to U.S. taxation. We maintain our assertion that all other cash and distributable reserves at our non-U.S. affiliates will continue to be indefinitely reinvested. We estimate the amount of additional local and withholding tax that would be payable on distributions to be in the range of $20 million to $30 million. We have not provided for taxes on certain tax-deferred income of a foreign operation. The income arose predominately from government grants. Taxes of approximately $1.6 million would become payable in the event the terms of the grant are not fulfilled. Income Tax Uncertainties We provide a liability for the amount of tax benefits realized from uncertain tax positions. A reconciliation of the beginning and ending amount of income tax uncertainties is as follows: 2019 2018 2017 Balance at January 1 $ 3,559 $ 3,080 $ 6,356 Increases based on tax positions for the current year 412 360 370 Increases based on tax positions of prior years 663 610 1,562 Settlements (558) (491) (4,874) Lapse of statute of limitations (429) — (334) Balance at December 31 $ 3,647 $ 3,559 $ 3,080 The amount of income tax uncertainties that, if recognized, would impact the effective tax rate is approximately $3.6 million. We estimate that it is reasonably possible that the liability for uncertain tax positions will decrease no more than $1.8 million in the next twelve months from the resolution of various uncertain positions as a result of the completion of tax audits, litigation and the expiration of the statute of limitations in various jurisdictions. We recognize interest and penalties accrued related to unrecognized tax benefits as a component of income taxes. As of December 31, 2019, 2018 and 2017, we had approximately $1.7 million, $1.9 million and $1.6 million, respectively, accrued for the payment of interest and penalties, of which approximately $0.2 million was recognized as a tax benefit for the year ended 2019 and $0.4 million and $0.1 million was recognized in income tax expense in the years ended December 31, 2018 and 2017, respectively. Aptar or its subsidiaries file income tax returns in the U.S. Federal jurisdiction and various state and foreign jurisdictions. The major tax jurisdictions we file in, with the years still subject to income tax examinations, are listed below: Tax Years Major Tax Subject to Jurisdiction Examination United States — Federal 2014-2019 United States — State 2010-2019 France 2016-2019 Germany 2015-2019 Italy 2014-2019 China 2010-2019

DEBT

DEBT	12 Months Ended
DEBT	Dec. 31, 2019
DEBT
DEBT	NOTE 7 DEBT Notes Payable, Revolving Credit Facility and Overdrafts At December 31, 2019 and 2018, our notes payable, revolving credit facility and overdrafts, consisted of the following: 2019 2018 Revolving credit facility $ 25,000 $ 79,000 Notes payable 1,436 4,544 Overdrafts 17,823 17,749 $ 44,259 $ 101,293 We maintain a multi-currency revolving credit facility with two tranches that matures in July 2022 which provides for unsecured financing of up to $300 million that is available in the U.S. and up to €150 million that is available to our wholly-owned UK subsidiary. $25.0 million was utilized under our U.S. facility and no balance was utilized under our euro-based revolving credit facility as of December 31, 2019. No balance was utilized under our U.S. facility and €69.0 million was utilized under our euro-based revolving credit facility as of December 31, 2018. There are no compensating balance requirements associated with our revolving credit facility. Each borrowing under the credit facility will bear interest at rates based on LIBOR, prime rates or other similar rates, in each case plus an applicable margin. A facility fee on the total amount of the facility is also payable quarterly, regardless of usage. The applicable margins for borrowings under the credit facility and the facility fee percentage may change from time to time depending on changes in AptarGroup’s consolidated leverage ratio. We incurred approximately $1.5 million in interest and fees related to this credit facility during both 2019 and 2018. Average borrowings under the revolving credit facility and notes payable were $34.1 million and $40.0 million for 2019 and 2018, respectively. The average annual interest rate on the revolving credit facility and notes payable was 1.6% and 1.9% for 2019 and 2018, respectively. Long-Term Obligations At December 31, 2019, our long-term obligations consisted of the following: Unamortized Debt Issuance Principal Costs Net Notes payable 0.00% – 10.90% , due in monthly and annual installments through 2028 $ 19,220 $ — $ 19,220 Senior unsecured notes 3.2% , due in 2022 75,000 64 74,936 Senior unsecured debts 3.2% USD floating swapped to 1.36% EUR fixed, equal annual installments through 2022 168,000 390 167,610 Senior unsecured notes 3.5% , due in 2023 125,000 144 124,856 Senior unsecured notes 1.0% , due in 2023 112,170 356 111,814 Senior unsecured notes 3.4% , due in 2024 50,000 63 49,937 Senior unsecured notes 3.5% , due in 2024 100,000 144 99,856 Senior unsecured notes 1.2% , due in 2024 224,340 742 223,598 Senior unsecured notes 3.6% , due in 2025 125,000 169 124,831 Senior unsecured notes 3.6% , due in 2026 125,000 169 124,831 Finance Lease Liabilities 29,952 — 29,952 $ 1,153,682 $ 2,241 $ 1,151,441 Current maturities of long-term obligations (65,988) — (65,988) Total long-term obligations $ 1,087,694 $ 2,241 $ 1,085,453 At December 31, 2018, our long-term obligations consisted of the following: Unamortized Debt Issuance Principal Costs Net Notes payable 0.00% – 16.00% , due in monthly and annual installments through 2028 $ 15,531 $ — $ 15,531 Senior unsecured notes 3.2% , due in 2022 75,000 88 74,912 Senior unsecured debts 4.0% USD floating swapped to 1.36% EUR fixed, equal annual installments through 2022 224,000 541 223,459 Senior unsecured notes 3.5% , due in 2023 125,000 181 124,819 Senior unsecured notes 1.0% , due in 2023 114,535 432 114,103 Senior unsecured notes 3.4% , due in 2024 50,000 76 49,924 Senior unsecured notes 3.5% , due in 2024 100,000 181 99,819 Senior unsecured notes 1.2% , due in 2024 229,070 904 228,166 Senior unsecured notes 3.6% , due in 2025 125,000 207 124,793 Senior unsecured notes 3.6% , due in 2026 125,000 208 124,792 Capital lease obligations 8,353 — 8,353 $ 1,191,489 $ 2,818 $ 1,188,671 Current maturities of long-term obligations (62,678) — (62,678) Total long-term obligations $ 1,128,811 $ 2,818 $ 1,125,993 The aggregate long-term maturities, excluding finance lease liabilities, which are discussed in Note 8, due annually for the next five years are $61,670 , $61,337 , $135,324 , $239,826, $375,169 and $250,404 thereafter. Covenants Our revolving credit facility and corporate long-term obligations require us to satisfy certain financial and other covenants including: Requirement Level at December 31, 2019 Consolidated Leverage Ratio (1) Maximum of 3.50 to 1.00 1.71 to 1.00 Consolidated Interest Coverage Ratio (1) Minimum of 3.00 to 1.00 16.21 to 1.00 (1) Definitions of ratios are included as part of the revolving credit facility agreement and the private placement agreements .

LEASE COMMITMENTS

LEASE COMMITMENTS	12 Months Ended
LEASE COMMITMENTS	Dec. 31, 2019
LEASE COMMITMENTS
LEASE COMMITMENTS	NOTE 8 LEASE COMMITMENTS We lease certain warehouse, plant, and office facilities as well as certain equipment under noncancelable operating and finance leases expiring at various dates through the year 2032. Most of the operating leases contain renewal options and certain leases include options to purchase the related asset during or at the end of the lease term. Amortization expense related to finance leases is included in depreciation expense while rent expense related to operating leases is included within cost of sales and selling research & development and administrative expenses (“SG&A”). Rent expense related to operating leases (including taxes, insurance and maintenance when included in the rent) amounted to $32.7 million in 2018 under the old lease accounting standard. The components of lease expense for the current period were as follows: Year Ended December 31, 2019 Operating lease cost $ 23,410 Finance lease cost: Amortization of right-of-use assets $ 4,217 Interest on lease liabilities 1,353 Total finance lease cost $ 5,570 Short-term lease and variable lease costs $ 8,629 Supplemental cash flow information related to leases was as follows: Year Ended December 31, 2019 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 21,872 Operating cash flows from finance leases 1,245 Financing cash flows from finance leases 4,730 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 15,226 Finance leases 15,957 Supplemental balance sheet information related to leases was as follows: December 31, 2019 Operating Leases Operating lease right-of-use assets $ 72,377 Accounts payable, accrued and other liabilities $ 16,578 Operating lease liabilities 55,276 Total operating lease liabilities $ 71,854 Finance Leases Property, plant and equipment, gross $ 47,020 Accumulated depreciation (4,271) Property, plant and equipment, net $ 42,749 Current maturities of long-term obligations, net of unamortized debt issuance cost $ 4,318 Long-term obligations, net of unamortized debt issuance cost 25,634 Total finance lease liabilities $ 29,952 Weighted Average Remaining Lease Term (in years) Operating leases 6.1 Finance leases 7.0 Weighted Average Discount Rate Operating leases 5.05 % Finance leases 5.13 % Maturities of lease liabilities as of December 31, 2019, were as follows: Operating Finance Leases Leases Year 1 $ 19,652 $ 5,655 Year 2 15,411 4,787 Year 3 10,740 3,870 Year 4 9,365 3,099 Year 5 6,998 2,658 Thereafter 22,331 18,051 Total lease payments 84,497 38,120 Less imputed interest (12,643) (8,168) Total $ 71,854 $ 29,952 Maturities of lease liabilities as of December 31, 2018 under the old lease accounting standard were as follows: Operating Capital Leases Leases Year 1 $ 26,512 $ 1,828 Year 2 21,386 1,653 Year 3 16,529 1,546 Year 4 12,549 1,160 Year 5 10,225 880 Thereafter 21,932 3,827 Total lease payments $ 109,133 10,894 Less imputed interest (2,541) Present value of future lease payments $ 8,353 As of December 31, 2019, we have additional operating and finance leases, primarily for buildings, that have not yet commenced of $1.8 million. These operating and finance leases will commence in 2020 with lease terms of 3 to 10 years .

RETIREMENT AND DEFERRED COMPENS

RETIREMENT AND DEFERRED COMPENSATION PLANS	12 Months Ended
RETIREMENT AND DEFERRED COMPENSATION PLANS	Dec. 31, 2019
RETIREMENT AND DEFERRED COMPENSATION PLANS
RETIREMENT AND DEFERRED COMPENSATION PLANS	NOTE 9 RETIREMENT AND DEFERRED COMPENSATION PLANS We have various noncontributory retirement plans covering certain of our domestic and foreign employees. Benefits under our retirement plans are based on participants’ years of service and annual compensation as defined by each plan. Annual cash contributions to fund pension costs accrued under our domestic plans are generally at least equal to the minimum funding amounts required by the Employee Retirement Income Security Act of 1974, as amended (“ERISA”). Certain pension commitments under our foreign plans are also funded according to local requirements or at our discretion. The following table presents the changes in the benefit obligations and plan assets for the most recent two years for our domestic and foreign plans. Domestic Plans Foreign Plans 2019 2018 2019 2018 Change in benefit obligation: Benefit obligation at beginning of year $ 180,803 $ 198,450 $ 104,911 $ 109,030 Service cost 11,093 11,396 5,921 5,954 Interest cost 7,381 6,878 2,023 1,828 Special termination benefit charge — — 64 62 Plan Amendment — — 18 — Curtailment/Settlement — — (271) (1,751) Transfer — — 939 — Business acquired — — — 1,937 Prior service cost — — (451) 35 Actuarial loss (gain) 39,209 (23,510) 13,575 (3,743) Benefits paid (11,211) (12,411) (4,130) (3,288) Foreign currency translation adjustment — — (2,109) (5,153) Benefit obligation at end of year $ 227,275 $ 180,803 $ 120,490 $ 104,911 Domestic Plans Foreign Plans 2019 2018 2019 2018 Change in plan assets: Fair value of plan assets at beginning of year $ 169,958 $ 169,600 $ 68,992 $ 73,384 Actual return on plan assets 29,618 (7,642) 3,851 (487) Employer contribution 436 20,411 6,542 2,780 Benefits paid (11,211) (12,411) (4,130) (3,288) Transfer — — 359 — Foreign currency translation adjustment — — (1,425) (3,397) Fair value of plan assets at end of year $ 188,801 $ 169,958 $ 74,189 $ 68,992 Funded status at end of year $ (38,474) $ (10,845) $ (46,301) $ (35,919) The following table presents the funded status amounts recognized in our Consolidated Balance Sheets as of December 31, 2019 and 2018. Domestic Plans Foreign Plans 2019 2018 2019 2018 Non-current assets $ — $ 207 $ 938 $ 500 Current liabilities (449) (430) (44) (8) Non-current liabilities (38,025) (10,622) (47,195) (36,411) $ (38,474) $ (10,845) $ (46,301) $ (35,919) The following table presents the amounts not recognized as components of periodic benefit cost that are recognized in accumulated other comprehensive loss as of December 31, 2019 and 2018. Domestic Plans Foreign Plans 2019 2018 2019 2018 Net actuarial loss $ 68,789 $ 48,776 $ 40,442 $ 29,761 Net prior service cost — — 3,774 4,656 Tax effects (15,821) (17,876) (14,040) (4,855) $ 52,968 $ 30,900 $ 30,176 $ 29,562 Changes in benefit obligations and plan assets recognized in other comprehensive income in 2019, 2018 and 2017 are as follows: Domestic Plans 2019 2018 2017 Current year actuarial (loss) gain $ (21,970) $ 4,611 $ (12,593) Amortization of net loss 1,957 4,873 3,205 $ (20,013) $ 9,484 $ (9,388) Foreign Plans 2019 2018 2017 Current year actuarial (loss) gain $ (11,999) $ 534 $ 2,952 Current year prior service cost 451 (35) (1,399) Transfer Prior service Cost (18) — — Transfer Actuarial (loss) gain (126) — — Recognition due to curtailment — 1,692 — Amortization of net loss 1,444 1,716 1,895 Amortization of prior service cost 449 720 400 $ (9,799) $ 4,627 $ 3,848 The following table presents the amounts in accumulated other comprehensive loss as of December 31, 2019 expected to be recognized as components of periodic benefit cost in 2020. Domestic Plans Foreign Plans Amortization of net loss $ 5,719 $ 2,092 Amortization of prior service cost — 391 $ 5,719 $ 2,483 Components of net periodic benefit cost: Domestic Plans 2019 2018 2017 Service cost $ 11,093 $ 11,396 $ 9,706 Interest cost 7,381 6,878 7,010 Expected return on plan assets (12,379) (11,257) (9,880) Amortization of net loss 1,957 4,873 3,205 Net periodic benefit cost $ 8,052 $ 11,890 $ 10,041 Foreign Plans 2019 2018 2017 Service cost $ 5,921 $ 5,954 $ 5,526 Interest cost 2,023 1,828 1,747 Expected return on plan assets (2,366) (2,610) (2,409) Amortization of net loss 1,444 1,716 1,895 Amortization of prior service cost 449 720 400 Net periodic benefit cost $ 7,471 $ 7,608 $ 7,159 Curtailment (246) (59) — Special termination benefit charge 65 62 — Total Net periodic benefit cost $ 7,290 $ 7,611 $ 7,159 The accumulated benefit obligation (“ABO”) for our domestic defined benefit pension plans was $205.3 million and $163.0 million at December 31, 2019 and 2018, respectively. The ABO for our foreign defined benefit pension plans was $91.8 million and $80.9 million at December 31, 2019 and 2018, respectively. The following table provides the projected benefit obligation (“PBO”), ABO, and fair value of plan assets for all pension plans with an ABO in excess of plan assets as of December 31, 2019 and 2018. Domestic Plans Foreign Plans 2019 2018 2019 2018 Projected benefit obligation $ 227,275 $ 11,052 $ 92,561 $ 93,029 Accumulated benefit obligation 205,326 9,216 65,062 68,981 Fair value of plan assets 188,801 — 46,371 56,611 The following table provides the PBO, ABO and fair value of plan assets for all pension plans with a PBO in excess of plan assets as of December 31, 2019 and 2018. Domestic Plans Foreign Plans 2019 2018 2019 2018 Projected benefit obligation $ 227,275 $ 11,052 $ 102,310 $ 92,555 Accumulated benefit obligation 205,326 9,216 73,943 68,506 Fair value of plan assets 188,801 — 55,260 56,136 During 2018, our domestic employee retirement plan has plan assets in excess of the PBO. Assumptions: Domestic Plans Foreign Plans 2019 2018 2017 2019 2018 2017 Weighted-average assumptions used to determine benefit obligations at December 31: Discount rate 3.20 % 4.20 % 3.55 % 1.04 % 1.82 % 1.62 % Rate of compensation increase 4.00 % 4.00 % 4.00 % 3.05 % 3.01 % 3.02 % Weighted-average assumptions used to determine net periodic benefit cost for years ended December 31: Discount rate 4.20 % 3.55 % 4.05 % 1.84 % 1.62 % 1.65 % Expected long-term return on plan assets 7.00 % 7.00 % 7.00 % 3.69 % 3.66 % 3.66 % Rate of compensation increase 4.00 % 4.00 % 4.00 % 3.05 % 3.02 % 3.00 % We develop the expected long-term rate of return assumptions based on historical experience and by evaluating input from the plans’ asset managers, including the managers’ review of asset class return expectations and benchmarks, economic indicators and long-term inflation assumptions. In order to determine the 2020 net periodic benefit cost, we expect to use the December 31, 2019 discount rates, December 31, 2019 rates of compensation increase assumptions and the same assumed long-term returns on domestic and foreign plan assets used for the 2019 net periodic benefit cost. Our domestic and foreign pension plan weighted-average asset allocations at December 31, 2019 and 2018 by asset category are as follows: Plan Assets: Domestic Plans Assets Foreign Plans Assets at December 31, at December 31, 2019 2018 2019 2018 Equity securities 49 % 44 % 4 % 4 % Fixed income securities 29 % 29 % 1 % 1 % Corporate debt securities — — 3 % 3 % Infrastructure 6 % 7 % — — Hedge funds 10 % 10 % — — Money market 1 % 5 % 3 % 1 % Investment Funds — — 89 % 91 % Real estate 5 % 5 % — — Total 100 % 100 % 100 % 100 % Our investment strategy for our domestic and foreign pension plans is to maximize the long-term rate of return on plan assets within an acceptable level of risk. The investment policy strives to have assets sufficiently diversified so that adverse or unexpected results from one security type will not have an unduly detrimental impact on the entire portfolio and accordingly, establishes a target allocation for each asset category within the portfolio. The domestic plan asset allocation is reviewed on a quarterly basis and the foreign plan asset allocation is reviewed annually. Rebalancing occurs as needed to comply with the investment strategy. The domestic plan target allocation for 2020 is 60% equity securities and 40% fixed income securities and infrastructure. The foreign plan target allocation for 2020 is 100% investment funds. Authoritative guidelines require the categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment. The three levels are defined as follows: ● Level 1: Unadjusted quoted prices in active markets for identical assets and liabilities. ● Level 2: Observable inputs other than those included in Level 1. For example, quoted prices for similar assets or liabilities in active markets or quoted prices for identical assets or liabilities in inactive markets. ● Level 3: Unobservable inputs reflecting management’s own assumptions about the inputs used in pricing the asset or liability. Domestic Fair Value Measurement Foreign Fair Value Measurement at December 31, 2019 at December 31, 2019 (In Thousands $) Total (Level 1) (Level 2) (Level 3) Total (Level 1) (Level 2) (Level 3) Cash and Short-term Securities (a) $ 1,988 $ 1,988 $ — $ — $ 2,030 $ 2,030 $ — $ — USD — 1,988 — — — — — — EUR — — — — — 2,012 — — Others — — — — — 18 — — Equity Securities (a) $ 81,997 $ 81,997 — — $ 2,995 $ 2,995 — — U.S. Large Cap Equities — 48,580 — — — — — — U.S. Small Cap Equities — 9,921 — — — — — — International Equities — 23,496 — — — 2,995 — — Fixed Income (a&b) $ 35,898 $ 35,898 — — $ 820 $ 820 — — Corporate debts securities — — — — $ 2,115 $ 2,115 — — Euro Corporate Bonds (a) — — — — — 2,115 — — Investment Funds — — — — $ 66,229 $ 23,797 $ 42,432 — Mutual Funds in Equities (a) — — — — — 4,025 — — Mutual Funds in Bonds (a) — — — — — 18,881 — — Mutual Funds Diversified (a&b) — — — — — 891 42,432 — Total Investments in Fair Value Hierarchy $ 119,883 $ 119,883 $ — $ — $ 74,189 $ 31,757 $ 42,432 $ — Investments at Net Asset Value per Share 68,918 — — — — — — — Total Investments $ 188,801 $ 119,883 $ — $ — $ 74,189 $ 31,757 $ 42,432 $ — Domestic Fair Value Measurement Foreign Fair Value Measurement at December 31, 2018 at December 31, 2018 (In Thousands $) Total (Level 1) (Level 2) (Level 3) Total (Level 1) (Level 2) (Level 3) Cash and Short-term Securities (a) $ 8,964 $ 8,964 $ — $ — $ 718 $ 718 $ — $ — USD — 8,964 — — — — — — EUR — — — — — 718 — — Equity Securities (a) $ 66,707 $ 66,707 — — $ 2,591 $ 2,591 — — U.S. Large Cap Equities — 38,804 — — — — — — U.S. Small Cap Equities — 7,747 — — — — — — International Equities — 20,156 — — — 2,591 — — Fixed Income (a&b) $ 32,272 $ 32,272 — — $ 717 $ 717 — — Corporate debts securities — — — — $ 2,097 $ 2,097 — — Euro Corporate Bonds (a) — — — — — 2,097 — — Investment Funds — — — — $ 62,869 $ 22,122 $ 40,747 — Mutual Funds in Equities (a) — — — — — 3,339 — — Mutual Funds in Bonds (a) — — — — — 18,060 — — Mutual Funds Diversified (a&b) — — — — — 723 40,747 — Total Investments in Fair Value Hierarchy $ 107,943 $ 107,943 $ — $ — $ 68,992 $ 28,245 $ 40,747 $ — Investments at Net Asset Value per Share 62,015 — — — — — — — Total Investments $ 169,958 $ 107,943 $ — $ — $ 68,992 $ 28,245 $ 40,747 $ — (a) Based on third party quotation from financial institution. (b) Based on observable market transactions. Contributions Annual cash contributions to fund pension costs accrued under our domestic plans are generally at least equal to the minimum funding amounts required by ERISA. We contributed $0.4 million to our domestic defined benefit plans in 2019 and although we have no minimum funding requirement, we plan to contribute approximately $0.4 million to pay our ongoing SERP annuity contracts in 2020. Contributions to fund pension costs accrued under our foreign plans are made in accordance with local laws or at our discretion. We contributed approximately $6.5 million to our foreign defined benefit plan in 2019 and expect to contribute approximately $0.7 million in 2020. Estimated Future Benefit Payments As of December 31, 2019, we expect the plans to make the following estimated benefit payments relating to our defined benefit plans over the next ten years: Domestic Plans Foreign Plans 2020 $ 11,064 $ 5,382 2021 11,134 2,904 2022 11,665 3,155 2023 12,467 4,676 2024 13,077 6,537 2025 - 2029 74,584 34,386 Other Plans We have a non-qualified supplemental pension plan for domestic employees which provides for pension amounts that would have been payable from our principal domestic pension plan if it were not for limitations imposed by income tax regulations. The liability for this plan, which is not funded, was $12.6 million and $11.1 million at December 31, 2019 and 2018, respectively. This amount is included in the liability for domestic plans shown above. We have a defined contribution 401(k) employee savings plan available to substantially all domestic employees. Company matching contributions are made in cash up to a maximum of 3% of the participating employee’s salary subject to income tax regulations. For each of the years ended December 31, 2019, 2018 and 2017, total contributions made to these plans were approximately $4.1 million, $3.7 million and $3.3 million, respectively. We have several foreign defined contribution plans, which require us to contribute a percentage of the participating employee’s salary according to local regulations. For each of the years ended December 31, 2019, 2018 and 2017, total contributions made to these plans were approximately $2.3 million, $2.4 million and $2.2 million, respectively. We have no additional postretirement or postemployment benefit plans.

ACCUMULATED OTHER COMPREHENSIVE

ACCUMULATED OTHER COMPREHENSIVE INCOME	12 Months Ended
ACCUMULATED OTHER COMPREHENSIVE INCOME	Dec. 31, 2019
ACCUMULATED OTHER COMPREHENSIVE INCOME
ACCUMULATED OTHER COMPREHENSIVE INCOME	NOTE 10 ACCUMULATED OTHER COMPREHENSIVE INCOME/(LOSS) Changes in Accumulated Other Comprehensive Income/(Loss) by Component: Foreign Defined Benefit Currency Pension Plans Derivatives Total Balance - December 31, 2016 $ (259,888) $ (59,775) $ (46) $ (319,709) Other comprehensive income (loss) before reclassifications 74,385 (8,944) (11,806) 53,635 Amounts reclassified from accumulated other comprehensive income (loss) — 4,124 8,648 12,772 Net current-period other comprehensive income (loss) 74,385 (4,820) (3,158) 66,407 Balance - December 31, 2017 $ (185,503) $ (64,595) $ (3,204) $ (253,302) Other comprehensive (loss) income before reclassifications (62,898) 5,266 16,624 (41,008) Amounts reclassified from accumulated other comprehensive income (loss) — 5,524 (15,060) (9,536) Net current-period other comprehensive (loss) income (62,898) 10,790 1,564 (50,544) Reclassification of stranded tax effects — (6,658) — (6,658) Balance - December 31, 2018 $ (248,401) $ (60,463) $ (1,640) $ (310,504) Other comprehensive (loss) income before reclassifications (8,723) (25,557) 8,026 (26,254) Amounts reclassified from accumulated other comprehensive income (loss) — 2,873 (8,063) (5,190) Net current-period other comprehensive (loss) income (8,723) (22,684) (37) (31,444) Balance - December 31, 2019 $ (257,124) $ (83,147) $ (1,677) $ (341,948) Reclassifications Out of Accumulated Other Comprehensive Income/(Loss): Amount Reclassified from Details about Accumulated Other Accumulated Other Affected Line in the Statement Comprehensive Income Components Comprehensive Income Where Net Income is Presented Year Ended December 31, 2019 2018 2017 Defined Benefit Pension Plans Amortization of net loss $ 3,401 $ 6,589 $ 5,100 (1) Amortization of prior service cost 449 720 400 (1) 3,850 7,309 5,500 Total before tax (977) (1,785) (1,376) Tax benefit $ 2,873 $ 5,524 $ 4,124 Net of tax Derivatives Changes in treasury locks $ — $ 26 $ 42 Interest Expense Changes in cross currency swap: interest component (4,805) (5,150) (1,526) Interest Expense Changes in cross currency swap: foreign exchange component (3,258) (13,025) 11,911 Miscellaneous, net (8,063) (18,149) 10,427 Total before tax — 3,089 (1,779) Tax benefit $ (8,063) $ (15,060) $ 8,648 Net of tax Total reclassifications for the period $ (5,190) $ (9,536) $ 12,772 (1) These accumulated other comprehensive income components are included in the computation of total net periodic benefit costs, net of tax (see Note 9 - Retirement and Deferred Compensation Plans for additional details).

DERIVATIVE INSTRUMENTS AND HEDG

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES	12 Months Ended
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES	Dec. 31, 2019
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES	NOTE 11 DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES We maintain a foreign exchange risk management policy designed to establish a framework to protect the value of our non-functional currency denominated transactions from adverse changes in exchange rates. Sales of our products can be denominated in a currency different from the currency in which the related costs to produce the product are denominated. Changes in exchange rates on such inter-country sales or intercompany loans can impact our results of operations. Our policy is not to engage in speculative foreign currency hedging activities, but to minimize our net foreign currency transaction exposure defined as firm commitments and transactions recorded and denominated in currencies other than the functional currency. We may use foreign currency forward exchange contracts, options and cross currency swaps to economically hedge these risks. For derivative instruments designated as hedges, we formally document the nature and relationships between the hedging instruments and the hedged items, as well as the risk management objectives, strategies for undertaking the various hedge transactions, and the method of assessing hedge effectiveness at inception. Quarterly thereafter, we formally assess whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in the fair value or cash flows of the hedged item. Additionally, in order to designate any derivative instrument as a hedge of an anticipated transaction, the significant characteristics and expected terms of any anticipated transaction must be specifically identified, and it must be probable that the anticipated transaction will occur. All derivative financial instruments used as hedges are recorded at fair value in the Consolidated Balance Sheets (See Note 12 – Fair Value). Cash Flow Hedge For derivative instruments that are designated and qualify as cash flow hedges, the changes in fair values are recorded in accumulated other comprehensive loss and included in changes in derivative gain/loss. The changes in the fair values of derivatives designated as cash flow hedges are reclassified from accumulated other comprehensive loss to net income when the underlying hedged item is recognized in earnings. Cash flows from the settlement of derivative contracts designated as cash flow hedges offset cash flows from the underlying hedged items and are included in operating activities in the Consolidated Statements of Cash Flows. As disclosed in Note 7 – Debt, our wholly owned UK subsidiary borrowed $280 million in term loan borrowings under a new credit facility. In order to mitigate the currency risk of U.S. dollar debt on a euro functional currency entity and to mitigate the risk of variability in interest rates, we entered into a EUR/USD floating-to-fixed cross currency swap on July 20, 2017 in the notional amount of $280 million to effectively hedge the foreign exchange and interest rate exposure on the $280 million term loan. Related to this hedge, approximately $1.7 million and $1.6 million, respectively, of net after-tax loss is included in accumulated other comprehensive loss at December 31, 2019 and 2018. The amount expected to be recognized into earnings during the next 12 months related to the interest component of our cross currency swap, based on prevailing foreign exchange and interest rates at December 31, 2019, is $2.8 million. The amount expected to be recognized into earnings during the next 12 months related to the foreign exchange component of our cross currency swap is dependent on fluctuations in currency exchange rates. As of December 31, 2019, the fair value of the cross currency swap was a $2.6 million asset. The swap contract expires on July 20, 2022. Hedge of Net Investments in Foreign Operations A significant number of our operations are located outside of the United States. Because of this, movements in exchange rates may have a significant impact on the translation of the financial condition and results of operations of our foreign entities. A weakening U.S. dollar relative to foreign currencies has an additive translation effect on our financial condition and results of operations. Conversely, a strengthening U.S. dollar has a dilutive effect. In some cases we maintain debt in these subsidiaries to offset the net asset exposure. We do not otherwise actively manage this risk using derivative financial instruments. In the event we plan on a full or partial liquidation of any of our foreign subsidiaries where our net investment is likely to be monetized, we will consider hedging the currency exposure associated with such a transaction. Other As of December 31, 2019, we have recorded the fair value of foreign currency forward exchange contracts of $0.2 million in prepaid and other and $0.4 million in accounts payable, accrued and other liabilities in the balance sheet. All forward exchange contracts outstanding as of December 31, 2019 had an aggregate notional contract amount of $51.5 million. Fair Value of Derivative Instruments in the Consolidated Balance Sheets as of December 31, 2019 and December 31, 2018 December 31, 2019 December 31, 2018 Derivatives Derivatives Derivatives not Derivatives not Designated Designated Designated Designated Balance Sheet as Hedging as Hedging as Hedging as Hedging Location Instruments Instruments Instruments Instruments Derivative Assets Foreign Exchange Contracts Prepaid and other $ — $ 206 $ — $ 259 Cross Currency Swap Contract (1) Prepaid and other 2,552 — — — $ 2,552 $ 206 $ — $ 259 Derivative Liabilities Foreign Exchange Contracts Accounts payable, accrued and other liabilities $ — $ 401 $ — $ 331 Cross Currency Swap Contract (1) Accounts payable, accrued and other liabilities — — 1,040 — $ — $ 401 $ 1,040 $ 331 (1) This cross currency swap contract is composed of both an interest component and a foreign exchange component. The Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income (Loss) for the Fiscal Years Ended December 31, 2019 and December 31, 2018 Amount of Gain (Loss) Total Amount Amount of Gain (Loss) Location of (Loss) Reclassified from of Affected Derivatives in Cash Recognized in Gain Recognized Accumulated Income Flow Hedging Other Comprehensive in Income on Other Comprehensive Statement Relationships Income on Derivative Derivatives Income on Derivative Line Item 2019 2018 2019 2018 Cross currency swap contract: Interest component $ 5,103 $ 7,014 Interest expense $ 4,805 $ 5,150 $ (35,489) Foreign exchange component 3,258 13,025 Miscellaneous, net 3,258 13,025 1,556 $ 8,361 $ 20,039 $ 8,063 $ 18,175 The Effect of Derivatives Not Designated as Hedging Instruments on the Consolidated Statements of Income for the Fiscal Years Ended December 31, 2019 and December 31, 2018 Amount of (Loss) Gain Derivatives Not Designated Location of (Loss) Gain Recognized Recognized in Income as Hedging Instruments in Income on Derivatives on Derivatives 2019 2018 Foreign Exchange Contracts Other (Expense) Income: $ (141) $ 652 $ (141) $ 652 Gross Amounts not Offset Gross Amounts Net Amounts in the Statement of Offset in the Presented in Financial Position Gross Statement of the Statement of Financial Cash Collateral Net Amount Financial Position Financial Position Instruments Received Amount Description December 31, 2019 Derivative Assets $ 2,758 — $ 2,758 — — $ 2,758 Total Assets $ 2,758 — $ 2,758 — — $ 2,758 Derivative Liabilities $ 401 — $ 401 — — $ 401 Total Liabilities $ 401 — $ 401 — — $ 401 December 31, 2018 Derivative Assets $ 259 — $ 259 — — $ 259 Total Assets $ 259 — $ 259 — — $ 259 Derivative Liabilities $ 1,371 — $ 1,371 — — $ 1,371 Total Liabilities $ 1,371 — $ 1,371 — — $ 1,371

FAIR VALUE

FAIR VALUE	12 Months Ended
FAIR VALUE	Dec. 31, 2019
FAIR VALUE
FAIR VALUE	NOTE 12 FAIR VALUE Authoritative guidelines require the categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment. The three levels are defined as follows: ● Level 1: Unadjusted quoted prices in active markets for identical assets and liabilities. ● Level 2: Observable inputs other than those included in Level 1. For example, quoted prices for similar assets or liabilities in active markets or quoted prices for identical assets or liabilities in inactive markets. ● Level 3: Unobservable inputs reflecting management’s own assumptions about the inputs used in pricing the asset or liability. As of December 31, 2019, the fair values of our financial assets and liabilities were categorized as follows: Total Level 1 Level 2 Level 3 Assets Foreign exchange contracts (1) $ 206 $ — $ 206 $ — Cross currency swap contract (1) 2,552 — 2,552 — Total assets at fair value $ 2,758 $ — $ 2,758 $ — Liabilities Foreign exchange contracts (1) $ 401 $ — $ 401 $ — Contingent consideration obligation 5,930 — — 5,930 Total liabilities at fair value $ 6,331 $ — $ 401 $ 5,930 As of December 31, 2018, the fair values of our financial assets and liabilities were categorized as follows: Total Level 1 Level 2 Level 3 Assets Foreign exchange contracts (1) $ 259 $ — $ 259 $ — Total assets at fair value $ 259 $ — $ 259 $ — Liabilities Foreign exchange contracts (1) $ 331 $ — $ 331 $ — Cross currency swap contract (1) 1,040 — 1,040 — Total liabilities at fair value $ 1,371 $ — $ 1,371 $ — (1) Market approach valuation technique based on observable market transactions of spot and forward rates. The carrying amounts of our other current financial instruments such as cash and equivalents, accounts and notes receivable, notes payable and current maturities of long-term obligations approximate fair value due to the short-term maturity of the instrument. We consider our long-term obligations a Level 2 liability and utilize the market approach valuation technique based on interest rates that are currently available to us for issuance of debt with similar terms and maturities. The estimated fair value of our long-term obligations was $1.1 billion as of December 31, 2019 and December 31, 2018. As discussed in Note 20 – Acquisitions, we have a contingent consideration obligation to the selling equity holders of Noble in connection with the Noble Acquisition (as defined herein) based on 2024 cumulative performance targets and a contingent consideration obligation to the selling equity holder of Gateway in connection with the Gateway Acquisitions (as defined herein) based on 2020 and 2022 performance targets. We consider these obligations a Level 3 liability and have estimated the aggregate fair value for these contingent consideration arrangements to be $2.9 million and $3.0 million, respectively, as of December 31, 2019. Additionally, during the year ended December 31, 2018, we had a contingent consideration obligation to the selling shareholders of Reboul SAS (“Reboul”) in connection with the Reboul Acquisition (as defined herein) based on 2018 earnings before net interest, taxes, depreciation and amortization (“EBITDA”). We consider this obligation a Level 3 liability; however, we estimated the aggregate fair value for this contingent consideration arrangement to be zero as of December 31, 2018.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
COMMITMENTS AND CONTINGENCIES	Dec. 31, 2019
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES	NOTE 13 COMMITMENTS AND CONTINGENCIES In the normal course of business, we are subject to a number of lawsuits and claims both actual and potential in nature. While management believes the resolution of these claims and lawsuits will not have a material adverse effect on our financial position or results of operations or cash flows, claims and legal proceedings are subject to inherent uncertainties, and unfavorable outcomes could occur that could include amounts in excess of any accruals which management has established. Were such unfavorable final outcomes to occur, it is possible that they could have a material adverse effect on our financial position, results of operations and cash flows. Under our Certificate of Incorporation, we have agreed to indemnify our officers and directors for certain events or occurrences while the officer or director is, or was, serving at our request in such capacity. The maximum potential amount of future payments we could be required to make under these indemnification agreements is unlimited; however, we have a directors and officers liability insurance policy that covers a portion of our exposure. As a result of our insurance policy coverage, we believe the estimated fair value of these indemnification agreements is minimal. We have no liabilities recorded for these agreements as of December 31, 2019. An environmental investigation, undertaken to assess areas of possible contamination, was completed at our facility in Jundiaí, São Paulo, Brazil. The facility is primarily an internal supplier of anodized aluminum components for certain of our dispensing systems. The testing indicated that soil and groundwater in certain areas of the facility were impacted above acceptable levels established by local regulations. In March 2017, we reported the findings to the relevant environmental authority, the Environmental Company of the State of São Paulo – CETESB. Based upon our best estimate, we recorded a reserve of $1.5 million (operating expense) in the first quarter of 2017 relating to this contingency. For the year ended December 31, 2019, we have paid approximately $0.6 million and made adjustments to the accrual based on our future anticipated expenditures. As of December 31, 2019, our outstanding reserve is $0.5 million. The ultimate loss associated with this environmental contingency is subject to the investigation and ongoing review of the CETESB. We will continue to evaluate the range of likely costs as the investigation proceeds and we have further clarity on the nature and extent of remediation that will be required. We note that the contamination, or any failure to complete any required remediation in a timely manner, could potentially result in fines or penalties. In March 2017, the Supreme Court of Brazil issued a decision that a certain state value added tax should not be included in the calculation of federal gross receipts taxes. The decision reduces our gross receipts tax in Brazil prospectively and, potentially, retrospectively. During the first quarter of 2019, we received a favorable court decision of $2.7 million for the retrospective right to recover part of our claim. This amount is recorded in cost of sales as a favorable impact of $1.7 million and $1.0 million was recognized as interest income. During the fourth quarter of 2018, we recorded an amount of $631 thousand based on the favorable court decision. If the Judicial Court grants full retrospective recovery, we estimate remaining potential recoveries of approximately $3 million to $10 million, including interest, depending on the future decisions of the Supreme Court of Brazil. Due to uncertainties around our remaining court recovery claims, we have not recorded any further amounts relating to the retrospective nature of this matter. In December 2019, tax authorities in Brazil notified us of a tax assessment of approximately $7.9 million, including interest and penalties of $3.0 million and $1.0 million, respectively, relating to differences in tax classification codes used for import duties for the period from January 2015 to August 2018. We are vigorously contesting the assessment, including interest and penalties, and have filed an administrative defense appeal in December 2019. Considering the complex nature of the assessment, we expect the appeal process to go through different levels of administrative and/or judicial processes. Accordingly, due to uncertainty of the timing and amounts of assessment, no liability is recorded as of December 31, 2019.

STOCK REPURCHASE PROGRAM

STOCK REPURCHASE PROGRAM	12 Months Ended
STOCK REPURCHASE PROGRAM	Dec. 31, 2019
STOCK REPURCHASE PROGRAM
STOCK REPURCHASE PROGRAM	NOTE 14 STOCK REPURCHASE PROGRAM We announced the $350 million share repurchase program in effect for the year ended December 31, 2018 on October 20, 2016. On April 18, 2019, we announced a new share repurchase authorization of up to $350 million of common stock. This authorization replaces previous authorizations and has no expiration date. Aptar may repurchase shares through the open market, privately negotiated transactions or other programs, subject to market conditions. In 2019 and 2018, we repurchased approximately 779 thousand and 668 thousand shares of our outstanding common stock at a total cost of $86.5 million and $61.7 million, respectively. As of December 31, 2019, there was $278.5 million of authorized share repurchases available to us.

CAPITAL STOCK

CAPITAL STOCK	12 Months Ended
CAPITAL STOCK	Dec. 31, 2019
CAPITAL STOCK
CAPITAL STOCK	NOTE 15 CAPITAL STOCK We have 199 million authorized shares of common stock. The number of shares of common stock and treasury stock and the share activity were as follows: Common Shares Treasury Shares 2019 2018 2019 2018 Balance at the beginning of the year 67,341,316 66,742,490 4,424,884 4,881,889 Employee option exercises 1,079,841 1,182,547 (367,705) (502,005) Director option exercises 146,083 — — — Restricted stock vestings 41,268 39,691 — — Common stock repurchases — — 778,848 45,000 Common stock repurchased and retired — (623,412) — — Balance at the end of the year 68,608,508 67,341,316 4,836,027 4,424,884 The cash dividends paid on the common stock for the years ended December 31, 2019, 2018 and 2017 aggregated $90.2 million, $82.3 million and $79.9 million, respectively.

STOCK-BASED COMPENSATION

STOCK-BASED COMPENSATION	12 Months Ended
STOCK-BASED COMPENSATION	Dec. 31, 2019
STOCK-BASED COMPENSATION
STOCK-BASED COMPENSATION	NOTE 16 STOCK-BASED COMPENSATION Historically we have issued stock options and restricted stock units (“RSUs”), which consist of time-based and performance-based awards, to employees under stock awards plans approved by stockholders. In addition, RSUs are issued to non-employee directors under a Restricted Stock Unit Award Agreement for Directors pursuant to the 2018 Equity Incentive Plan. Previously, non-employee directors were issued stock options under a Director Stock Option Plan. Stock options are awarded with the exercise price equal to the market price on the date of grant and generally vest over three years and expire 10 years after grant. RSUs granted to employees vest according to a specified performance period and/or vesting period. Time-based RSUs generally vest over three years . Performance-based RSUs vest at the end of the specified performance period, generally three years , assuming required performance or market vesting conditions are met. Performance-based RSUs have one of two vesting conditions: (1) based on Aptar’s internal financial performance metrics and (2) based on Aptar’s total shareholder return (“TSR”) relative to total shareholder returns of an industrial peer group, subject to discretion if the overall TSR is negative at the conclusion of the performance period. At the time of vesting, Aptar will issue or cause to be issued in the employee’s name the vested shares of common stock. In addition, RSU awards are generally net settled (shares are withheld to cover the employee tax obligation). Director RSUs are only time-based and generally vest over one year . Compensation expense recorded attributable to stock options for the year ended December 31, 2019 was approximately $5.7 million ( $4.5 million after tax). Approximately $4.8 million of the compensation expense was recorded in SG&A expenses and the balance was recorded in cost of sales. Compensation expense recorded attributable to stock options for the year ended December 31, 2018 was approximately $10.9 million ( $8.4 million after tax). Approximately $8.7 million of the compensation expense was recorded in SG&A and the balance was recorded in cost of sales. Compensation expense recorded attributable to stock options for the year ended December 31, 2017 was approximately $15.2 million ( $10.5 million after tax). Approximately $13.2 million of the compensation expense was recorded in SG&A expenses and the balance was recorded in cost of sales. For stock option grants, we used historical data to estimate expected life and volatility. The weighted-average fair value of stock options granted under the Stock Awards Plans was $14.82 and $11.86 per share in 2018 and 2017, respectively. These values were estimated on the respective dates of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions: Stock Awards Plans: Years Ended December 31, 2018 2017 Dividend Yield 1.5 % 1.7 % Expected Stock Price Volatility 14.2 % 15.8 % Risk-free Interest Rate 2.8 % 2.2 % Expected Life of Option (years) 6.6 6.7 A summary of option activity under our stock plans as of December 31, 2019, and changes during the period then ended is presented below: Stock Awards Plans Director Stock Option Plans Weighted Average Weighted Average Options Exercise Price Options Exercise Price Outstanding, January 1, 2019 6,761,055 $ 65.76 155,200 $ 58.13 Granted — — — — Exercised (1,560,047) 57.10 (19,949) 55.99 Forfeited or expired (156,828) 73.15 — — Outstanding at December 31, 2019 5,044,180 $ 68.32 135,251 $ 58.45 Exercisable at December 31, 2019 4,288,542 $ 66.01 135,251 $ 58.45 Weighted-Average Remaining Contractual Term (Years): Outstanding at December 31, 2019 5.4 3.2 Exercisable at December 31, 2019 5.0 3.2 Aggregate Intrinsic Value: Outstanding at December 31, 2019 $ 239,033 $ 7,732 Exercisable at December 31, 2019 $ 212,745 $ 7,732 Intrinsic Value of Options Exercised During the Years Ended: December 31, 2019 $ 87,251 $ 1,172 December 31, 2018 $ 72,951 $ 2,286 December 31, 2017 $ 51,140 $ 1,995 The grant date fair value of options vested during the years ended December 31, 2019, 2018 and 2017 was $17.5 million, $16.5 million and $16.9 million, respectively. Cash received from option exercises was approximately $90.2 million and the actual tax benefit realized for the tax deduction from option exercises was approximately $19.5 million in the year ended December 31, 2019. As of December 31, 2019, the remaining valuation of stock option awards to be expensed in future periods was $2.3 million and the related weighted-average period over which it is expected to be recognized is 1.0 year. The fair value of both time-based RSUs and performance-based RSUs pertaining to internal performance metrics is determined using the closing price of our common stock and expected dividend on the grant date. The fair value of performance-based RSUs pertaining to TSR is estimated using a Monte Carlo simulation. Inputs and assumptions used to calculate the fair value are shown in the table below. The fair value of these RSUs is expensed over the vesting period using the straight-line method or using the graded vesting method when an employee becomes eligible to retain the award at retirement. Year Ended December 31, 2019 2018 Fair value per stock award $ 134.97 $ 128.70 Grant date stock price $ 104.51 $ 89.42 Assumptions: Aptar's stock price expected volatility 16.50 % 12.30 % Expected average volatility of peer companies 31.90 % 27.50 % Correlation assumption 37.40 % 20.20 % Risk-free interest rate 2.19 % 2.42 % Dividend yield assumption 1.30 % 1.43 % A summary of RSU activity as of December 31, 2019, and changes during the period then ended is presented below: Time-Based RSUs Performance-Based RSUs Weighted Average Weighted Average Units Grant-Date Fair Value Units Grant-Date Fair Value Nonvested at January 1, 2019 261,487 $ 91.78 69,990 $ 111.55 Granted 295,412 97.80 123,246 119.35 Vested (51,433) 88.77 — — Forfeited (24,737) 98.72 (11,556) 117.04 Nonvested at December 31, 2019 480,729 $ 95.45 181,680 $ 117.26 Included in the December 31, 2019 time-based RSUs are 11,490 units awarded to non-employee directors and 14,257 units vested related to non-employee directors. Compensation expense recorded attributable to RSUs for the years ended December 31, 2019, 2018 and 2017 was approximately $18.2 million, $8.7 million and $3.7 million, respectively. The actual tax benefit realized for the tax deduction from RSUs was approximately $1.0 million for the year ended December 31, 2019. The fair value of units vested during the years ended December 31, 2019, 2018 and 2017 was $4.6 million, $3.0 million and $4.7 million, respectively. The intrinsic value of units vested for the years ended December 31, 2019, 2018 and 2017 was $5.4 million, $3.7 million and $5.2 million, respectively. As of December 31, 2019, there was $28.9 million of total unrecognized compensation cost relating to RSU awards which is expected to be recognized over a weighted average period of 2.9 years. We have a long-term incentive program for certain employees. Each award is based on the cumulative TSR of our common stock during a three year performance period compared to a peer group. The total expense related to this program for awards outstanding as of December 31, 2019 is approximately $2.7 million. For the years ended December 31, 2019, 2018 and 2017, we recognized expense of $0.8 million, $1.2 million and $0.7 million, respectively. The accrued awards will be paid in the first quarter of 2020 with no future grants anticipated as this TSR incentive program is no longer awarded.

EARNINGS PER SHARE

EARNINGS PER SHARE	12 Months Ended
EARNINGS PER SHARE	Dec. 31, 2019
EARNINGS PER SHARE
EARNINGS PER SHARE	NOTE 17 EARNINGS PER SHARE Basic net income per share is calculated by dividing net income attributable to Aptar by the weighted-average number of common shares outstanding during the period. Diluted net income per share is calculated by dividing the net income attributable to Aptar by the weighted-average number of common and common equivalent shares outstanding during the applicable period. The difference between basic and diluted earnings per share is attributable to stock based compensation awards. Share-based compensation awards for which total employee proceeds exceed the average market price over the applicable period would have an antidilutive effect on earnings per share, and accordingly, are excluded from the calculation of diluted earnings per share. The reconciliation of basic and diluted earnings per share (“EPS”) for the years ended December 31, 2019, 2018 and 2017 are as follows: Income Shares Per Share (Numerator) (Denominator) Amount For the Year Ended December 31, 2019 Basic EPS Income available to common stockholders $ 242,202 63,574 $ 3.81 Effect of Dilutive Securities Stock options 2,344 Restricted stock 232 Diluted EPS Income available to common stockholders $ 242,202 66,150 $ 3.66 For the Year Ended December 31, 2018 Basic EPS Income available to common stockholders $ 194,745 62,437 $ 3.12 Effect of Dilutive Securities Stock options 2,440 Restricted stock 81 Diluted EPS Income available to common stockholders $ 194,745 64,958 $ 3.00 For the Year Ended December 31, 2017 Basic EPS Income available to common stockholders $ 220,030 62,435 $ 3.52 Effect of Dilutive Securities Stock options 2,106 Restricted stock 55 Diluted EPS Income available to common stockholders $ 220,030 64,596 $ 3.41

SEGMENT INFORMATION

SEGMENT INFORMATION	12 Months Ended
SEGMENT INFORMATION	Dec. 31, 2019
SEGMENT INFORMATION
SEGMENT INFORMATION	NOTE 18 SEGMENT INFORMATION We are organized into three reporting segments. Operations that sell dispensing systems and sealing solutions primarily to the beauty, personal care and home care markets form the Beauty + Home segment. Operations that sell dispensing systems and sealing solutions to the prescription drug, consumer health care, injectables and active packaging markets form the Pharma segment. Operations that sell dispensing systems and sealing solutions to the food and beverage markets form the Food + Beverage segment. The accounting policies of the segments are the same as those described in Note 1 – Summary of Significant Accounting Policies. In order to more closely align with how the markets analyze our segment results, we have changed our non-U.S. GAAP segment measure of profitability from Segment Income to Adjusted EBITDA beginning in 2018. All internal segment reporting and discussions of results with our Chief Operating Decision Maker (CODM) are now based on segment Adjusted EBITDA. All references to segment profitability have been updated for this change. Financial information regarding our reporting segments is shown below: Year Ended December 31, 2019 2018 2017 Total Sales: Beauty + Home $ 1,376,027 $ 1,446,231 $ 1,333,048 Pharma 1,100,463 955,069 805,913 Food + Beverage 418,017 386,689 352,483 Total Sales $ 2,894,507 $ 2,787,989 $ 2,491,444 Less: Intersegment Sales: Beauty + Home $ 23,313 $ 19,849 $ 19,262 Pharma 9,412 417 33 Food + Beverage 2,050 2,962 2,866 Total Intersegment Sales $ 34,775 $ 23,228 $ 22,161 Net Sales: Beauty + Home $ 1,352,714 $ 1,426,382 $ 1,313,786 Pharma 1,091,051 954,652 805,880 Food + Beverage 415,967 383,727 349,617 Net Sales $ 2,859,732 $ 2,764,761 $ 2,469,283 Adjusted EBITDA (1): Beauty + Home $ 181,150 $ 185,926 $ 173,227 Pharma 387,483 343,706 275,933 Food + Beverage 68,108 57,589 62,903 Corporate & Other, unallocated (44,406) (36,285) (37,457) Acquisition-related costs (2) (3,927) (23,770) — Restructuring Initiatives (3) (20,472) (63,829) (2,208) Gain on insurance recovery (4) — — 10,648 Depreciation and amortization (5) (194,552) (171,747) (153,094) Interest Expense (35,489) (32,626) (40,597) Interest Income 4,174 7,056 5,470 Income before Income Taxes $ 342,069 $ 266,020 $ 294,825 Depreciation and Amortization: Beauty + Home $ 82,778 $ 83,546 $ 79,422 Pharma 65,590 51,495 41,143 Food + Beverage 35,728 27,467 24,720 Corporate & Other 10,456 9,239 7,809 Depreciation and Amortization $ 194,552 $ 171,747 $ 153,094 Capital Expenditures: Beauty + Home $ 96,040 $ 101,371 $ 76,425 Pharma 89,702 54,433 33,005 Food + Beverage 45,130 41,236 38,730 Corporate & Other 13,933 25,739 18,924 Transfer of Corporate Technology Expenditures (6) (2,529) (11,527) (10,460) Capital Expenditures $ 242,276 $ 211,252 $ 156,624 Total Assets: Beauty + Home $ 1,378,292 $ 1,373,816 $ 1,358,283 Pharma 1,422,815 1,324,696 881,443 Food + Beverage 534,527 501,700 296,271 Corporate & Other 226,485 177,523 601,826 Total Assets $ 3,562,119 $ 3,377,735 $ 3,137,823 (1) We evaluate performance of our reporting segments and allocate resources based upon Adjusted EBITDA. Adjusted EBITDA is defined as earnings before net interest, taxes, depreciation, amortization, unallocated corporate expenses, restructuring, acquisition-related costs and insurance recoveries. (2) Acquisition-related costs include transaction costs and purchase accounting adjustments related to inventory for acquisitions (see Note 20 – Acquisitions for further details). (3) Restructuring Initiatives includes expense items for the years ended December 31, 2019 and 2018 as follows (see Note 21 – Restructuring Initiatives for further details): Year Ended December 31, 2019 2018 2017 Restructuring Initiatives by Segment Beauty + Home $ 17,682 $ 52,244 $ 529 Pharma 632 3,589 — Food + Beverage 391 4,185 1,679 Corporate & Other 1,767 3,811 — Total Restructuring Initiatives $ 20,472 $ 63,829 $ 2,208 (4) The gain on insurance recovery relates to the Annecy fire (see Note 19 – Insurance Settlement Receivable for further details). (5) Depreciation and amortization includes amortization related to acquisition purchase accounting adjustments for backlog. See the reconciliation of Non-U.S. GAAP measures starting on page 22 . (6) The transfer of corporate technology expenditures represents amounts of projects managed by corporate for the benefit of specific entities within each segment. Once the projects are complete, all related costs are allocated from corporate to and paid by the appropriate entity and the associated assets are then depreciated at the entity level. Geographic Information The following are net sales and long-lived asset information by geographic area and product information for the years ended December 31, 2019, 2018 and 2017: 2019 2018 2017 Net Sales to Unaffiliated Customers (1): United States $ 836,768 $ 726,336 $ 642,164 Europe: France 895,110 862,364 744,856 Germany 452,409 474,369 416,802 Italy 141,867 144,044 131,523 Other Europe 149,083 146,701 132,992 Total Europe 1,638,469 1,627,478 1,426,173 Other Foreign Countries 384,495 410,947 400,946 Total $ 2,859,732 $ 2,764,761 $ 2,469,283 Property, Plant and Equipment United States $ 300,820 $ 265,004 $ 182,434 Europe: France 338,288 308,250 266,804 Germany 163,782 154,505 163,948 Italy 53,562 54,978 57,080 Other Europe 63,636 59,411 59,963 Total Europe 619,268 577,144 547,795 Other Foreign Countries 167,590 149,465 137,677 Total $ 1,087,678 $ 991,613 $ 867,906 (1) Sales are attributed to countries based upon where the sales invoice to unaffiliated customers is generated. No single customer represents 6% or more of our net sales in 2019, 2018 or 2017.

INSURANCE SETTLEMENT RECEIVABLE

INSURANCE SETTLEMENT RECEIVABLE	12 Months Ended
INSURANCE SETTLEMENT RECEIVABLE	Dec. 31, 2019
INSURANCE SETTLEMENT RECEIVABLE
INSURANCE SETTLEMENT RECEIVABLE	NOTE 19 INSURANCE SETTLEMENT RECEIVABLE A fire caused damage to our facility in Annecy, France in June 2016. The fire was contained to one of three production units and there were no reported injuries. Aptar Annecy supplies anodized aluminum components for certain Aptar dispensing systems. We are insured for the damages caused by the fire, including business interruption insurance, and we do not expect this incident to have a material impact on our financial results. Losses related to the Annecy fire of $18.9 million and $20.3 million were incurred during 2018 and 2017, respectively. For the year ended December 31, 2019, we received insurance proceeds of $3.4 million, and have no insurance receivable at year-end. Operating Income was negatively impacted by $5.8 million during 2018. These 2018 losses negatively impacted the Beauty + Home and Pharma segments by $3.8 million and $2.0 million, respectively. Operating income was negatively impacted by $5.6 million during 2017. During 2017, we also recognized $10.6 million of gain due to the insurance recovery on the involuntary conversion of fixed assets related to this fire, which is included in Other (Expense) Income on the Consolidated Statements of Income. These 2017 amounts impacted the Beauty + Home segment. The final settlement is still in process of negotiation with the insurance company.

ACQUISITIONS

ACQUISITIONS	12 Months Ended
ACQUISITIONS	Dec. 31, 2019
ACQUISITIONS
ACQUISITIONS	NOTE 20 ACQUISITIONS Business Combinations On October 31, 2019, we completed our acquisition (the “Noble Acquisition”) of 100% of the equity interests of Noble International Holdings, Inc., Genia Medical, Inc. and JBCB Holdings, LLC (collectively referred to as “Noble”). Noble, based in Orlando, FL, is a leading provider in developing patient-centric advanced drug delivery system training devices including autoinjector, prefilled syringe, onbody and respiratory devices for the world’s leading biopharmaceutical companies and original equipment manufacturers. The purchase price was approximately $62.3 million (net of $1.6 million of cash acquired) and was funded by cash on hand. As part of the Noble Acquisition, we are also obligated to pay to the selling equityholders of Noble certain contingent consideration based on 2024 cumulative financial performance metrics defined in the purchase agreement. Based on projection as of the acquisition date, we estimated the aggregate fair value for this contingent consideration arrangement to be $2.9 million utilizing the Black-Scholes valuation model. We are in the process of finalizing purchase accounting. As of December 31, 2019, $5 million was held in restricted cash pending the finalization of a working capital adjustment. The results of Noble’s operations have been included in the Condensed Consolidated Financial Statements within our Pharma segment since the date of acquisition. On June 5, 2019, we completed our acquisition (the “Nanopharm Acquisition”) of all of the outstanding capital stock of Nanopharm Ltd. (“Nanopharm”). Nanopharm, located in Newport, UK, is a science-driven, leading provider of orally inhaled and nasal drug product design and development services. The purchase price was approximately $38.1 million (net of $1.8 million of cash acquired) and was funded by cash on hand. The results of Nanopharm’s operations have been included in the Condensed Consolidated Financial Statements within our Pharma segment since the date of acquisition. On May 31, 2019, we completed our acquisition (the “Gateway Acquisition”) of all of the outstanding equity interests of Gateway Analytical LLC (“Gateway”). Gateway, located in Gibsonia, PA, provides industry-leading particulate detection and predictive analytical services to customers developing injectable medicines. The purchase price was approximately $7.0 million and was funded by cash on hand. As part of the Gateway Acquisition, we are also obligated to pay to the selling equityholder of Gateway certain contingent consideration based on 2020 and 2022 performance targets defined in the purchase agreement. Based on projections as of the acquisition date, we estimated the aggregate fair value for this contingent consideration arrangement to be $3.0 million. The results of Gateway’s operations have been included in the Condensed Consolidated Financial Statements within our Pharma segment since the date of acquisition. On August 27, 2018, we completed our acquisition (the “CSP Technologies Acquisition”) of all of the outstanding capital stock of CSP Technologies S.à r.l. (“CSP Technologies”). CSP Technologies is a leader in active packaging technology based on proprietary material science expertise for the pharma and food service markets. CSP Technologies operates manufacturing locations in the U.S. and France. The preliminary purchase price was approximately $553.5 million and was funded by cash on hand. As of December 31, 2018, $5 million was held in restricted cash pending the finalization of a working capital adjustment. The $5 million cash amount was released from restriction in January 2019 after the finalization of the working capital adjustment, resulting in a refund of $1.0 million. CSP Technologies contributed net sales of $48.9 million and pretax loss of $10.2 million for the year ended December 31, 2018. Sales of $33.9 million and $15.0 million were reported in the Pharma and Food + Beverage segments, respectively, for the year ended December 31, 2018. Pretax loss of $10.3 million and pretax income of $0.1 million were reported in the Pharma and Food + Beverage segments, respectively, for the year ended December 31, 2018. Included in pretax income is $14.1 million of fair value adjustment amortization for inventory sold during 2018. For the year ended December 31, 2019, we recognized $3.4 million in transaction costs related to the acquisitions of Noble, Nanopharm and Gateway. For the year ended December 31, 2018, we recognized $9.0 million in transaction costs related to the acquisition of CSP Technologies. These costs are reflected in the selling, research & development and administration section of the Consolidated Statements of Income and within acquisition-related costs as disclosed in Note 18 – Segment Information. The following table summarizes the assets acquired and liabilities assumed as of the acquisition date at estimated fair value. 2019 2018 Assets Cash and equivalents $ 3,427 $ 24,053 Accounts receivable 3,504 20,847 Inventories — 42,169 Prepaid and other 2,478 3,995 Property, plant and equipment 4,267 99,194 Goodwill 59,143 278,020 Intangible assets 52,980 177,120 Other miscellaneous assets 430 1,039 Liabilities Current maturities of long-term obligations — 129 Accounts payable, accrued and other liabilities 5,388 31,989 Long-term obligations — 6,037 Deferred income taxes 2,592 38,442 Retirement and deferred compensation plans — 1,038 Deferred and other non-current liabilities 1,598 15,344 Net assets acquired $ 116,651 $ 553,458 The following table is a summary of the fair value estimates of the acquired identifiable intangible assets and weighted-average useful lives as of the acquisition date: 2019 2018 Weighted-Average Estimated Weighted-Average Estimated Useful Life Fair Value Useful Life Fair Value (in years) of Asset (in years) of Asset Acquired technology 8 $ 9,160 12 $ 46,700 Customer relationships 11 39,379 16 113,300 Trademarks and trade names 4 2,457 9 14,600 License agreements and other 1 1,984 11 2,520 Total $ 52,980 $ 177,120 Goodwill in the amount of $59.1 million and $278.0 million was recorded related to the 2019 and 2018 acquisitions, respectively. For 2019, $59.1 million is included in the Pharma segment and, for 2018, $174.3 million and $103.7 million is included in the Pharma and Food + Beverage segments, respectively. Goodwill is calculated as the excess of the consideration transferred over the net assets acquired and represents the estimated future economic benefits arising from other assets acquired that could not be individually identified and separately recognized. Goodwill largely consists of leveraging our commercial presence in selling the Noble, Nanopharm, Gateway and CSP Technologies lines of products in markets where they did not previously operate and the abilities of the acquired companies to maintain their competitive advantage from a technical viewpoint. Goodwill will not be amortized, but will be tested for impairment at least annually. For 2019 acquisitions, goodwill of $29.6 million will be deductible for tax purposes. For the 2018 acquisitions, we do not expect any of the goodwill will be deductible for tax purposes. Pro forma results of operations for 2019 acquisitions have not been presented as the effects of these business combinations individually and in aggregate were not material to the consolidated results of operations. The unaudited pro forma results presented below include the effects of the CSP Technologies acquisition as if it had occurred as of January 1, 2017. The unaudited pro forma results reflect certain adjustments related to the acquisition, such as intangible asset amortization, fair value adjustments for inventory and financing costs related to the change in our debt structure. The 2018 pro forma earnings were adjusted to exclude $16.7 million after tax ($ 22.0 million pretax) of transaction and other costs. The aforementioned costs include compensation, consulting, legal and advisory fees. The 2018 pro forma earnings were also adjusted to exclude $10.9 million after tax ($ 14.1 million pretax) of nonrecurring expense related to the fair value adjustment to acquisition-date inventory. The 2017 pro forma earnings were adjusted to include these adjustments. The pro forma results do not include any synergies or other expected benefits of the acquisition. Accordingly, the unaudited pro forma financial information below is not necessarily indicative of either future results of operations or results that might have been achieved had the acquisition been completed on the dates indicated. Years Ended December 31, 2018 2017 Net Sales $ 2,857,765 $ 2,605,095 Net Income Attributable to AptarGroup Inc. 208,717 230,753 Net Income per common share — basic 3.34 3.70 Net Income per common share — diluted 3.21 3.57 On May 1, 2018, we acquired 100% of the common stock of Reboul, a French manufacturer specializing in stamping, decorating and assembling metal and plastic packaging for the cosmetics and luxury markets, for an initial purchase price of approximately $3.5 million (net of $112 thousand of cash acquired) (the “Reboul Acquisition”). The results of Reboul’s operations have been included in the consolidated financial statements within our Beauty + Home segment since the date of acquisition. As part of the Reboul Acquisition, we were obligated to pay to the selling shareholders of Reboul certain contingent consideration based on 2018 EBITDA as defined in the purchase agreement. These targets were not achieved and we did not pay any contingent consideration. Subsequent to year end, on February 13, 2020, we entered into a securities purchase agreement to acquire 100% of the membership interests of Fusion Packaging I, LP (“Fusion”), contingent on the closing date of the transaction. Fusion, based in Dallas, TX, is a global leader in the design, engineering, manufacturing and distribution of luxury packaging for the beauty industry. The transaction is subject to customary regulatory approvals and other customary closing conditions. The purchase will be funded with available cash on hand and/or borrowings under our revolving credit facility. Asset Acquisition On August 2, 2019, we completed our asset acquisition (the “Bapco Acquisition”) of the remaining 80% ownership interest in the capital stock of Bapco Closures Holdings Limited (“Bapco”), for $3.8 million (net of $2.9 million of cash acquired). The 20% ownership investment previously held in Bapco is now included within the intangible assets acquired. Bapco, located in Horesell, UK, provides innovative closures sealing technology that provides package integrity and tamper evidence. The results of Bapco’s operations have been included in the Condensed Consolidated Financial Statements within our Food + Beverage segment since the date of acquisition. Equity and Other Investments On October 1, 2019, we entered into a strategic definitive agreement to acquire 49% of the equity interests in three related companies: Suzhou Hsing Kwang, Suqian Hsing Kwang and Suzhou BTY, (collectively referred to as “BTY”), contingent on the settlement date of the transaction. We have a call option to acquire an additional 26% to 31% of BTY’s equity interests following the initial lock-up period of 5 years based on a predetermined formula. Subsequent to the second lock-up period, which ends 3 years subsequent to the initial lock-up period, we have a call option to acquire the remaining equity interests of BTY based on a predetermined formula. Additionally, the selling shareholders of BTY have a put option for the remaining equity interest to be acquired by Aptar based on a predetermined formula. The BTY entities are leading Chinese manufacturers of high quality, decorative metal components, metal-plastic sub-assemblies, and complete color cosmetics packaging solutions for the beauty industry. Subsequent to the year ended December 31, 2019, on January 1, 2020 the transaction closed for an approximate purchase price of $32 million for our 49% share. During August 2019, we also invested an aggregate amount of $3.5 million in two preferred equity investments in sustainability companies that are accounted for at cost less impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer. There were no indications of impairment nor were there any changes from observable price changes noted in the three months ended December 31, 2019. In May 2018, we invested $10.0 million in preferred equity stock of Reciprocal Labs Corporation, doing business as Propeller Health, consistent with measurement alternative guidance described in Note 1 above. No impairment charge was recorded during 2018 against this investment. We recorded a gain of approximately $6.5 million during the fourth quarter of 2018 by adjusting the carrying amount to its expected sales proceeds as this investment was subsequently sold during January 2019.

RESTRUCTURING INITIATIVES

RESTRUCTURING INITIATIVES	12 Months Ended
RESTRUCTURING INITIATIVES	Dec. 31, 2019
RESTRUCTURING INITIATIVES.
RESTRUCTURING INITIATIVES	NOTE 21 RESTRUCTURING INITIATIVES In late 2017, we began a business transformation to drive profitable sales growth, increase operational excellence, enhance our approach to innovation and improve organizational effectiveness. The primary focus of the plan will be the Beauty + Home segment; however, certain global general and administrative functions will also be addressed. During 2019 and 2018, we recognized approximately $20.5 million and $63.8 million of restructuring costs related to this plan, respectively. Using current exchange rates, we expect total implementation costs of approximately $110 million for these initiatives. The cumulative expense incurred to date was $86.5 million. We also anticipate making capital investments related to the transformation plan of approximately $55 million, of which the $38 million has been incurred to date. As of December 31, 2019 we have recorded the following activity associated with the transformation plan: Beginning Net Charges Ending Reserve at for the Year Interest and Reserve at 12/31/2018 Ended 12/31/2019 Cash Paid FX Impact 12/31/2019 Employee severance $ 3,934 $ 8,104 $ (4,813) $ (135) $ 7,090 Professional fees and other costs 11,101 12,368 (19,795) (65) 3,609 Totals $ 15,035 $ 20,472 $ (24,608) $ (200) $ 10,699

QUARTERLY DATA (UNAUDITED)

QUARTERLY DATA (UNAUDITED)	12 Months Ended
QUARTERLY DATA (UNAUDITED)	Dec. 31, 2019
QUARTERLY DATA (UNAUDITED)
QUARTERLY DATA (UNAUDITED)	NOTE 22 QUARTERLY DATA (UNAUDITED) Quarterly results of operations and per share information for the years ended December 31, 2019 and 2018 are as follows: Quarter Total First Second Third Fourth for Year Year Ended December 31, 2019: Net sales $ 744,460 $ 742,661 $ 701,278 $ 671,333 $ 2,859,732 Gross profit (1) 233,841 231,739 215,222 193,588 874,390 Net Income 62,999 73,921 56,769 48,538 242,227 Net Income Attributable to AptarGroup, Inc. 63,004 73,915 56,750 48,533 242,202 Per Common Share — 2019: Net Income Attributable to AptarGroup, Inc. Basic $ 1.00 $ 1.16 $ .89 $ .76 $ 3.81 Diluted .96 1.12 .85 .73 3.66 Average number of shares outstanding: Basic 62,964 63,471 64,010 63,835 63,574 Diluted 65,349 66,232 66,702 66,192 66,150 Year Ended December 31, 2018: Net sales $ 703,350 $ 710,608 $ 665,775 $ 685,028 $ 2,764,761 Gross profit (1) 209,171 209,018 192,544 184,775 795,508 Net Income 59,288 55,781 39,022 40,675 194,766 Net Income Attributable to AptarGroup, Inc. 59,300 55,775 38,996 40,674 194,745 Per Common Share — 2018: Net Income Attributable to AptarGroup, Inc. Basic $ .95 $ .89 $ .63 $ .65 $ 3.12 Diluted .92 .86 .60 .62 3.00 Average number of shares outstanding: Basic 62,128 62,402 62,378 62,834 62,437 Diluted 64,414 64,850 65,129 65,344 64,958 (1) Gross profit is defined as net sales less cost of sales and depreciation.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
SUBSEQUENT EVENTS	Dec. 31, 2019
SUBSEQUENT EVENTS.
SUBSEQUENT EVENTS	NOTE 23 SUBSEQUENT EVENTS On January 1, 2020, the BTY transaction closed for an approximate purchase price of $32 million for our 49% share. Refer to Note 20- Acquisitions for further details on the investment. On February 13, 2020, we entered into a securities purchase agreement to acquire 100% of the membership interests of Fusion. Refer to Note 20 – Acquisitions for further details on the acquisition.

SCHEDULE II - VALUATION AND QUA

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS	12 Months Ended
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS	Dec. 31, 2019
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS	AptarGroup, Inc. SCHEDULE II – VALUATION AND QUALIFYING ACCOUNT S For the years ended December 31, 2019, 2018 and 2017 Dollars in thousands Balance at Charged to Charged Deductions Balance Beginning Costs and to Other from at End of Of Period Expenses Accounts Reserve (a) Period 2019 Allowance for doubtful accounts $ 3,541 $ 782 $ — $ (697) $ 3,626 Deferred tax valuation allowance 11,189 12,058 1,508 (1,435) 23,320 2018 Allowance for doubtful accounts $ 3,161 $ 923 $ — $ (543) $ 3,541 Deferred tax valuation allowance 5,414 4,230 2,604 (1,059) 11,189 2017 Allowance for doubtful accounts $ 2,989 $ 235 $ — $ (63) $ 3,161 Deferred tax valuation allowance 4,070 3,640 — (2,296) 5,414 (a) Write-off accounts considered uncollectible, net of recoveries and foreign currency impact adjustments.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	Dec. 31, 2019
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
BASIS OF PRESENTATION	BASIS OF PRESENTATION The accompanying consolidated financial statements include the accounts of AptarGroup, Inc. and our subsidiaries. The terms “AptarGroup”, “Aptar”, “Company”, “we”, “us” or “our” as used herein refer to AptarGroup, Inc. and our subsidiaries. All significant intercompany accounts and transactions have been eliminated. Certain previously reported amounts have been reclassified to conform to the current period presentation. AptarGroup’s organizational structure consists of three market-focused business segments which are Beauty + Home, Pharma and Food + Beverage. This is a strategic structure which allows us to be more closely aligned with our customers and the markets in which they operate. In late 2017, Aptar began a business transformation plan to drive profitable sales growth, increase operational excellence, enhance our approach to innovation and improve organizational effectiveness (see Note 21 – Restructuring Initiatives for further details). The primary focus of the plan is the Beauty + Home segment; however, certain global general and administrative functions are also addressed. During 2019, 2018 and 2017, we recognized approximately $20.5 million, $63.8 million and $2.2 million, respectively, of restructuring costs related to this plan. During the quarter ended June 30, 2018, primarily based on published estimates which indicate that Argentina's three-year cumulative inflation rate has exceeded 100%, we concluded that Argentina has become a highly inflationary economy. Beginning July 1, 2018, we have applied highly inflationary accounting for our Argentinian subsidiaries. We have changed the functional currency from the Argentinian peso to the U.S. dollar. Local currency monetary assets and liabilities were remeasured into U.S. dollars using exchange rates as of the latest balance sheet date, with remeasurement adjustments and other transaction gains and losses recognized in net earnings. During the last half of 2018, we recognized approximately $0.8 million of currency gains due to these changes. Our Argentinian operations contributed approximately less than 2.0% of consolidated net assets and revenues at and for the year ended December 31, 2019.
ACCOUNTING ESTIMATES	ACCOUNTING ESTIMATES The financial statements are prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). This process requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
CASH MANAGEMENT	CASH AND CASH EQUIVALENTS We consider all investments that are readily convertible to known amounts of cash with an original maturity of three months or less when purchased to be cash equivalents.
INVENTORIES	INVENTORIES Inventories are stated at lower of cost or net realizable value. Costs included in inventories are raw materials, direct labor and manufacturing overhead.
INVESTMENTS IN EQUITY SECURITIES	INVESTMENTS IN EQUITY SECURITIES We account for our 20% to 50% owned investments using the equity method. Equity investments that do not result in consolidation and are not accounted for under the equity method are measured at fair value. Any related changes in fair value is recognized in net income unless the investments qualify for a practicality exception. In May 2018, we invested $10.0 million in preferred equity stock of Reciprocal Labs Corporation, doing business as Propeller Health. During 2018, we increased the value of this investment by approximately $6.5 million due to fair value inputs. This investment was ultimately sold during January 2019 for an amount of $16.5 million (see Note 20 – Acquisitions for further details). During August 2019, we also invested an aggregate amount of $3.5 million in two preferred equity investments that are accounted for at cost less impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer. There were no indications of impairment nor were there any changes from observable price changes noted for the year ended December 31, 2019. There were no dividends received from affiliated companies in 2019, 2018 and 2017.
PROPERTY AND DEPRECIATION	PROPERTY AND DEPRECIATION Properties are stated at cost. Depreciation is determined on a straight-line basis over the estimated useful lives for financial reporting purposes and accelerated methods for income tax reporting. Generally, the estimated useful lives are 10 to 40 years for buildings and improvements and 3 to 15 years for machinery and equipment.
FINITE-LIVED INTANGIBLE ASSETS	FINITE-LIVED INTANGIBLE ASSETS Finite-lived intangibles, consisting of patents, acquired technology, customer relationships, trademarks and trade names and license agreements acquired in purchase transactions, are capitalized and amortized over their useful lives which range from 1 to 20 years.
GOODWILL	GOODWILL The Company has historically evaluated the excess of purchase price over the fair value of the net assets acquired (“goodwill”) for impairment annually as of December 31 or more frequently if impairment indicators arose in accordance with Accounting Standards Codification (“ASC”) Topic 350, “Intangibles - Goodwill and Other.” In the fourth quarter of 2019, the Company changed the date of its annual assessment of goodwill to October 1 for all reporting units. The change in testing date for goodwill is a change in accounting principle, which management believes is preferable as the new date of the assessment better aligns with the Company’s budgeting process and will create a more efficient and timely process surrounding the impairment tests. The change in the assessment date does not delay, accelerate or avoid a potential impairment charge. The Company has determined that it is impracticable to objectively determine projected cash flows and related valuation estimates that would have been used as of each October 1 of prior reporting periods without the use of hindsight. As such, the Company prospectively applied the change in annual goodwill impairment testing date from October 1, 2019. We believe that the accounting estimates related to determining the fair value of our reporting units is a critical accounting estimate because: (1) it is highly susceptible to change from period to period because it requires management to make assumptions about the future cash flows for each reporting unit over several years, and (2) the impact that recognizing an impairment would have on the assets reported on our balance sheet as well as our results of operations could be material. Management’s determination of the fair value of our reporting units, based on future cash flows for the reporting units, requires significant judgment and the use of estimates and assumptions related to projected revenue growth rates, the terminal growth factor, as well as the discount rate. Actual cash flows in the future may differ significantly from those forecasted today. The estimates and assumptions for future cash flows and its impact on the impairment testing of goodwill is a critical accounting estimate. Management believes goodwill in purchase transactions has continuing value. Goodwill is not amortized and must be tested annually, or more frequently as circumstances dictate, for impairment. The annual goodwill impairment test may first consider qualitative factors to determine whether it is more likely than not (i.e., greater than 50 percent chance) that the fair value of a reporting unit is less than its book value. This is sometimes referred to as the “step zero” approach and is an optional step in the annual goodwill impairment analysis. Management has performed this qualitative assessment as of October 1, 2019 for each of our reporting units. Based on our review of macroeconomic, industry, and market events and circumstances as well as the overall financial performance of the reporting units, we determined that it was more likely than not that the fair value of these reporting units was greater than their carrying amounts. During the third quarter of 2019, we performed a separate quantitative impairment assessment using a discounted cash flow analysis of the Active Packaging reporting unit, which was formed as a result of the CSP Technologies Acquisition in the third quarter of 2018. We calculated the fair value of the Active Packaging reporting unit and compared it with the associated carrying value (the “step one” approach) as of July 1, 2019. Based on this quantitative analysis, the fair value of the reporting unit exceeded the carrying value and therefore no impairment loss was recognized.
IMPAIRMENT OF LONG-LIVED ASSETS	IMPAIRMENT OF LONG-LIVED ASSETS Long-lived assets, such as property, plant and equipment and finite-lived intangibles, are evaluated for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. An impairment loss is recognized when estimated undiscounted future cash flows expected to result from the use of the asset plus net proceeds expected from disposition of the asset (if any) are less than the carrying value of the asset.
DERIVATIVES INSTRUMENTS AND HEDGING ACTIVITIES	DERIVATIVES INSTRUMENTS AND HEDGING ACTIVITIES Derivative financial instruments are recorded in the Consolidated Balance Sheets at fair value as either assets or liabilities. Changes in the fair value of derivatives are recorded in each period in earnings or other comprehensive income, depending on whether a derivative is designated and effective as part of a hedge transaction.
RETIREMENT OF COMMON STOCK	RETIREMENT OF COMMON STOCK During 2019, we repurchased 779 thousand shares of common stock, all of which were returned to treasury stock. During 2018, we repurchased 668 thousand shares of common stock, of which 623 thousand shares were immediately retired. Common stock was reduced by the number of shares retired at $0.01 par value per share. We allocate the excess purchase price over par value between additional paid-in capital and retained earnings.
RESEARCH & DEVELOPMENT EXPENSES	RESEARCH & DEVELOPMENT EXPENSES Research and development costs, net of any customer funded research and development or government research and development credits, are expensed as incurred. These costs amounted to $82.8 million, $75.3 million and $68.2 million in 2019, 2018 and 2017, respectively.
INCOME TAXES	INCOME TAXES We compute taxes on income in accordance with the tax rules and regulations of the many taxing authorities where the income is earned. The income tax rates imposed by these taxing authorities may vary substantially. Taxable income may differ from pre-tax income for financial accounting purposes. To the extent that these differences create timing differences between the tax basis of an asset or liability and its reported amount in the financial statements, an appropriate provision for deferred income taxes is made. All of our non-U.S. earnings are subject to U.S. taxation, either from the transition tax enacted in the U.S. by the Tax Cuts and Jobs Act (“TCJA”) on accumulated non-U.S. earnings as of the end of 2017 or the global intangible low-taxed income (“GILTI”) provisions on non-U.S. earnings thereafter. We maintain our assertion that the cash and distributable reserves at our non-U.S. affiliates are indefinitely reinvested. We will provide for the necessary withholding and local income taxes when management decides that an affiliate should make a distribution. These decisions are made taking into consideration the financial requirements of the non-U.S. affiliates and the global cash management goals of the Company. We provide a liability for the amount of unrecognized tax benefits from uncertain tax positions. This liability is provided whenever we determine that a tax benefit will not meet a more-likely-than-not threshold for recognition. See Note 6 – Income Taxes for more information.
TRANSLATION OF FOREIGN CURRENCIES	TRANSLATION OF FOREIGN CURRENCIES The functional currencies of the majority of our foreign operations are the local currencies. Assets and liabilities of our foreign operations are translated into U.S. dollars at the rates of exchange on the balance sheet date. Sales and expenses are translated at the average rates of exchange prevailing during the year. The related translation adjustments are accumulated in a separate section of Stockholders’ Equity. Realized and unrealized foreign currency transaction gains and losses are reflected in income, as a component of miscellaneous income and expense, and represented losses of $1.7 million, $1.7 million and $5.0 million in 2019, 2018 and 2017, respectively.
STOCK BASED COMPENSATION	STOCK-BASED COMPENSATION Accounting standards require the application of the non-substantive vesting approach which means that an award is fully vested when the employee’s retention of the award is no longer contingent on providing future service. Under this approach, compensation costs are recognized over the requisite service period of the award instead of ratably over the vesting period stated in the grant. As such, costs are recognized immediately if the employee is retirement eligible on the date of grant or over the period from the date of grant until retirement eligibility if retirement eligibility is reached before the end of the vesting period stated in the grant. See Note 16 – Stock-Based Compensation for more information.
REVENUE RECOGNITION	REVENUE RECOGNITION At inception of customer contracts, we assess the goods and services promised in order to identify a performance obligation for each promise to transfer a good or service (or bundle of goods or services) that is distinct. To identify the performance obligations, we consider all the goods or services promised in the contract, whether explicitly stated or implied based on customary business practices. For a contract that has more than one performance obligation, we allocate the total contract consideration to each distinct performance obligation on a relative standalone selling price basis. Revenue is recognized when (or as) the performance obligations are satisfied (i.e., when the customer obtains control of the good or service). The majority of our revenues are derived from product and tooling sales; however, we also receive revenues from service, license, exclusivity and royalty arrangements, which are considered insignificant. See specific discussions about methods of accounting for control transfers of product and tooling sales in Note 2 – Revenue.
LEASES	LEASES We determine if an arrangement is a lease at inception. Operating lease assets are included in operating lease right-of-use (“ROU”) assets and operating lease liabilities are included in accounts payable accrued and other liabilities in our Consolidated Balance Sheets. Finance leases are included in property, plant and equipment, current maturities of long-term obligations and long-term obligations in our Consolidated Balance Sheets. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. We use the implicit rate when readily determinable. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at the commencement date of the lease in determining the present value of lease payments. The operating lease ROU asset includes any lease payments made as well as initial direct costs incurred and excludes lease incentives. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term. We have lease agreements with lease and non-lease components, which are generally accounted for separately. For certain equipment leases, we account for the lease and non-lease components as a single lease component. We have elected not to recognize right-of-use assets and lease liabilities that arise from short-term leases (a lease whose term is 12 months or less and does not include a purchase option that we are reasonably certain to exercise). Certain vehicle lease contracts include guaranteed residual value that is considered in the determination of lease classification. The probability of having to satisfy a residual value guarantee is not considered for the purpose of lease classification, but is considered when measuring a lease liability.
ADOPTION OF RECENT ACCOUNTING PRONOUNCEMENTS	ADOPTION OF RECENT ACCOUNTING PRONOUNCEMENTS Changes to U.S. GAAP are established by the Financial Accounting Standards Board (“FASB”) in the form of Accounting Standards Updates (“ASUs”) to the FASB’s Accounting Standards Codification. In February 2016, the FASB issued a new standard related to leases to increase transparency and comparability among organizations. Most prominent among the changes in the standard is the recognition of ROU assets and lease liabilities by lessees for those leases classified as operating leases, as our accounting for finance leases remained substantially unchanged. Under the new standard, disclosures are required to meet the objective of enabling users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases. We adopted the standard on January 1, 2019 using a modified retrospective transition, with the effective date method. Under this method, financial results reported in periods prior to 2019 are not recast. We elected the package of practical expedients permitted under the transition guidance within the new standard, which among other things, allows companies to carry forward their historical lease classification. We also implemented internal controls and key system functionality to enable the preparation of financial information on adoption. The impact of adoption of the standard to previously reported results is shown below. Balance at Balance at December 31, January 1, 2018 Adjustments 2019 Consolidated Balance Sheets Operating lease right-of-use assets $ — $ 83,222 $ 83,222 Prepaid and other 118,245 (1,383) 116,862 Property, plant and equipment 991,613 5,876 997,489 Current maturities of long-term obligations, net of unamortized debt issuance costs 62,678 2,631 65,309 Accounts payable, accrued and other liabilities 525,199 20,508 545,707 Operating lease liabilities — 61,331 61,331 Long-term obligations, net of unamortized debt issuance costs 1,125,993 3,245 1,129,238 In May 2014, the FASB issued ASU 2014-09, which amended the guidance for recognition of revenue from customer contracts. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in the amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. On January 1, 2018, we adopted this standard and all the related amendments (the “new revenue standard”) for all contracts. This adoption was accounted for using the modified retrospective method. We recognized the cumulative effect of initially applying the new revenue standard as an adjustment to the January 1, 2018 opening balance of retained earnings. Comparative information for the prior periods has not been restated and continues to be reported under the accounting standards in effect prior to January 1, 2018. Balance at Balance at December 31, 2017 Adjustment January 1, 2018 Consolidated Balance Sheets Assets Inventories $ 337,216 $ (7,064) $ 330,152 Prepaid and other 109,791 6,411 116,202 Liabilities Accounts payable, accrued and other liabilities 461,579 (5,706) 455,873 Deferred income taxes 20,995 1,292 22,287 Deferred and other non-current liabilities 5,608 824 6,432 Stockholders’ Equity Retained earnings 1,301,147 2,937 1,304,084 A majority of our sales revenue continues to be recognized when products are shipped from our manufacturing facilities. For certain custom product and tooling sales where revenue was previously recognized when the products were shipped, we now recognize revenue over the time required to manufacture the product or build the tool in accordance with the new revenue standard. We also have certain extended warranty contracts, which under the new standard are considered a separate performance obligation and are required to be deferred and recognized into revenue over the life of the agreement. In accordance with the new revenue standard requirements, the disclosure of the impact of adoption on our consolidated statements of income and balance sheets is as follows: For the Year Ended December 31, 2018 Balances Without Effect of As Adoption of Change Reported ASC 606 Higher/(Lower) Consolidated Statements of Income Net Sales Beauty + Home $ 1,426,382 $ 1,424,701 $ 1,681 Pharma 954,652 954,497 155 Food + Beverage 383,727 385,001 (1,274) Costs and Expenses Cost of sales (exclusive of depreciation and amortization) 1,812,961 1,811,290 1,671 Provision for income taxes 71,254 71,541 (287) Net income 194,766 195,588 (822) December 31, 2018 Balances Without Effect of As Adoption of Change Reported ASC 606 Higher/(Lower) Consolidated Balance Sheets Assets Inventories $ 381,110 $ 391,315 $ (10,205) Prepaid and other 118,245 108,490 9,755 Liabilities Accounts payable, accrued and other liabilities 525,199 529,168 (3,969) Deferred income taxes 53,917 52,912 1,005 Deferred and other non-current liabilities 23,465 23,066 399 Stockholders’ Equity Retained earnings 1,371,826 1,369,711 2,115 In January 2016, the FASB issued ASU 2016-01, which provides guidance on the classification and measurement of financial assets and liabilities (equity securities and financial liabilities) under the fair value option and the presentation and disclosure requirements for financial instruments. In February 2018, ASU 2018-03 was issued to clarify certain aspects of the guidance issued in January 2016. The guidance modifies how entities measure equity investments and present changes in the fair value of financial liabilities. Under the new guidance, entities measure equity investments that do not result in consolidation and are not accounted for under the equity method at fair value and recognize any related changes in fair value in net income unless the investments qualify for the new practicality exception. A measurement alternative exists for those equity investments that do not have a readily determinable fair value. These investments may be measured at cost less impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer. The standard also includes a new impairment model for equity investments without readily determinable fair values. The new model is a single-step model under which we are required to perform a qualitative assessment each reporting period to identify impairment. When a qualitative assessment indicates that an impairment exists, we will estimate the fair value of the investment and recognize in current earnings an impairment loss equal to the difference between the fair value and the carrying amount of the equity investment. The new standard is effective for fiscal years and interim periods beginning after December 15, 2017. We adopted the requirements of this standard during the first quarter of 2018. In November 2016, the FASB issued ASU 2016-18, which provides guidance to address the diversity in the classification and presentation of changes in restricted cash on the statement of cash flows. The amendments in this standard require that a statement of cash flows explain the change during the period in the total cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. The new standard is effective for fiscal years and interim periods beginning after December 15, 2017. We adopted the requirements of this standard during the first quarter of 2018 and appropriate disclosures are included on the statement of cash flows to the extent applicable. In February 2018, the FASB issued ASU 2018-02, which provides guidance on the reclassification of certain tax effects from accumulated other comprehensive income. This guidance allows for the reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the TCJA. The new standard is effective for fiscal years and interim periods beginning after December 15, 2018. We elected to early adopt this standard in the fourth quarter of 2018. As part of this adoption, we elected to reclassify $6.7 million of stranded income tax effects of the TCJA from accumulated other comprehensive income to retained earnings at the beginning of the fourth quarter of 2018. Other accounting standards that have been issued by the FASB or other standards-setting bodies did not have a material impact on our consolidated financial statements.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	Dec. 31, 2019
Accounting Standards Update 2014-09 \| Restatement of beginning balances
Summary of impacts of adoption of recent accounting pronouncements	Balance at Balance at December 31, 2017 Adjustment January 1, 2018 Consolidated Balance Sheets Assets Inventories $ 337,216 $ (7,064) $ 330,152 Prepaid and other 109,791 6,411 116,202 Liabilities Accounts payable, accrued and other liabilities 461,579 (5,706) 455,873 Deferred income taxes 20,995 1,292 22,287 Deferred and other non-current liabilities 5,608 824 6,432 Stockholders’ Equity Retained earnings 1,301,147 2,937 1,304,084
Accounting Standards Update 2014-09 \| Cumulative effect of change
Summary of impacts of adoption of recent accounting pronouncements	For the Year Ended December 31, 2018 Balances Without Effect of As Adoption of Change Reported ASC 606 Higher/(Lower) Consolidated Statements of Income Net Sales Beauty + Home $ 1,426,382 $ 1,424,701 $ 1,681 Pharma 954,652 954,497 155 Food + Beverage 383,727 385,001 (1,274) Costs and Expenses Cost of sales (exclusive of depreciation and amortization) 1,812,961 1,811,290 1,671 Provision for income taxes 71,254 71,541 (287) Net income 194,766 195,588 (822) December 31, 2018 Balances Without Effect of As Adoption of Change Reported ASC 606 Higher/(Lower) Consolidated Balance Sheets Assets Inventories $ 381,110 $ 391,315 $ (10,205) Prepaid and other 118,245 108,490 9,755 Liabilities Accounts payable, accrued and other liabilities 525,199 529,168 (3,969) Deferred income taxes 53,917 52,912 1,005 Deferred and other non-current liabilities 23,465 23,066 399 Stockholders’ Equity Retained earnings 1,371,826 1,369,711 2,115
Accounting Standards Update 2016-02 \| Restatement of beginning balances
Summary of impacts of adoption of recent accounting pronouncements	Balance at Balance at December 31, January 1, 2018 Adjustments 2019 Consolidated Balance Sheets Operating lease right-of-use assets $ — $ 83,222 $ 83,222 Prepaid and other 118,245 (1,383) 116,862 Property, plant and equipment 991,613 5,876 997,489 Current maturities of long-term obligations, net of unamortized debt issuance costs 62,678 2,631 65,309 Accounts payable, accrued and other liabilities 525,199 20,508 545,707 Operating lease liabilities — 61,331 61,331 Long-term obligations, net of unamortized debt issuance costs 1,125,993 3,245 1,129,238

REVENUE (Tables)

REVENUE (Tables)	12 Months Ended
REVENUE (Tables)	Dec. 31, 2019
REVENUE.
Schedule of revenue by segment by geographic area	For the Year Ended December 31, 2019 Latin Segment Europe Domestic America Asia Total Beauty + Home $ 792,255 $ 310,411 $ 160,048 $ 90,000 $ 1,352,714 Pharma 729,882 297,871 26,344 36,954 1,091,051 Food + Beverage 116,332 228,486 33,996 37,153 415,967 Total $ 1,638,469 $ 836,768 $ 220,388 $ 164,107 $ 2,859,732 For the Year Ended December 31, 2018 Latin Segment Europe Domestic America Asia Total Beauty + Home $ 816,359 $ 334,881 $ 178,392 $ 96,750 $ 1,426,382 Pharma 696,079 196,928 25,485 36,160 954,652 Food + Beverage 115,040 194,527 31,742 42,418 383,727 Total $ 1,627,478 $ 726,336 $ 235,619 $ 175,328 $ 2,764,761
Schedule of opening and closing balances of contract assets and contract liabilities	Balance as of Balance as of Increase/ December 31, 2018 December 31, 2019 (Decrease) (opening) (closing) Contract asset (current) $ 15,858 $ 16,245 $ 387 Contract asset (long-term) $ — $ — $ — Contract liability (current) $ 68,134 $ 79,305 $ 11,171 Contract liability (long-term) $ 11,261 $ 9,779 $ (1,482)

INVENTORIES (Tables)

INVENTORIES (Tables)	12 Months Ended
INVENTORIES (Tables)	Dec. 31, 2019
INVENTORIES
Schedule of inventories, by component	2019 2018 Raw materials $ 111,653 $ 110,720 Work in process 123,750 131,091 Finished goods 140,392 139,299 Total $ 375,795 $ 381,110

GOODWILL AND OTHER INTANGIBLE_2

GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)	12 Months Ended
GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)	Dec. 31, 2019
GOODWILL AND OTHER INTANGIBLE ASSETS
Schedule of changes in the carrying amount of goodwill	Beauty + Food + Corporate Home Pharma Beverage & Other Total Balance as of December 31, 2017 Goodwill $ 223,947 $ 203,069 $ 16,871 $ 1,615 $ 445,502 Accumulated impairment losses — — — (1,615) (1,615) $ 223,947 $ 203,069 $ 16,871 $ — $ 443,887 Acquisition 5,565 174,343 103,678 — 283,586 Reallocation, net — (8,048) 8,048 — — Foreign currency exchange effects (5,579) (9,481) (318) — (15,378) Balance as of December 31, 2018 Goodwill $ 223,933 $ 359,883 $ 128,279 $ 1,615 $ 713,710 Accumulated impairment losses — — — (1,615) (1,615) $ 223,933 $ 359,883 $ 128,279 $ — $ 712,095 Acquisition — 57,934 — — 57,934 Foreign currency exchange effects (2,275) (4,167) (126) — (6,568) Balance as of December 31, 2019 Goodwill $ 221,658 $ 413,650 $ 128,153 $ 1,615 $ 765,076 Accumulated impairment losses — — — (1,615) (1,615) $ 221,658 $ 413,650 $ 128,153 $ — $ 763,461
Summary of amortized intangible assets	2019 2018 Weighted Average Gross Gross Amortization Period Carrying Accumulated Net Carrying Accumulated Net (Years) Amount Amortization Value Amount Amortization Value Amortized intangible assets: Patents 7.2 $ 2,804 (1,318) $ 1,486 $ 5,427 $ (5,294) $ 133 Acquired technology 13.0 100,511 (25,430) 75,081 92,389 (18,304) 74,085 Customer relationships 13.6 217,934 (33,924) 184,010 179,597 (20,439) 159,158 Trademarks and trade names 7.0 35,015 (11,003) 24,012 21,243 (5,914) 15,329 License agreements and other 10.3 16,153 (9,658) 6,495 13,852 (7,653) 6,199 Total intangible assets 12.6 $ 372,417 $ (81,333) $ 291,084 $ 312,508 $ (57,604) $ 254,904
Schedule of future estimated amortization expense	2020 $ 31,135 2021 29,582 2022 29,343 2023 29,171 2024 and thereafter 171,853

ACCOUNTS PAYABLE AND ACCRUED _2

ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)	12 Months Ended
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)	Dec. 31, 2019
ACCOUNTS PAYABLE, ACCRUED AND OTHER LIABILITIES.
Components of accounts payable and accrued liabilities	2019 2018 Accounts payable, principally trade $ 192,739 $ 164,528 Accrued employee compensation costs 163,839 168,349 Customer deposits and other unearned income 86,820 67,775 Other accrued liabilities 129,630 124,547 Total $ 573,028 $ 525,199

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
INCOME TAXES (Tables)	Dec. 31, 2019
INCOME TAXES
Schedule of income before income taxes	Years Ended December 31, 2019 2018 2017 United States $ 94,612 $ 34,404 $ 36,139 International 247,457 231,616 258,686 Total $ 342,069 $ 266,020 $ 294,825
Components of provision (benefit) for income taxes	Years Ended December 31, 2019 2018 2017 Current: U.S. Federal $ 2,129 $ 10,273 $ (342) State/Local 883 877 230 International 88,084 83,456 72,670 $ 91,096 $ 94,606 $ 72,558 Deferred: U.S. Federal/State $ 4,670 $ (17,019) $ 2,570 International 4,076 (6,333) (332) $ 8,746 $ (23,352) $ 2,238 Total $ 99,842 $ 71,254 $ 74,796
Schedule of reconciliation of actual income tax provision and the tax provision computed by applying statutory federal income tax rate	Years Ended December 31, 2019 2018 2017 Income tax at statutory rate $ 71,835 $ 55,864 $ 103,189 State income taxes (benefits), net of federal (tax) benefit 2,622 (1,516) (2,620) Investment incentives (2,530) (1,900) (1,900) Tax resolutions (1,915) (3,400) (5,188) Excess tax benefits from share-based compensation (12,520) (10,800) (10,383) Deferred benefits from tax rate changes — (2,800) (5,055) U.S. GILTI and BEAT (1,485) 5,625 — U.S. tax reform - transition tax — (2,570) 31,575 Results of forward contract — — (23,883) Valuation allowance 10,623 3,170 1,344 Rate differential on earnings of foreign operations 29,807 26,424 (16,097) Other items, net 3,405 3,157 3,814 Actual income tax provision $ 99,842 $ 71,254 $ 74,796 Effective income tax rate 29.2 % 26.8 % 25.4 %
Components of significant deferred tax assets and liabilities	2019 2018 Deferred Tax Assets: Net operating loss carryforwards $ 24,941 $ 22,462 Operating and finance leases 25,440 — Pension liabilities 24,925 15,405 Share-based compensation 6,082 10,130 U.S. federal tax credits 8,575 12,045 U.S. state tax credits 7,881 10,186 Vacation and bonus 7,645 6,891 Research and development 7,539 6,945 Inventory 5,993 6,038 Workers compensation 3,835 3,373 Other 16,496 13,985 Total gross deferred tax assets 139,352 107,460 Less valuation allowance (23,320) (11,189) Net deferred tax assets 116,032 96,271 Deferred Tax Liabilities: Acquisition related intangibles 62,851 59,004 Depreciation and amortization 28,284 31,140 Operating and finance leases 27,555 2,034 Other 6,215 10,351 Total gross deferred tax liabilities 124,905 102,529 Net deferred tax (liabilities) assets $ (8,873) $ (6,258)
Schedule of reconciliation of the beginning and ending amount of income tax uncertainties	2019 2018 2017 Balance at January 1 $ 3,559 $ 3,080 $ 6,356 Increases based on tax positions for the current year 412 360 370 Increases based on tax positions of prior years 663 610 1,562 Settlements (558) (491) (4,874) Lapse of statute of limitations (429) — (334) Balance at December 31 $ 3,647 $ 3,559 $ 3,080
Summary of major tax jurisdictions the Company files in, with the years still subject to income tax examinations	Tax Years Major Tax Subject to Jurisdiction Examination United States — Federal 2014-2019 United States — State 2010-2019 France 2016-2019 Germany 2015-2019 Italy 2014-2019 China 2010-2019

DEBT (Tables)

DEBT (Tables)	12 Months Ended
DEBT (Tables)	Dec. 31, 2019
DEBT
Schedule of short-term debt	2019 2018 Revolving credit facility $ 25,000 $ 79,000 Notes payable 1,436 4,544 Overdrafts 17,823 17,749 $ 44,259 $ 101,293
Schedule of long-term obligations	At December 31, 2019, our long-term obligations consisted of the following: Unamortized Debt Issuance Principal Costs Net Notes payable 0.00% – 10.90% , due in monthly and annual installments through 2028 $ 19,220 $ — $ 19,220 Senior unsecured notes 3.2% , due in 2022 75,000 64 74,936 Senior unsecured debts 3.2% USD floating swapped to 1.36% EUR fixed, equal annual installments through 2022 168,000 390 167,610 Senior unsecured notes 3.5% , due in 2023 125,000 144 124,856 Senior unsecured notes 1.0% , due in 2023 112,170 356 111,814 Senior unsecured notes 3.4% , due in 2024 50,000 63 49,937 Senior unsecured notes 3.5% , due in 2024 100,000 144 99,856 Senior unsecured notes 1.2% , due in 2024 224,340 742 223,598 Senior unsecured notes 3.6% , due in 2025 125,000 169 124,831 Senior unsecured notes 3.6% , due in 2026 125,000 169 124,831 Finance Lease Liabilities 29,952 — 29,952 $ 1,153,682 $ 2,241 $ 1,151,441 Current maturities of long-term obligations (65,988) — (65,988) Total long-term obligations $ 1,087,694 $ 2,241 $ 1,085,453 At December 31, 2018, our long-term obligations consisted of the following: Unamortized Debt Issuance Principal Costs Net Notes payable 0.00% – 16.00% , due in monthly and annual installments through 2028 $ 15,531 $ — $ 15,531 Senior unsecured notes 3.2% , due in 2022 75,000 88 74,912 Senior unsecured debts 4.0% USD floating swapped to 1.36% EUR fixed, equal annual installments through 2022 224,000 541 223,459 Senior unsecured notes 3.5% , due in 2023 125,000 181 124,819 Senior unsecured notes 1.0% , due in 2023 114,535 432 114,103 Senior unsecured notes 3.4% , due in 2024 50,000 76 49,924 Senior unsecured notes 3.5% , due in 2024 100,000 181 99,819 Senior unsecured notes 1.2% , due in 2024 229,070 904 228,166 Senior unsecured notes 3.6% , due in 2025 125,000 207 124,793 Senior unsecured notes 3.6% , due in 2026 125,000 208 124,792 Capital lease obligations 8,353 — 8,353 $ 1,191,489 $ 2,818 $ 1,188,671 Current maturities of long-term obligations (62,678) — (62,678) Total long-term obligations $ 1,128,811 $ 2,818 $ 1,125,993
Schedule of covenants on revolving credit facility and corporate long-term obligations	Requirement Level at December 31, 2019 Consolidated Leverage Ratio (1) Maximum of 3.50 to 1.00 1.71 to 1.00 Consolidated Interest Coverage Ratio (1) Minimum of 3.00 to 1.00 16.21 to 1.00 (1) Definitions of ratios are included as part of the revolving credit facility agreement and the private placement agreements .

LEASE COMMITMENTS (Tables)

LEASE COMMITMENTS (Tables)	12 Months Ended
LEASE COMMITMENTS (Tables)	Dec. 31, 2019
LEASE COMMITMENTS
Schedule of components of lease expense	Year Ended December 31, 2019 Operating lease cost $ 23,410 Finance lease cost: Amortization of right-of-use assets $ 4,217 Interest on lease liabilities 1,353 Total finance lease cost $ 5,570 Short-term lease and variable lease costs $ 8,629
Schedule of supplemental cash flow information related to leases	Year Ended December 31, 2019 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 21,872 Operating cash flows from finance leases 1,245 Financing cash flows from finance leases 4,730 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 15,226 Finance leases 15,957
Schedule of supplemental balance sheet information related to leases	December 31, 2019 Operating Leases Operating lease right-of-use assets $ 72,377 Accounts payable, accrued and other liabilities $ 16,578 Operating lease liabilities 55,276 Total operating lease liabilities $ 71,854 Finance Leases Property, plant and equipment, gross $ 47,020 Accumulated depreciation (4,271) Property, plant and equipment, net $ 42,749 Current maturities of long-term obligations, net of unamortized debt issuance cost $ 4,318 Long-term obligations, net of unamortized debt issuance cost 25,634 Total finance lease liabilities $ 29,952 Weighted Average Remaining Lease Term (in years) Operating leases 6.1 Finance leases 7.0 Weighted Average Discount Rate Operating leases 5.05 % Finance leases 5.13 %
Schedule of maturities of lease liabilities	Maturities of lease liabilities as of December 31, 2019, were as follows: Operating Finance Leases Leases Year 1 $ 19,652 $ 5,655 Year 2 15,411 4,787 Year 3 10,740 3,870 Year 4 9,365 3,099 Year 5 6,998 2,658 Thereafter 22,331 18,051 Total lease payments 84,497 38,120 Less imputed interest (12,643) (8,168) Total $ 71,854 $ 29,952 Maturities of lease liabilities as of December 31, 2018 under the old lease accounting standard were as follows: Operating Capital Leases Leases Year 1 $ 26,512 $ 1,828 Year 2 21,386 1,653 Year 3 16,529 1,546 Year 4 12,549 1,160 Year 5 10,225 880 Thereafter 21,932 3,827 Total lease payments $ 109,133 10,894 Less imputed interest (2,541) Present value of future lease payments $ 8,353

RETIREMENT AND DEFERRED COMPE_2

RETIREMENT AND DEFERRED COMPENSATION PLANS (Tables)	12 Months Ended
RETIREMENT AND DEFERRED COMPENSATION PLANS (Tables)	Dec. 31, 2019
RETIREMENT AND DEFERRED COMPENSATION PLANS
Change in the projected benefit obligation, plan assets at fair value and funded status	Domestic Plans Foreign Plans 2019 2018 2019 2018 Change in benefit obligation: Benefit obligation at beginning of year $ 180,803 $ 198,450 $ 104,911 $ 109,030 Service cost 11,093 11,396 5,921 5,954 Interest cost 7,381 6,878 2,023 1,828 Special termination benefit charge — — 64 62 Plan Amendment — — 18 — Curtailment/Settlement — — (271) (1,751) Transfer — — 939 — Business acquired — — — 1,937 Prior service cost — — (451) 35 Actuarial loss (gain) 39,209 (23,510) 13,575 (3,743) Benefits paid (11,211) (12,411) (4,130) (3,288) Foreign currency translation adjustment — — (2,109) (5,153) Benefit obligation at end of year $ 227,275 $ 180,803 $ 120,490 $ 104,911 Domestic Plans Foreign Plans 2019 2018 2019 2018 Change in plan assets: Fair value of plan assets at beginning of year $ 169,958 $ 169,600 $ 68,992 $ 73,384 Actual return on plan assets 29,618 (7,642) 3,851 (487) Employer contribution 436 20,411 6,542 2,780 Benefits paid (11,211) (12,411) (4,130) (3,288) Transfer — — 359 — Foreign currency translation adjustment — — (1,425) (3,397) Fair value of plan assets at end of year $ 188,801 $ 169,958 $ 74,189 $ 68,992 Funded status at end of year $ (38,474) $ (10,845) $ (46,301) $ (35,919)
Schedule of funded status amounts recognized in the Consolidated Balance Sheet	Domestic Plans Foreign Plans 2019 2018 2019 2018 Non-current assets $ — $ 207 $ 938 $ 500 Current liabilities (449) (430) (44) (8) Non-current liabilities (38,025) (10,622) (47,195) (36,411) $ (38,474) $ (10,845) $ (46,301) $ (35,919)
Schedule of amounts not recognized as components of periodic benefit cost that are recognized in accumulated other comprehensive loss	Domestic Plans Foreign Plans 2019 2018 2019 2018 Net actuarial loss $ 68,789 $ 48,776 $ 40,442 $ 29,761 Net prior service cost — — 3,774 4,656 Tax effects (15,821) (17,876) (14,040) (4,855) $ 52,968 $ 30,900 $ 30,176 $ 29,562
Schedule of changes in benefit obligations and plan assets recognized in other comprehensive income	Domestic Plans 2019 2018 2017 Current year actuarial (loss) gain $ (21,970) $ 4,611 $ (12,593) Amortization of net loss 1,957 4,873 3,205 $ (20,013) $ 9,484 $ (9,388) Foreign Plans 2019 2018 2017 Current year actuarial (loss) gain $ (11,999) $ 534 $ 2,952 Current year prior service cost 451 (35) (1,399) Transfer Prior service Cost (18) — — Transfer Actuarial (loss) gain (126) — — Recognition due to curtailment — 1,692 — Amortization of net loss 1,444 1,716 1,895 Amortization of prior service cost 449 720 400 $ (9,799) $ 4,627 $ 3,848
Schedule of amounts in accumulated other comprehensive loss expected to be recognized as components of periodic benefit cost in the next 12 months	Domestic Plans Foreign Plans Amortization of net loss $ 5,719 $ 2,092 Amortization of prior service cost — 391 $ 5,719 $ 2,483
Components of net periodic benefit cost	Domestic Plans 2019 2018 2017 Service cost $ 11,093 $ 11,396 $ 9,706 Interest cost 7,381 6,878 7,010 Expected return on plan assets (12,379) (11,257) (9,880) Amortization of net loss 1,957 4,873 3,205 Net periodic benefit cost $ 8,052 $ 11,890 $ 10,041 Foreign Plans 2019 2018 2017 Service cost $ 5,921 $ 5,954 $ 5,526 Interest cost 2,023 1,828 1,747 Expected return on plan assets (2,366) (2,610) (2,409) Amortization of net loss 1,444 1,716 1,895 Amortization of prior service cost 449 720 400 Net periodic benefit cost $ 7,471 $ 7,608 $ 7,159 Curtailment (246) (59) — Special termination benefit charge 65 62 — Total Net periodic benefit cost $ 7,290 $ 7,611 $ 7,159
Schedule of projected benefit obligation ("PBO"), ABO, and fair value of plan assets for all pension plans with an ABO in excess of plan assets	Domestic Plans Foreign Plans 2019 2018 2019 2018 Projected benefit obligation $ 227,275 $ 11,052 $ 92,561 $ 93,029 Accumulated benefit obligation 205,326 9,216 65,062 68,981 Fair value of plan assets 188,801 — 46,371 56,611
Schedule of PBO, ABO, and fair value of plan assets for all pension plans with a PBO in excess of plan assets	Domestic Plans Foreign Plans 2019 2018 2019 2018 Projected benefit obligation $ 227,275 $ 11,052 $ 102,310 $ 92,555 Accumulated benefit obligation 205,326 9,216 73,943 68,506 Fair value of plan assets 188,801 — 55,260 56,136
Schedule of weighted-average assumptions used to determine benefit obligations and net periodic benefit cost	Domestic Plans Foreign Plans 2019 2018 2017 2019 2018 2017 Weighted-average assumptions used to determine benefit obligations at December 31: Discount rate 3.20 % 4.20 % 3.55 % 1.04 % 1.82 % 1.62 % Rate of compensation increase 4.00 % 4.00 % 4.00 % 3.05 % 3.01 % 3.02 % Weighted-average assumptions used to determine net periodic benefit cost for years ended December 31: Discount rate 4.20 % 3.55 % 4.05 % 1.84 % 1.62 % 1.65 % Expected long-term return on plan assets 7.00 % 7.00 % 7.00 % 3.69 % 3.66 % 3.66 % Rate of compensation increase 4.00 % 4.00 % 4.00 % 3.05 % 3.02 % 3.00 %
Schedule of domestic and foreign pension plan weighted-average asset allocations by asset category	Domestic Plans Assets Foreign Plans Assets at December 31, at December 31, 2019 2018 2019 2018 Equity securities 49 % 44 % 4 % 4 % Fixed income securities 29 % 29 % 1 % 1 % Corporate debt securities — — 3 % 3 % Infrastructure 6 % 7 % — — Hedge funds 10 % 10 % — — Money market 1 % 5 % 3 % 1 % Investment Funds — — 89 % 91 % Real estate 5 % 5 % — — Total 100 % 100 % 100 % 100 %
Summary of fair value of pension plan assets	Domestic Fair Value Measurement Foreign Fair Value Measurement at December 31, 2019 at December 31, 2019 (In Thousands $) Total (Level 1) (Level 2) (Level 3) Total (Level 1) (Level 2) (Level 3) Cash and Short-term Securities (a) $ 1,988 $ 1,988 $ — $ — $ 2,030 $ 2,030 $ — $ — USD — 1,988 — — — — — — EUR — — — — — 2,012 — — Others — — — — — 18 — — Equity Securities (a) $ 81,997 $ 81,997 — — $ 2,995 $ 2,995 — — U.S. Large Cap Equities — 48,580 — — — — — — U.S. Small Cap Equities — 9,921 — — — — — — International Equities — 23,496 — — — 2,995 — — Fixed Income (a&b) $ 35,898 $ 35,898 — — $ 820 $ 820 — — Corporate debts securities — — — — $ 2,115 $ 2,115 — — Euro Corporate Bonds (a) — — — — — 2,115 — — Investment Funds — — — — $ 66,229 $ 23,797 $ 42,432 — Mutual Funds in Equities (a) — — — — — 4,025 — — Mutual Funds in Bonds (a) — — — — — 18,881 — — Mutual Funds Diversified (a&b) — — — — — 891 42,432 — Total Investments in Fair Value Hierarchy $ 119,883 $ 119,883 $ — $ — $ 74,189 $ 31,757 $ 42,432 $ — Investments at Net Asset Value per Share 68,918 — — — — — — — Total Investments $ 188,801 $ 119,883 $ — $ — $ 74,189 $ 31,757 $ 42,432 $ — Domestic Fair Value Measurement Foreign Fair Value Measurement at December 31, 2018 at December 31, 2018 (In Thousands $) Total (Level 1) (Level 2) (Level 3) Total (Level 1) (Level 2) (Level 3) Cash and Short-term Securities (a) $ 8,964 $ 8,964 $ — $ — $ 718 $ 718 $ — $ — USD — 8,964 — — — — — — EUR — — — — — 718 — — Equity Securities (a) $ 66,707 $ 66,707 — — $ 2,591 $ 2,591 — — U.S. Large Cap Equities — 38,804 — — — — — — U.S. Small Cap Equities — 7,747 — — — — — — International Equities — 20,156 — — — 2,591 — — Fixed Income (a&b) $ 32,272 $ 32,272 — — $ 717 $ 717 — — Corporate debts securities — — — — $ 2,097 $ 2,097 — — Euro Corporate Bonds (a) — — — — — 2,097 — — Investment Funds — — — — $ 62,869 $ 22,122 $ 40,747 — Mutual Funds in Equities (a) — — — — — 3,339 — — Mutual Funds in Bonds (a) — — — — — 18,060 — — Mutual Funds Diversified (a&b) — — — — — 723 40,747 — Total Investments in Fair Value Hierarchy $ 107,943 $ 107,943 $ — $ — $ 68,992 $ 28,245 $ 40,747 $ — Investments at Net Asset Value per Share 62,015 — — — — — — — Total Investments $ 169,958 $ 107,943 $ — $ — $ 68,992 $ 28,245 $ 40,747 $ — (a) Based on third party quotation from financial institution. (b) Based on observable market transactions.
Schedule of estimated benefit payments relating to defined benefit plans over the next ten years	Domestic Plans Foreign Plans 2020 $ 11,064 $ 5,382 2021 11,134 2,904 2022 11,665 3,155 2023 12,467 4,676 2024 13,077 6,537 2025 - 2029 74,584 34,386

ACCUMULATED OTHER COMPREHENSI_2

ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)	12 Months Ended
ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)	Dec. 31, 2019
ACCUMULATED OTHER COMPREHENSIVE INCOME
Changes in Accumulated Other Comprehensive Income/(Loss) by Component	Foreign Defined Benefit Currency Pension Plans Derivatives Total Balance - December 31, 2016 $ (259,888) $ (59,775) $ (46) $ (319,709) Other comprehensive income (loss) before reclassifications 74,385 (8,944) (11,806) 53,635 Amounts reclassified from accumulated other comprehensive income (loss) — 4,124 8,648 12,772 Net current-period other comprehensive income (loss) 74,385 (4,820) (3,158) 66,407 Balance - December 31, 2017 $ (185,503) $ (64,595) $ (3,204) $ (253,302) Other comprehensive (loss) income before reclassifications (62,898) 5,266 16,624 (41,008) Amounts reclassified from accumulated other comprehensive income (loss) — 5,524 (15,060) (9,536) Net current-period other comprehensive (loss) income (62,898) 10,790 1,564 (50,544) Reclassification of stranded tax effects — (6,658) — (6,658) Balance - December 31, 2018 $ (248,401) $ (60,463) $ (1,640) $ (310,504) Other comprehensive (loss) income before reclassifications (8,723) (25,557) 8,026 (26,254) Amounts reclassified from accumulated other comprehensive income (loss) — 2,873 (8,063) (5,190) Net current-period other comprehensive (loss) income (8,723) (22,684) (37) (31,444) Balance - December 31, 2019 $ (257,124) $ (83,147) $ (1,677) $ (341,948)
Reclassifications Out of Accumulated Other Comprehensive (Loss) Income	Amount Reclassified from Details about Accumulated Other Accumulated Other Affected Line in the Statement Comprehensive Income Components Comprehensive Income Where Net Income is Presented Year Ended December 31, 2019 2018 2017 Defined Benefit Pension Plans Amortization of net loss $ 3,401 $ 6,589 $ 5,100 (1) Amortization of prior service cost 449 720 400 (1) 3,850 7,309 5,500 Total before tax (977) (1,785) (1,376) Tax benefit $ 2,873 $ 5,524 $ 4,124 Net of tax Derivatives Changes in treasury locks $ — $ 26 $ 42 Interest Expense Changes in cross currency swap: interest component (4,805) (5,150) (1,526) Interest Expense Changes in cross currency swap: foreign exchange component (3,258) (13,025) 11,911 Miscellaneous, net (8,063) (18,149) 10,427 Total before tax — 3,089 (1,779) Tax benefit $ (8,063) $ (15,060) $ 8,648 Net of tax Total reclassifications for the period $ (5,190) $ (9,536) $ 12,772 (1) These accumulated other comprehensive income components are included in the computation of total net periodic benefit costs, net of tax (see Note 9 - Retirement and Deferred Compensation Plans for additional details).

DERIVATIVE INSTRUMENTS AND HE_2

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)	12 Months Ended
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)	Dec. 31, 2019
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
Schedule of Fair Value of Derivative Instruments in the Consolidated Balance Sheets	Fair Value of Derivative Instruments in the Consolidated Balance Sheets as of December 31, 2019 and December 31, 2018 December 31, 2019 December 31, 2018 Derivatives Derivatives Derivatives not Derivatives not Designated Designated Designated Designated Balance Sheet as Hedging as Hedging as Hedging as Hedging Location Instruments Instruments Instruments Instruments Derivative Assets Foreign Exchange Contracts Prepaid and other $ — $ 206 $ — $ 259 Cross Currency Swap Contract (1) Prepaid and other 2,552 — — — $ 2,552 $ 206 $ — $ 259 Derivative Liabilities Foreign Exchange Contracts Accounts payable, accrued and other liabilities $ — $ 401 $ — $ 331 Cross Currency Swap Contract (1) Accounts payable, accrued and other liabilities — — 1,040 — $ — $ 401 $ 1,040 $ 331 (1) This cross currency swap contract is composed of both an interest component and a foreign exchange component.
Schedule of Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income (Loss)	The Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income (Loss) for the Fiscal Years Ended December 31, 2019 and December 31, 2018 Amount of Gain (Loss) Total Amount Amount of Gain (Loss) Location of (Loss) Reclassified from of Affected Derivatives in Cash Recognized in Gain Recognized Accumulated Income Flow Hedging Other Comprehensive in Income on Other Comprehensive Statement Relationships Income on Derivative Derivatives Income on Derivative Line Item 2019 2018 2019 2018 Cross currency swap contract: Interest component $ 5,103 $ 7,014 Interest expense $ 4,805 $ 5,150 $ (35,489) Foreign exchange component 3,258 13,025 Miscellaneous, net 3,258 13,025 1,556 $ 8,361 $ 20,039 $ 8,063 $ 18,175
Schedule of Effect of Derivatives Not Designated as Hedging Instruments on the Consolidated Statements of Income	The Effect of Derivatives Not Designated as Hedging Instruments on the Consolidated Statements of Income for the Fiscal Years Ended December 31, 2019 and December 31, 2018 Amount of (Loss) Gain Derivatives Not Designated Location of (Loss) Gain Recognized Recognized in Income as Hedging Instruments in Income on Derivatives on Derivatives 2019 2018 Foreign Exchange Contracts Other (Expense) Income: $ (141) $ 652 $ (141) $ 652
Schedule of offsetting derivative assets and liabilities	Gross Amounts not Offset Gross Amounts Net Amounts in the Statement of Offset in the Presented in Financial Position Gross Statement of the Statement of Financial Cash Collateral Net Amount Financial Position Financial Position Instruments Received Amount Description December 31, 2019 Derivative Assets $ 2,758 — $ 2,758 — — $ 2,758 Total Assets $ 2,758 — $ 2,758 — — $ 2,758 Derivative Liabilities $ 401 — $ 401 — — $ 401 Total Liabilities $ 401 — $ 401 — — $ 401 December 31, 2018 Derivative Assets $ 259 — $ 259 — — $ 259 Total Assets $ 259 — $ 259 — — $ 259 Derivative Liabilities $ 1,371 — $ 1,371 — — $ 1,371 Total Liabilities $ 1,371 — $ 1,371 — — $ 1,371

FAIR VALUE (Tables)

FAIR VALUE (Tables)	12 Months Ended
FAIR VALUE (Tables)	Dec. 31, 2019
FAIR VALUE
Schedule of fair values of financial assets and liabilities	As of December 31, 2019, the fair values of our financial assets and liabilities were categorized as follows: Total Level 1 Level 2 Level 3 Assets Foreign exchange contracts (1) $ 206 $ — $ 206 $ — Cross currency swap contract (1) 2,552 — 2,552 — Total assets at fair value $ 2,758 $ — $ 2,758 $ — Liabilities Foreign exchange contracts (1) $ 401 $ — $ 401 $ — Contingent consideration obligation 5,930 — — 5,930 Total liabilities at fair value $ 6,331 $ — $ 401 $ 5,930 As of December 31, 2018, the fair values of our financial assets and liabilities were categorized as follows: Total Level 1 Level 2 Level 3 Assets Foreign exchange contracts (1) $ 259 $ — $ 259 $ — Total assets at fair value $ 259 $ — $ 259 $ — Liabilities Foreign exchange contracts (1) $ 331 $ — $ 331 $ — Cross currency swap contract (1) 1,040 — 1,040 — Total liabilities at fair value $ 1,371 $ — $ 1,371 $ — (1) Market approach valuation technique based on observable market transactions of spot and forward rates.

CAPITAL STOCK (Tables)

CAPITAL STOCK (Tables)	12 Months Ended
CAPITAL STOCK (Tables)	Dec. 31, 2019
CAPITAL STOCK
Schedule of number of shares of common stock and treasury stock and the share activity	Common Shares Treasury Shares 2019 2018 2019 2018 Balance at the beginning of the year 67,341,316 66,742,490 4,424,884 4,881,889 Employee option exercises 1,079,841 1,182,547 (367,705) (502,005) Director option exercises 146,083 — — — Restricted stock vestings 41,268 39,691 — — Common stock repurchases — — 778,848 45,000 Common stock repurchased and retired — (623,412) — — Balance at the end of the year 68,608,508 67,341,316 4,836,027 4,424,884

STOCK-BASED COMPENSATION (Table

STOCK-BASED COMPENSATION (Tables)	12 Months Ended
STOCK-BASED COMPENSATION (Tables)	Dec. 31, 2019
STOCK-BASED COMPENSATION
Weighted-average assumptions used to estimate fair value of stock options granted	Stock Awards Plans: Years Ended December 31, 2018 2017 Dividend Yield 1.5 % 1.7 % Expected Stock Price Volatility 14.2 % 15.8 % Risk-free Interest Rate 2.8 % 2.2 % Expected Life of Option (years) 6.6 6.7
Summary of option activity	Stock Awards Plans Director Stock Option Plans Weighted Average Weighted Average Options Exercise Price Options Exercise Price Outstanding, January 1, 2019 6,761,055 $ 65.76 155,200 $ 58.13 Granted — — — — Exercised (1,560,047) 57.10 (19,949) 55.99 Forfeited or expired (156,828) 73.15 — — Outstanding at December 31, 2019 5,044,180 $ 68.32 135,251 $ 58.45 Exercisable at December 31, 2019 4,288,542 $ 66.01 135,251 $ 58.45 Weighted-Average Remaining Contractual Term (Years): Outstanding at December 31, 2019 5.4 3.2 Exercisable at December 31, 2019 5.0 3.2 Aggregate Intrinsic Value: Outstanding at December 31, 2019 $ 239,033 $ 7,732 Exercisable at December 31, 2019 $ 212,745 $ 7,732 Intrinsic Value of Options Exercised During the Years Ended: December 31, 2019 $ 87,251 $ 1,172 December 31, 2018 $ 72,951 $ 2,286 December 31, 2017 $ 51,140 $ 1,995
Weighted-average assumptions used to estimate fair value of restricted stock units	Year Ended December 31, 2019 2018 Fair value per stock award $ 134.97 $ 128.70 Grant date stock price $ 104.51 $ 89.42 Assumptions: Aptar's stock price expected volatility 16.50 % 12.30 % Expected average volatility of peer companies 31.90 % 27.50 % Correlation assumption 37.40 % 20.20 % Risk-free interest rate 2.19 % 2.42 % Dividend yield assumption 1.30 % 1.43 %
Summary of restricted stock unit activity	Time-Based RSUs Performance-Based RSUs Weighted Average Weighted Average Units Grant-Date Fair Value Units Grant-Date Fair Value Nonvested at January 1, 2019 261,487 $ 91.78 69,990 $ 111.55 Granted 295,412 97.80 123,246 119.35 Vested (51,433) 88.77 — — Forfeited (24,737) 98.72 (11,556) 117.04 Nonvested at December 31, 2019 480,729 $ 95.45 181,680 $ 117.26

EARNINGS PER SHARE (Tables)

EARNINGS PER SHARE (Tables)	12 Months Ended
EARNINGS PER SHARE (Tables)	Dec. 31, 2019
EARNINGS PER SHARE
Reconciliation of Basic and Diluted Earnings Per Share	Income Shares Per Share (Numerator) (Denominator) Amount For the Year Ended December 31, 2019 Basic EPS Income available to common stockholders $ 242,202 63,574 $ 3.81 Effect of Dilutive Securities Stock options 2,344 Restricted stock 232 Diluted EPS Income available to common stockholders $ 242,202 66,150 $ 3.66 For the Year Ended December 31, 2018 Basic EPS Income available to common stockholders $ 194,745 62,437 $ 3.12 Effect of Dilutive Securities Stock options 2,440 Restricted stock 81 Diluted EPS Income available to common stockholders $ 194,745 64,958 $ 3.00 For the Year Ended December 31, 2017 Basic EPS Income available to common stockholders $ 220,030 62,435 $ 3.52 Effect of Dilutive Securities Stock options 2,106 Restricted stock 55 Diluted EPS Income available to common stockholders $ 220,030 64,596 $ 3.41

SEGMENT INFORMATION (Tables)

SEGMENT INFORMATION (Tables)	12 Months Ended
SEGMENT INFORMATION (Tables)	Dec. 31, 2019
SEGMENT INFORMATION
Financial information regarding the Company's reportable segments	Year Ended December 31, 2019 2018 2017 Total Sales: Beauty + Home $ 1,376,027 $ 1,446,231 $ 1,333,048 Pharma 1,100,463 955,069 805,913 Food + Beverage 418,017 386,689 352,483 Total Sales $ 2,894,507 $ 2,787,989 $ 2,491,444 Less: Intersegment Sales: Beauty + Home $ 23,313 $ 19,849 $ 19,262 Pharma 9,412 417 33 Food + Beverage 2,050 2,962 2,866 Total Intersegment Sales $ 34,775 $ 23,228 $ 22,161 Net Sales: Beauty + Home $ 1,352,714 $ 1,426,382 $ 1,313,786 Pharma 1,091,051 954,652 805,880 Food + Beverage 415,967 383,727 349,617 Net Sales $ 2,859,732 $ 2,764,761 $ 2,469,283 Adjusted EBITDA (1): Beauty + Home $ 181,150 $ 185,926 $ 173,227 Pharma 387,483 343,706 275,933 Food + Beverage 68,108 57,589 62,903 Corporate & Other, unallocated (44,406) (36,285) (37,457) Acquisition-related costs (2) (3,927) (23,770) — Restructuring Initiatives (3) (20,472) (63,829) (2,208) Gain on insurance recovery (4) — — 10,648 Depreciation and amortization (5) (194,552) (171,747) (153,094) Interest Expense (35,489) (32,626) (40,597) Interest Income 4,174 7,056 5,470 Income before Income Taxes $ 342,069 $ 266,020 $ 294,825 Depreciation and Amortization: Beauty + Home $ 82,778 $ 83,546 $ 79,422 Pharma 65,590 51,495 41,143 Food + Beverage 35,728 27,467 24,720 Corporate & Other 10,456 9,239 7,809 Depreciation and Amortization $ 194,552 $ 171,747 $ 153,094 Capital Expenditures: Beauty + Home $ 96,040 $ 101,371 $ 76,425 Pharma 89,702 54,433 33,005 Food + Beverage 45,130 41,236 38,730 Corporate & Other 13,933 25,739 18,924 Transfer of Corporate Technology Expenditures (6) (2,529) (11,527) (10,460) Capital Expenditures $ 242,276 $ 211,252 $ 156,624 Total Assets: Beauty + Home $ 1,378,292 $ 1,373,816 $ 1,358,283 Pharma 1,422,815 1,324,696 881,443 Food + Beverage 534,527 501,700 296,271 Corporate & Other 226,485 177,523 601,826 Total Assets $ 3,562,119 $ 3,377,735 $ 3,137,823 (1) We evaluate performance of our reporting segments and allocate resources based upon Adjusted EBITDA. Adjusted EBITDA is defined as earnings before net interest, taxes, depreciation, amortization, unallocated corporate expenses, restructuring, acquisition-related costs and insurance recoveries. (2) Acquisition-related costs include transaction costs and purchase accounting adjustments related to inventory for acquisitions (see Note 20 – Acquisitions for further details). (3) Restructuring Initiatives includes expense items for the years ended December 31, 2019 and 2018 as follows (see Note 21 – Restructuring Initiatives for further details): Year Ended December 31, 2019 2018 2017 Restructuring Initiatives by Segment Beauty + Home $ 17,682 $ 52,244 $ 529 Pharma 632 3,589 — Food + Beverage 391 4,185 1,679 Corporate & Other 1,767 3,811 — Total Restructuring Initiatives $ 20,472 $ 63,829 $ 2,208 (4) The gain on insurance recovery relates to the Annecy fire (see Note 19 – Insurance Settlement Receivable for further details). (5) Depreciation and amortization includes amortization related to acquisition purchase accounting adjustments for backlog. See the reconciliation of Non-U.S. GAAP measures starting on page 22 . (6) The transfer of corporate technology expenditures represents amounts of projects managed by corporate for the benefit of specific entities within each segment. Once the projects are complete, all related costs are allocated from corporate to and paid by the appropriate entity and the associated assets are then depreciated at the entity level.
Restructuring Initiatives	Year Ended December 31, 2019 2018 2017 Restructuring Initiatives by Segment Beauty + Home $ 17,682 $ 52,244 $ 529 Pharma 632 3,589 — Food + Beverage 391 4,185 1,679 Corporate & Other 1,767 3,811 — Total Restructuring Initiatives $ 20,472 $ 63,829 $ 2,208
Schedule of net sales and long-lived asset information by geographic area	2019 2018 2017 Net Sales to Unaffiliated Customers (1): United States $ 836,768 $ 726,336 $ 642,164 Europe: France 895,110 862,364 744,856 Germany 452,409 474,369 416,802 Italy 141,867 144,044 131,523 Other Europe 149,083 146,701 132,992 Total Europe 1,638,469 1,627,478 1,426,173 Other Foreign Countries 384,495 410,947 400,946 Total $ 2,859,732 $ 2,764,761 $ 2,469,283 Property, Plant and Equipment United States $ 300,820 $ 265,004 $ 182,434 Europe: France 338,288 308,250 266,804 Germany 163,782 154,505 163,948 Italy 53,562 54,978 57,080 Other Europe 63,636 59,411 59,963 Total Europe 619,268 577,144 547,795 Other Foreign Countries 167,590 149,465 137,677 Total $ 1,087,678 $ 991,613 $ 867,906 (1) Sales are attributed to countries based upon where the sales invoice to unaffiliated customers is generated.

ACQUISITIONS (Tables)

ACQUISITIONS (Tables)	12 Months Ended
ACQUISITIONS (Tables)	Dec. 31, 2019
ACQUISITIONS
Summary of assets acquired and liabilities assumed at estimated fair value	2019 2018 Assets Cash and equivalents $ 3,427 $ 24,053 Accounts receivable 3,504 20,847 Inventories — 42,169 Prepaid and other 2,478 3,995 Property, plant and equipment 4,267 99,194 Goodwill 59,143 278,020 Intangible assets 52,980 177,120 Other miscellaneous assets 430 1,039 Liabilities Current maturities of long-term obligations — 129 Accounts payable, accrued and other liabilities 5,388 31,989 Long-term obligations — 6,037 Deferred income taxes 2,592 38,442 Retirement and deferred compensation plans — 1,038 Deferred and other non-current liabilities 1,598 15,344 Net assets acquired $ 116,651 $ 553,458
Summary of the fair value estimates of the acquired identifiable intangible assets and weighted-average useful lives as of the acquisition date	2019 2018 Weighted-Average Estimated Weighted-Average Estimated Useful Life Fair Value Useful Life Fair Value (in years) of Asset (in years) of Asset Acquired technology 8 $ 9,160 12 $ 46,700 Customer relationships 11 39,379 16 113,300 Trademarks and trade names 4 2,457 9 14,600 License agreements and other 1 1,984 11 2,520 Total $ 52,980 $ 177,120
Schedule of unaudited pro forma financial information	Years Ended December 31, 2018 2017 Net Sales $ 2,857,765 $ 2,605,095 Net Income Attributable to AptarGroup Inc. 208,717 230,753 Net Income per common share — basic 3.34 3.70 Net Income per common share — diluted 3.21 3.57

RESTRUCTURING INITIATIVES (Tabl

RESTRUCTURING INITIATIVES (Tables)	12 Months Ended
RESTRUCTURING INITIATIVES (Tables)	Dec. 31, 2019
RESTRUCTURING INITIATIVES.
Activity associated with the entity's restructuring initiatives	Beginning Net Charges Ending Reserve at for the Year Interest and Reserve at 12/31/2018 Ended 12/31/2019 Cash Paid FX Impact 12/31/2019 Employee severance $ 3,934 $ 8,104 $ (4,813) $ (135) $ 7,090 Professional fees and other costs 11,101 12,368 (19,795) (65) 3,609 Totals $ 15,035 $ 20,472 $ (24,608) $ (200) $ 10,699

QUARTERLY DATA (UNAUDITED) (Tab

QUARTERLY DATA (UNAUDITED) (Tables)	12 Months Ended
QUARTERLY DATA (UNAUDITED) (Tables)	Dec. 31, 2019
QUARTERLY DATA (UNAUDITED)
Schedule of quarterly results of operations and per share information	Quarter Total First Second Third Fourth for Year Year Ended December 31, 2019: Net sales $ 744,460 $ 742,661 $ 701,278 $ 671,333 $ 2,859,732 Gross profit (1) 233,841 231,739 215,222 193,588 874,390 Net Income 62,999 73,921 56,769 48,538 242,227 Net Income Attributable to AptarGroup, Inc. 63,004 73,915 56,750 48,533 242,202 Per Common Share — 2019: Net Income Attributable to AptarGroup, Inc. Basic $ 1.00 $ 1.16 $ .89 $ .76 $ 3.81 Diluted .96 1.12 .85 .73 3.66 Average number of shares outstanding: Basic 62,964 63,471 64,010 63,835 63,574 Diluted 65,349 66,232 66,702 66,192 66,150 Year Ended December 31, 2018: Net sales $ 703,350 $ 710,608 $ 665,775 $ 685,028 $ 2,764,761 Gross profit (1) 209,171 209,018 192,544 184,775 795,508 Net Income 59,288 55,781 39,022 40,675 194,766 Net Income Attributable to AptarGroup, Inc. 59,300 55,775 38,996 40,674 194,745 Per Common Share — 2018: Net Income Attributable to AptarGroup, Inc. Basic $ .95 $ .89 $ .63 $ .65 $ 3.12 Diluted .92 .86 .60 .62 3.00 Average number of shares outstanding: Basic 62,128 62,402 62,378 62,834 62,437 Diluted 64,414 64,850 65,129 65,344 64,958 (1) Gross profit is defined as net sales less cost of sales and depreciation.

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Basis of Presentation (Details) - Argentina - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2019
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Amount Recognized in Income Due to Inflationary Accounting	$ 0.8
Maximum \| Consolidated net revenues \| Geographic concentration risk
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Concentration risk percentage		2.00%

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Adoption of ASU 2016-02 and ASU 2018-02 (Details) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2018	Dec. 31, 2019	Jan. 01, 2019	Jan. 01, 2018	Dec. 31, 2017
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating lease right-of-use assets		$ 72,377	$ 83,222
Prepaid and other	$ 118,245	115,048	116,862	$ 116,202	$ 109,791
Property, plant and equipment	991,613	1,087,678	997,489		867,906
Current maturities of long-term obligations, net of unamortized debt issuance costs	62,678	65,988	65,309
Accounts payable, accrued and other liabilities	525,199	573,028	545,707	$ 455,873	$ 461,579
Operating lease liabilities		55,276	61,331
Long-term obligations, net of unamortized debt issuance costs	1,125,993	$ 1,085,453	1,129,238
Reclassification of stranded income tax effects from AOCI to retained earnings	$ 6,700
Accounting Standards Update 2016-02 \| Adjustment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating lease right-of-use assets			83,222
Prepaid and other			(1,383)
Property, plant and equipment			5,876
Current maturities of long-term obligations, net of unamortized debt issuance costs			2,631
Accounts payable, accrued and other liabilities			20,508
Operating lease liabilities			61,331
Long-term obligations, net of unamortized debt issuance costs			$ 3,245

SUMMARY OF SIGNIFICANT ACCOUN_6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue Recognition, Adjustments to Opening Balances (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Jan. 01, 2019	Dec. 31, 2018	Jan. 01, 2018	Dec. 31, 2017
Assets
Inventories	$ 375,795		$ 381,110	$ 330,152	$ 337,216
Prepaid and other	115,048	$ 116,862	118,245	116,202	109,791
Liabilities
Accounts payable, accrued and other liabilities	573,028	$ 545,707	525,199	455,873	461,579
Deferred income taxes	41,388		53,917	22,287	20,995
Deferred and other non-current liabilities	23,250		23,465	6,432	5,608
Stockholders' Equity
Retained earnings	$ 1,523,820		1,371,826	1,304,084	$ 1,301,147
Adjustment/Effect of Change \| Accounting Standards Update 2014-09
Assets
Inventories			(10,205)	(7,064)
Prepaid and other			9,755	6,411
Liabilities
Accounts payable, accrued and other liabilities			(3,969)	(5,706)
Deferred income taxes			1,005	1,292
Deferred and other non-current liabilities			399	824
Stockholders' Equity
Retained earnings			$ 2,115	$ 2,937

SUMMARY OF SIGNIFICANT ACCOUN_7

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue Recognition, Balances Reported with and without Adoption of ASC 606 (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Jan. 01, 2019	Jan. 01, 2018
Consolidated Statements of Income
Net sales	$ 671,333	$ 701,278	$ 742,661	$ 744,460	$ 685,028	$ 665,775	$ 710,608	$ 703,350	$ 2,859,732	$ 2,764,761	$ 2,469,283
Costs and Expenses
Cost of sales									1,818,398	1,812,961	1,603,070
Provision for income taxes									99,842	71,254	74,796
Net income	48,538	$ 56,769	$ 73,921	$ 62,999	40,675	$ 39,022	$ 55,781	$ 59,288	242,227	194,766	220,029
Assets
Accounts and note receivable	558,428				569,630				558,428	569,630
Inventories	375,795				381,110				375,795	381,110	337,216		$ 330,152
Prepaid and other	115,048				118,245				115,048	118,245	109,791	$ 116,862	116,202
Liabilities
Accounts payable, accrued and other liabilities	573,028				525,199				573,028	525,199	461,579	$ 545,707	455,873
Deferred income taxes	41,388				53,917				41,388	53,917	20,995		22,287
Deferred and other non-current liabilities	23,250				23,465				23,250	23,465	5,608		6,432
Stockholders' Equity
Retained earnings	$ 1,523,820				1,371,826				1,523,820	1,371,826	1,301,147		1,304,084
Beauty + Home
Consolidated Statements of Income
Net sales									1,352,714	1,426,382	1,313,786
Pharma
Consolidated Statements of Income
Net sales									1,091,051	954,652	805,880
Food + Beverage
Consolidated Statements of Income
Net sales									$ 415,967	383,727	$ 349,617
Balances Without Adoption of ASC 606 \| Accounting Standards Update 2014-09
Costs and Expenses
Cost of sales										1,811,290
Provision for income taxes										71,541
Net income										195,588
Assets
Inventories					391,315					391,315
Prepaid and other					108,490					108,490
Liabilities
Accounts payable, accrued and other liabilities					529,168					529,168
Deferred income taxes					52,912					52,912
Deferred and other non-current liabilities					23,066					23,066
Stockholders' Equity
Retained earnings					1,369,711					1,369,711
Balances Without Adoption of ASC 606 \| Accounting Standards Update 2014-09 \| Beauty + Home
Consolidated Statements of Income
Net sales										1,424,701
Balances Without Adoption of ASC 606 \| Accounting Standards Update 2014-09 \| Pharma
Consolidated Statements of Income
Net sales										954,497
Balances Without Adoption of ASC 606 \| Accounting Standards Update 2014-09 \| Food + Beverage
Consolidated Statements of Income
Net sales										385,001
Adjustment/Effect of Change \| Accounting Standards Update 2014-09
Costs and Expenses
Cost of sales										1,671
Provision for income taxes										(287)
Net income										(822)
Assets
Inventories					(10,205)					(10,205)			(7,064)
Prepaid and other					9,755					9,755			6,411
Liabilities
Accounts payable, accrued and other liabilities					(3,969)					(3,969)			(5,706)
Deferred income taxes					1,005					1,005			1,292
Deferred and other non-current liabilities					399					399			824
Stockholders' Equity
Retained earnings					$ 2,115					2,115			$ 2,937
Adjustment/Effect of Change \| Accounting Standards Update 2014-09 \| Beauty + Home
Consolidated Statements of Income
Net sales										1,681
Adjustment/Effect of Change \| Accounting Standards Update 2014-09 \| Pharma
Consolidated Statements of Income
Net sales										155
Adjustment/Effect of Change \| Accounting Standards Update 2014-09 \| Food + Beverage
Consolidated Statements of Income
Net sales										$ (1,274)

SUMMARY OF SIGNIFICANT ACCOUN_8

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Adoption of ASU 2017-07 (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cost of sales	$ 1,818,398	$ 1,812,961	$ 1,603,070
Selling, research & development and administrative	454,617	429,955	387,424
Total Operating Expenses	2,488,039	2,478,492	2,145,796
Operating Income	371,693	286,269	323,487
Miscellaneous, net	1,556	5,550	6,694
Total Other (Expense) Income	(29,624)	(20,249)	(28,662)
Income before Income Taxes	$ 342,069	266,020	$ 294,825
Accounting Standards Update 2018-02 \| Retained Earnings
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Adoption of accounting standards		6,658
Accounting Standards Update 2018-02 \| Accumulated Other Comprehensive Income/(Loss)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Adoption of accounting standards		$ (6,658)

SUMMARY OF SIGNIFICANT ACCOUN_9

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) $ / shares in Units, shares in Thousands, $ in Thousands	1 Months Ended	12 Months Ended
	Jan. 31, 2019USD ($)	Dec. 31, 2019USD ($)segment$ / sharesshares	Dec. 31, 2018USD ($)$ / sharesshares	Dec. 31, 2017USD ($)	Aug. 31, 2019USD ($)	May 31, 2018USD ($)
Number of reportable segments \| segment		3
Total Restructuring Initiatives		$ 20,472	$ 63,829	$ 2,208
INVESTMENTS IN EQUITY SECURITIES
Dividends received from affiliates		0	0	0
Proceeds from sale of investment in equity securities		16,487
Investment in unconsolidated affiliate		3,530	10,000	5,000
Increase (decrease) in value of preferred equity stock investment			$ 6,500
GOODWILL
Impairment of goodwill		$ 0
RETIREMENT OF COMMON STOCK
Common stock repurchased (retired and held in treasury) (in shares) \| shares		779	668
Common stock repurchased and retired (in shares) \| shares			623
Common stock, par value (in dollars per share) \| $ / shares		$ 0.01	$ 0.01
RESEARCH & DEVELOPMENT EXPENSES
Research and development expenses incurred net of customer funded research and development or government research and development credits		$ 82,800	$ 75,300	68,200
INCOME TAXES
Net benefit related to additional guidance with respect to the calculation of the transition tax		0	2,570	(31,575)
Net benefit related to the change in the federal corporate tax rate		0	2,800	5,055
TRANSLATION OF FOREIGN CURRENCIES
Foreign Currency Transaction Gain (Loss), before Tax		(1,700)	(1,700)	(5,000)
ADOPTION OF RECENT ACCOUNTING PRONOUNCEMENTS
Provision for Income Taxes		$ 99,842	71,254	74,796
Preferred equity stocks
INVESTMENTS IN EQUITY SECURITIES
Proceeds from sale of investment in equity securities	$ 16,500
Investment in preferred equity stock						$ 10,000
Increase (decrease) in value of preferred equity stock investment			6,500
Cost method investments					$ 3,500
Buildings and improvements \| Minimum
PROPERTY AND DEPRECIATION
Estimated useful lives		10 years
Buildings and improvements \| Maximum
PROPERTY AND DEPRECIATION
Estimated useful lives		40 years
Machinery and equipment \| Minimum
PROPERTY AND DEPRECIATION
Estimated useful lives		3 years
Machinery and equipment \| Maximum
PROPERTY AND DEPRECIATION
Estimated useful lives		15 years
Finite-Lived Intangible Assets \| Minimum
FINITE-LIVED INTANGIBLE ASSETS
Finite-Lived Intangible Asset, Useful Life		1 year
Finite-Lived Intangible Assets \| Maximum
FINITE-LIVED INTANGIBLE ASSETS
Finite-Lived Intangible Asset, Useful Life		20 years
Beauty + Home
Total Restructuring Initiatives		$ 17,682	52,244	529
Pharma
Total Restructuring Initiatives		632	3,589
Food + Beverage
Total Restructuring Initiatives		391	4,185	1,679
Corporate & Other
Total Restructuring Initiatives		1,767	3,811
Business Transformation
Total Restructuring Initiatives		$ 20,472	$ 63,829	$ 2,208

REVENUE - Revenue by Geographic

REVENUE - Revenue by Geographic Segment (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
REVENUE
Net revenue	$ 2,859,732	$ 2,764,761
Beauty + Home
REVENUE
Net revenue	1,352,714	1,426,382
Pharma
REVENUE
Net revenue	1,091,051	954,652
Food + Beverage
REVENUE
Net revenue	415,967	383,727
Europe
REVENUE
Net revenue	1,638,469	1,627,478
Europe \| Beauty + Home
REVENUE
Net revenue	792,255	816,359
Europe \| Pharma
REVENUE
Net revenue	729,882	696,079
Europe \| Food + Beverage
REVENUE
Net revenue	116,332	115,040
North America
REVENUE
Net revenue	836,768	726,336
North America \| Beauty + Home
REVENUE
Net revenue	310,411	334,881
North America \| Pharma
REVENUE
Net revenue	297,871	196,928
North America \| Food + Beverage
REVENUE
Net revenue	228,486	194,527
Latin America
REVENUE
Net revenue	220,388	235,619
Latin America \| Beauty + Home
REVENUE
Net revenue	160,048	178,392
Latin America \| Pharma
REVENUE
Net revenue	26,344	25,485
Latin America \| Food + Beverage
REVENUE
Net revenue	33,996	31,742
Asia
REVENUE
Net revenue	164,107	175,328
Asia \| Beauty + Home
REVENUE
Net revenue	90,000	96,750
Asia \| Pharma
REVENUE
Net revenue	36,954	36,160
Asia \| Food + Beverage
REVENUE
Net revenue	$ 37,153	$ 42,418

REVENUE - Contract Assets and C

REVENUE - Contract Assets and Contract Liabilities (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
REVENUE.
Contract asset (current)	$ 16,245	$ 15,858
Increase / (decrease) in contract asset (current)	387
Contract liability (current)	79,305	68,134
Increase / (decrease) in contract liability (current)	11,171
Contract liability (long-term)	9,779	11,261
Increase / (decrease) in contract liability (long-term)	(1,482)
Revenue recognized previously included in current contract liabilities	61,300
Revenue recognized previously included in current contract liabilities at beginning of the year	32,600
Unearned revenue associated with outstanding contracts	515	$ 758
Estimated revenue to be recognized in 2020	228
Estimated revenue to be recognized after 2020	$ 287

INVENTORIES (Details)

INVENTORIES (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018	Jan. 01, 2018	Dec. 31, 2017
Inventories, by component
Raw materials	$ 111,653	$ 110,720
Work in process	123,750	131,091
Finished goods	140,392	139,299
Total	$ 375,795	$ 381,110	$ 330,152	$ 337,216

GOODWILL AND OTHER INTANGIBLE_3

GOODWILL AND OTHER INTANGIBLE ASSETS (Schedule of Goodwill) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Changes in the carrying amount of goodwill
Goodwill	$ 765,076	$ 713,710	$ 445,502
Accumulated impairment losses	(1,615)	(1,615)	(1,615)
Goodwill, Total	763,461	712,095	443,887
Acquisition	(57,934)	(283,586)
Foreign currency exchange effects	(6,568)	(15,378)
Impairment of goodwill	0
Operating segment \| Beauty + Home
Changes in the carrying amount of goodwill
Goodwill	221,658	223,933	223,947
Goodwill, Total	221,658	223,933	223,947
Acquisition		(5,565)
Foreign currency exchange effects	(2,275)	(5,579)
Operating segment \| Pharma
Changes in the carrying amount of goodwill
Goodwill	413,650	359,883	203,069
Goodwill, Total	413,650	359,883	203,069
Acquisition	(57,934)	(174,343)
Reallocation, net		(8,048)
Foreign currency exchange effects	(4,167)	(9,481)
Operating segment \| Food + Beverage
Changes in the carrying amount of goodwill
Goodwill	128,153	128,279	16,871
Goodwill, Total	128,153	128,279	16,871
Acquisition		(103,678)
Reallocation, net		8,048
Foreign currency exchange effects	(126)	(318)
Corporate Non-Segment
Changes in the carrying amount of goodwill
Goodwill	1,615	1,615	1,615
Accumulated impairment losses	$ (1,615)	$ (1,615)	$ (1,615)

GOODWILL AND OTHER INTANGIBLE_4

GOODWILL AND OTHER INTANGIBLE ASSETS (Summary of Intangible Assets) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Amortized intangible assets:
Gross Carrying Amount	$ 372,417	$ 312,508
Accumulated Amortization	(81,333)	(57,604)
Net Value	291,084	254,904
Aggregate amortization expense	27,608	15,455	$ 10,339
Future estimated amortization expense
2020	31,135
2021	29,582
2022	29,343
2023	29,171
2024 and thereafter	$ 171,853
Weighted Average
Amortized intangible assets:
Amortization Period	12 years 7 months 6 days
Patents
Amortized intangible assets:
Gross Carrying Amount	$ 2,804	5,427
Accumulated Amortization	(1,318)	(5,294)
Net Value	$ 1,486	133
Patents \| Weighted Average
Amortized intangible assets:
Amortization Period	7 years 2 months 12 days
Acquired technology
Amortized intangible assets:
Gross Carrying Amount	$ 100,511	92,389
Accumulated Amortization	(25,430)	(18,304)
Net Value	$ 75,081	74,085
Acquired technology \| Weighted Average
Amortized intangible assets:
Amortization Period	13 years
Customer relationships
Amortized intangible assets:
Gross Carrying Amount	$ 217,934	179,597
Accumulated Amortization	(33,924)	(20,439)
Net Value	$ 184,010	159,158
Customer relationships \| Weighted Average
Amortized intangible assets:
Amortization Period	13 years 7 months 6 days
Trademarks and trade names
Amortized intangible assets:
Gross Carrying Amount	$ 35,015	21,243
Accumulated Amortization	(11,003)	(5,914)
Net Value	$ 24,012	15,329
Trademarks and trade names \| Weighted Average
Amortized intangible assets:
Amortization Period	7 years
License agreements and other
Amortized intangible assets:
Gross Carrying Amount	$ 16,153	13,852
Accumulated Amortization	(9,658)	(7,653)
Net Value	$ 6,495	$ 6,199
License agreements and other \| Weighted Average
Amortized intangible assets:
Amortization Period	10 years 3 months 18 days

ACCOUNTS PAYABLE, ACCRUED AND O

ACCOUNTS PAYABLE, ACCRUED AND OTHER LIABILITIES (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Jan. 01, 2019	Dec. 31, 2018	Jan. 01, 2018	Dec. 31, 2017
ACCOUNTS PAYABLE, ACCRUED AND OTHER LIABILITIES.
Accounts payable, principally trade	$ 192,739		$ 164,528
Accrued employee compensation costs	163,839		168,349
Customer deposits and other unearned income	86,820		67,775
Other accrued liabilities	129,630		124,547
Total	$ 573,028	$ 545,707	$ 525,199	$ 455,873	$ 461,579

INCOME TAXES (Details)

INCOME TAXES (Details) - USD ($) $ in Thousands	12 Months Ended
INCOME TAXES (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Income before income taxes:
United States	$ 94,612	$ 34,404	$ 36,139
International	247,457	231,616	258,686
Income before Income Taxes	342,069	266,020	294,825
Current:
U.S. Federal	2,129	10,273	(342)
State/Local	883	877	230
International	88,084	83,456	72,670
Total Current	91,096	94,606	72,558
Deferred:
U.S. Federal/State	4,670	(17,019)	2,570
International	4,076	(6,333)	(332)
Total Deferred	8,746	(23,352)	2,238
Total	$ 99,842	$ 71,254	$ 74,796
Statutory federal income tax rate (as a percent)	21.00%	21.00%	35.00%
Reconciliation of actual income tax provision and tax provision computed by applying statutory federal income tax rate
Income tax at statutory rate	$ 71,835	$ 55,864	$ 103,189
State income taxes (benefits), net of federal benefit (tax)	2,622	(1,516)	(2,620)
Investment incentives	(2,530)	(1,900)	(1,900)
Tax resolutions	(1,915)	(3,400)	(5,188)
Excess tax benefits from equity compensation	(12,520)	(10,800)	(10,383)
Deferred benefits from tax rate changes	0	(2,800)	(5,055)
U.S. GILTI and BEAT	(1,485)	5,625
U.S. tax reform - transition tax	0	(2,570)	31,575
Results of forward contract	0		(23,883)
Valuation allowance	10,623	3,170	1,344
Rate differential on earnings of foreign operations	29,807	26,424	(16,097)
Other items, net	3,405	3,157	3,814
Total	$ 99,842	$ 71,254	$ 74,796
Effective income tax rate (as a percent)	29.20%	26.80%	25.40%
Tax benefits from employee share-based compensation	$ 12,500
Deferred Tax Assets:
Net operating loss carryforwards	24,941	$ 22,462
Operating and finance leases	25,440
Pension liabilities	24,925	15,405
Stock compensation	6,082	10,130
U.S. federal tax credits	8,575	12,045
U.S. state tax credits	7,881	10,186
Vacation and bonus	7,645	6,891
Research and development	7,539	6,945
Inventory	5,993	6,038
Workers compensation	3,835	3,373
Other	16,496	13,985
Total gross deferred tax assets	139,352	107,460
Less valuation allowance	(23,320)	(11,189)
Net deferred tax assets	116,032	96,271
Deferred Tax Liabilities:
Acquisition related intangibles	62,851	59,004
Depreciation and amortization	28,284	31,140
Operating and finance leases	27,555	2,034
Other	6,215	10,351
Total gross deferred tax liabilities	124,905	102,529
Net deferred tax liabilities	(8,873)	$ (6,258)
Increase (decrease) in valuation allowance	12,100
Tax-effected net operating loss carryforwards not subject to expiration	20,800
Tax-effected net operating loss subject to expiration	4,100
Amount of state tax credit carryforwards subject to expiration	7,900
Foreign Tax Authority \| Minimum
Deferred Tax Liabilities:
Estimated additional tax payable on previously unremitted earnings	20,000
Foreign Tax Authority \| Maximum
Deferred Tax Liabilities:
Estimated additional tax payable on previously unremitted earnings	$ 30,000
Internal Revenue Service (IRS)
Reconciliation of actual income tax provision and tax provision computed by applying statutory federal income tax rate
Deferred benefits from tax rate changes			$ (6,800)
France
Reconciliation of actual income tax provision and tax provision computed by applying statutory federal income tax rate
Tax resolutions			(2,000)
France and Argentina
Reconciliation of actual income tax provision and tax provision computed by applying statutory federal income tax rate
Deferred benefits from tax rate changes			1,700
Europe
Reconciliation of actual income tax provision and tax provision computed by applying statutory federal income tax rate
Tax resolutions			$ (3,200)

INCOME TAXES (Reconciliation of

INCOME TAXES (Reconciliation of Income Tax Uncertainties) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Valuation Allowance [Line Items]
Valuation allowance	$ 23,320	$ 11,189
Reconciliation of the beginning and ending amount of income tax uncertainties
Balance at the beginning of period	3,559	3,080	$ 6,356
Increases based on tax positions for the current year	412	360	370
Increases based on tax positions of prior years	663	610	1,562
Settlements	(558)	(491)	(4,874)
Lapse of statute of limitations	(429)		(334)
Balance at the end of period	3,647	3,559	3,080
Foreign taxes payable in the event of non-fulfillment of terms of government grants	1,600
Amount of income tax uncertainties that, if recognized, would impact the effective tax rate	3,600
Decrease in liability for uncertain tax positions, high end of range	1,800
Unrecognized tax benefits, amount accrued for the payment of interest and penalties	1,700	1,900	1,600
Unrecognized tax benefits, amount recognized in income tax expense	(200)	$ 400	$ 100
Deferred tax assets related to tax credit carryforwards, U.S. state
Valuation Allowance [Line Items]
Valuation allowance	3,100
Deferred tax assets for specified locations
Valuation Allowance [Line Items]
Valuation allowance	$ 20,200

DEBT - Short-term Debt Obligati

DEBT - Short-term Debt Obligations (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Short-term Debt [Line Items]
Notes payable, revolving credit facility and overdrafts	$ 44,259	$ 101,293
Revolving credit facility
Short-term Debt [Line Items]
Notes payable, revolving credit facility and overdrafts	25,000	79,000
Notes payable
Short-term Debt [Line Items]
Notes payable, revolving credit facility and overdrafts	1,436	4,544
Overdrafts
Short-term Debt [Line Items]
Notes payable, revolving credit facility and overdrafts	$ 17,823	$ 17,749

DEBT (Details)

DEBT (Details) $ in Thousands, € in Millions	3 Months Ended	12 Months Ended
DEBT (Details) $ in Thousands, € in Millions	Sep. 30, 2017USD ($)	Dec. 31, 2019USD ($)	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)	Dec. 31, 2019EUR (€)	Jan. 01, 2019USD ($)	Dec. 31, 2018EUR (€)
Components of the company's debt obligations
Consolidated Leverage Ratio		1.71			1.71
Consolidated Interest Coverage Ratio		16.21			16.21
Long-term obligations gross including current maturities		$ 1,153,682	$ 1,191,489
Current maturities of long-term obligations		(65,988)	(62,678)
Total long-term obligations		1,087,694	1,128,811
Deferred Finance Costs, Net, Total		2,241	2,818
Deferred debt issuance costs noncurrent		2,241	2,818
Long-term obligations including current maturities		1,151,441	1,188,671
Current maturities of long-term obligations		(65,988)	(62,678)			$ (65,309)
Long-term obligations, net of unamortized debt issuance costs		1,085,453	1,125,993			$ 1,129,238
Aggregate long-term maturities, excluding finance lease obligations
Year One		61,670
Year Two		61,337
Year Three		135,324
Year Four		239,826
Year Five		375,169
After Year Five		$ 250,404
Minimum
Components of the company's debt obligations
Consolidated Interest Coverage Ratio		3			3
Maximum
Components of the company's debt obligations
Consolidated Leverage Ratio		3.50			3.50
Unsecured lines of credit
Components of the company's debt obligations
Average borrowings		$ 34,100	$ 40,000
Average annual interest rate on short-term notes payable (as a percent)		1.60%	1.90%
Compensating balance requirement		$ 0
Revolving credit facility
Components of the company's debt obligations
Credit facility interest and fees		1,500	$ 1,500
5-year revolving credit facility maturing in July 2022
Components of the company's debt obligations
Revolving credit facility maximum borrowing capacity		300,000			€ 150
Amount outstanding under line of credit		25,000	0		€ 0		€ 69
Notes payable
Components of the company's debt obligations
Proceeds from debt	$ 280,000			$ 280,000
Long-term obligations gross including current maturities		168,000	224,000
Deferred Finance Costs, Net, Total		390	541
Long-term obligations including current maturities		$ 167,610	$ 223,459
Interest rate on notes (as a percent)		1.36%	1.36%		1.36%		1.36%
Floating interest rate prior to conversion to a fixed interest rate		3.20%	4.00%		3.20%		4.00%
Notes payable 0.00% - 10.90%, due in monthly and annual installments through 2028
Components of the company's debt obligations
Long-term obligations gross including current maturities		$ 19,220	$ 15,531
Long-term obligations including current maturities		$ 19,220	$ 15,531
Notes payable 0.00% - 10.90%, due in monthly and annual installments through 2028 \| Minimum
Components of the company's debt obligations
Interest rate on notes (as a percent)		0.00%	0.00%		0.00%		0.00%
Notes payable 0.00% - 10.90%, due in monthly and annual installments through 2028 \| Maximum
Components of the company's debt obligations
Interest rate on notes (as a percent)		10.90%	16.00%		10.90%		16.00%
Senior unsecured notes 3.2%, due in 2022
Components of the company's debt obligations
Long-term obligations gross including current maturities		$ 75,000	$ 75,000
Deferred Finance Costs, Net, Total		64	88
Long-term obligations including current maturities		$ 74,936	$ 74,912
Interest rate on notes (as a percent)		3.20%	3.20%		3.20%		3.20%
Senior unsecured notes 3.5%, due in 2023
Components of the company's debt obligations
Long-term obligations gross including current maturities		$ 125,000	$ 125,000
Deferred Finance Costs, Net, Total		144	181
Long-term obligations including current maturities		$ 124,856	$ 124,819
Interest rate on notes (as a percent)		3.50%	3.50%		3.50%		3.50%
Senior unsecured notes 0.98%, due in 2023
Components of the company's debt obligations
Long-term obligations gross including current maturities		$ 112,170	$ 114,535
Deferred Finance Costs, Net, Total		356	432
Long-term obligations including current maturities		$ 111,814	$ 114,103
Interest rate on notes (as a percent)		1.00%	1.00%		1.00%		1.00%
Senior unsecured notes 3.4%, due in 2024
Components of the company's debt obligations
Long-term obligations gross including current maturities		$ 50,000	$ 50,000
Deferred Finance Costs, Net, Total		63	76
Long-term obligations including current maturities		$ 49,937	$ 49,924
Interest rate on notes (as a percent)		3.40%	3.40%		3.40%		3.40%
Senior unsecured notes 3.5%, due in 2024
Components of the company's debt obligations
Long-term obligations gross including current maturities		$ 100,000	$ 100,000
Deferred Finance Costs, Net, Total		144	181
Long-term obligations including current maturities		$ 99,856	$ 99,819
Interest rate on notes (as a percent)		3.50%	3.50%		3.50%		3.50%
Senior unsecured notes 1.17%, due in 2024
Components of the company's debt obligations
Long-term obligations gross including current maturities		$ 224,340	$ 229,070
Deferred Finance Costs, Net, Total		742	904
Long-term obligations including current maturities		$ 223,598	$ 228,166
Interest rate on notes (as a percent)		1.20%	1.20%		1.20%		1.20%
Senior unsecured notes 3.6%, due in 2025
Components of the company's debt obligations
Long-term obligations gross including current maturities		$ 125,000	$ 125,000
Deferred Finance Costs, Net, Total		169	207
Long-term obligations including current maturities		$ 124,831	$ 124,793
Interest rate on notes (as a percent)		3.60%	3.60%		3.60%		3.60%
Senior unsecured notes 3.6%, due in 2026
Components of the company's debt obligations
Long-term obligations gross including current maturities		$ 125,000	$ 125,000
Deferred Finance Costs, Net, Total		169	208
Long-term obligations including current maturities		$ 124,831	$ 124,792
Interest rate on notes (as a percent)		3.60%	3.60%		3.60%		3.60%
Capital lease obligations
Components of the company's debt obligations
Long-term obligations gross including current maturities		$ 29,952	$ 8,353
Long-term obligations including current maturities		$ 29,952	$ 8,353

LEASE COMMITMENTS - Components

LEASE COMMITMENTS - Components of Lease Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
LEASE COMMITMENTS
Rent expense under operating leases		$ 32,700
Components of lease expense:
Operating lease cost	$ 23,410
Finance lease cost:
Amortization of right-of-use assets	4,217
Interest on lease liabilities	1,353
Total finance lease cost	5,570
Short-term lease and variable lease costs	$ 8,629

LEASE COMMITMENTS - Supplementa

LEASE COMMITMENTS - Supplemental Cash Flow Information (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2019USD ($)
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$ 21,872
Operating cash flows from finance leases	1,245
Financing cash flows from finance leases	4,730
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	15,226
Finance leases	$ 15,957

LEASE COMMITMENTS - Supplemen_2

LEASE COMMITMENTS - Supplemental Balance Sheet Information (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Jan. 01, 2019
Operating Leases
Operating lease right-of-use assets	$ 72,377	$ 83,222
Operating lease liability, current	$ 16,578
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	Accounts Payable, Accrued Liabilities, and Derivative Liabilities, Current
Operating lease liabilities	$ 55,276	$ 61,331
Total operating lease liabilities	71,854
Finance Leases
Finance leases included in property, plant and equipment, gross	47,020
Accumulated depreciation of finance leases included in property, plant and equipment, net	(4,271)
Total finance leases	$ 42,749
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	Property, Plant and Equipment, Net
Current portion of finance lease liabilities	$ 4,318
Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]	Long-term Debt and Capital Lease Obligations, Current
Noncurrent portion of finance lease liabilities	$ 25,634
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	Long-term Debt and Capital Lease Obligations
Total finance lease liabilities	$ 29,952
Weighted Average Remaining Lease Term (in years)
Operating leases	6 years 1 month 6 days
Finance leases	7 years
Weighted Average Discount Rate
Operating leases	5.05%
Finance leases	5.13%

LEASE COMMITMENTS - Maturities

LEASE COMMITMENTS - Maturities of Lease Liabilities (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Maturities of operating lease liabilities:
Year 1	$ 19,652
Year 2	15,411
Year 3	10,740
Year 4	9,365
Year 5	6,998
Thereafter	22,331
Total lease payments	84,497
Less imputed interest	(12,643)
Total operating lease liabilities	71,854
Maturities of finance lease liabilities:
Year 1	5,655
Year 2	4,787
Year 3	3,870
Year 4	3,099
Year 5	2,658
Thereafter	18,051
Total lease payments	38,120	$ 10,894
Less imputed interest	(8,168)
Total finance lease liabilities	29,952
Future minimum payments under noncancelable operating leases, by year and in the aggregate
Year 1		26,512
Year 2		21,386
Year 3		16,529
Year 4		12,549
Year 5		10,225
Thereafter		21,932
Total lease payments		109,133
Future minimum payments under capital leases, by year and in the aggregate
Year 1		1,828
Year 2		1,653
Year 3		1,546
Year 4		1,160
Year 5		880
Thereafter		3,827
Less imputed interest		(2,541)
Present value of future minimum lease payments		$ 8,353
Amount of additional operating and finance leases that have not yet commenced	$ 1,800
Minimum
Future minimum payments under capital leases, by year and in the aggregate
Term of operating and finance leases that have not yet commenced	3 years
Maximum
Future minimum payments under capital leases, by year and in the aggregate
Term of operating and finance leases that have not yet commenced	10 years

RETIREMENT AND DEFERRED COMPE_3

RETIREMENT AND DEFERRED COMPENSATION PLANS (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
United States
Change in benefit obligation:
Benefit obligation at beginning of year	$ 180,803	$ 198,450
Service cost	11,093	11,396	$ 9,706
Interest cost	7,381	6,878	7,010
Actuarial (gain) loss	39,209	(23,510)
Benefits paid	(11,211)	(12,411)
Benefit obligation at end of year	227,275	180,803	198,450
Change in plan assets:
Fair value of plan assets at beginning of year	169,958	169,600
Actual return on plan assets	29,618	(7,642)
Employer contribution	436	20,411
Benefits paid	(11,211)	(12,411)
Fair value of plan assets at end of year	188,801	169,958	169,600
Funded status at end of year				$ (38,474)	$ (10,845)
Funded status amounts recognized in Consolidated Balance Sheet
Non-current assets					207
Current liabilities				(449)	(430)
Non-current liabilities				(38,025)	(10,622)
Funded status amount				(38,474)	(10,845)
Amounts recognized in accumulated other comprehensive loss
Net actuarial loss				68,789	48,776
Tax effects				(15,821)	(17,876)
Net amount recognized				52,968	30,900
Changes in benefit obligations and plan assets recognized in other comprehensive income
Current year actuarial gain (loss)	(21,970)	4,611	(12,593)
Amortization of net loss	1,957	4,873	3,205
Net amount recognized	(20,013)	9,484	(9,388)
Amounts in accumulated other comprehensive loss expected to be recognized as components of periodic benefit cost in next fiscal year
Amortization of net loss				5,719
Amount expected to be recognized in next fiscal year				5,719
Components of net periodic benefit cost:
Service cost	11,093	11,396	9,706
Interest cost	7,381	6,878	7,010
Expected return on plan assets	(12,379)	(11,257)	(9,880)
Amortization of net loss	1,957	4,873	3,205
Net periodic benefit cost	$ 8,052	$ 11,890	$ 10,041
Accumulated benefit obligation				205,300	163,000
Projected benefit obligation ("PBO"), ABO, and fair value of plan assets for all pension plans with an ABO in excess of plan assets
Projected benefit obligation				227,275	11,052
Accumulated benefit obligation				205,326	9,216
Fair value of plan assets				188,801
PBO, ABO, and fair value of plan assets for all pension plans with a PBO in excess of plan assets
Projected benefit obligation				227,275	11,052
Accumulated benefit obligation				205,326	$ 9,216
Fair value of plan assets				$ 188,801
Weighted-average assumptions used to determine benefit obligations
Discount rate (as a percent)				3.20%	4.20%	3.55%
Rate of compensation increase (as a percent)				4.00%	4.00%	4.00%
Weighted-average assumptions used to determine net periodic benefit cost
Discount rate (as a percent)	4.20%	3.55%	4.05%
Expected long-term return on plan assets (as a percent)	7.00%	7.00%	7.00%
Rate of compensation increase (as a percent)	4.00%	4.00%	4.00%
Plan Assets:
Weighted-average asset allocations (as a percent)				100.00%	100.00%
Total Investments in Fair Value Hierarchy				$ 119,883	$ 107,943
Total Investments	$ 188,801	$ 169,600	$ 169,600	188,801	169,958	$ 169,600
Minimum funding requirement	0
Expected contribution in next fiscal year				400
United States \| Cash and Short Term Securities
Plan Assets:
Total Investments in Fair Value Hierarchy				$ 1,988	$ 8,964
United States \| Equity Securities
Plan Assets:
Weighted-average asset allocations (as a percent)				49.00%	44.00%
Target allocation (as a percent)				60.00%
Total Investments in Fair Value Hierarchy				$ 81,997	$ 66,707
United States \| Fixed Income Funds
Plan Assets:
Weighted-average asset allocations (as a percent)				29.00%	29.00%
Total Investments in Fair Value Hierarchy				$ 35,898	$ 32,272
United States \| Hedge Fund
Plan Assets:
Weighted-average asset allocations (as a percent)				10.00%	10.00%
United States \| Infrastructure
Plan Assets:
Weighted-average asset allocations (as a percent)				6.00%	7.00%
United States \| Money market
Plan Assets:
Weighted-average asset allocations (as a percent)				1.00%	5.00%
United States \| Fixed income securities and infrastructure
Plan Assets:
Target allocation (as a percent)				40.00%
United States \| Real Estate Funds
Plan Assets:
Weighted-average asset allocations (as a percent)				5.00%	5.00%
United States \| Level 1
Change in plan assets:
Fair value of plan assets at beginning of year	107,943
Fair value of plan assets at end of year	119,883	107,943
Plan Assets:
Total Investments in Fair Value Hierarchy				$ 119,883	$ 107,943
Total Investments	107,943	107,943		119,883	107,943
United States \| Level 1 \| Cash and Short Term Securities
Plan Assets:
Total Investments in Fair Value Hierarchy				1,988	8,964
United States \| Level 1 \| Cash and Short Term Securities \| USD
Plan Assets:
Total Investments in Fair Value Hierarchy				1,988	8,964
United States \| Level 1 \| Equity Securities
Plan Assets:
Total Investments in Fair Value Hierarchy				81,997	66,707
United States \| Level 1 \| US Large Cap Equities
Plan Assets:
Total Investments in Fair Value Hierarchy				48,580	38,804
United States \| Level 1 \| US Small Cap Equities
Plan Assets:
Total Investments in Fair Value Hierarchy				9,921	7,747
United States \| Level 1 \| International Equities
Plan Assets:
Total Investments in Fair Value Hierarchy				23,496	20,156
United States \| Level 1 \| Fixed Income Funds
Plan Assets:
Total Investments in Fair Value Hierarchy				35,898	32,272
United States \| Net Asset Value per Share
Plan Assets:
Investments at Net Asset Value per Share				68,918	62,015
Foreign Plans
Change in benefit obligation:
Benefit obligation at beginning of year	104,911	109,030
Service cost	5,921	5,954	5,526
Interest cost	2,023	1,828	1,747
Special termination benefit charge	64	62
Plan amendment	18
Curtailment/Settlement	(271)	(1,751)
Transfer	939
Business acquired		1,937
Prior service cost	(451)	35
Actuarial (gain) loss	13,575	(3,743)
Benefits paid	(4,130)	(3,288)
Foreign currency translation adjustment	(2,109)	(5,153)
Benefit obligation at end of year	120,490	104,911	109,030
Change in plan assets:
Fair value of plan assets at beginning of year	68,992	73,384
Actual return on plan assets	3,851	(487)
Employer contribution	6,542	2,780
Benefits paid	(4,130)	(3,288)
Transfer	359
Foreign currency translation adjustment	(1,425)	(3,397)
Fair value of plan assets at end of year	74,189	68,992	73,384
Funded status at end of year				(46,301)	(35,919)
Funded status amounts recognized in Consolidated Balance Sheet
Non-current assets				938	500
Current liabilities				(44)	(8)
Non-current liabilities				(47,195)	(36,411)
Funded status amount				(46,301)	(35,919)
Amounts recognized in accumulated other comprehensive loss
Net actuarial loss				40,442	29,761
Net prior service cost				3,774	4,656
Tax effects				(14,040)	(4,855)
Net amount recognized				30,176	29,562
Changes in benefit obligations and plan assets recognized in other comprehensive income
Current year actuarial gain (loss)	(11,999)	534	2,952
Current year prior service cost	451	(35)	(1,399)
Transfer Prior service cost	(18)
Transfer Actuarial (loss) gain	(126)
Recognition due to curtailment		1,692
Amortization of net loss	1,444	1,716	1,895
Amortization of prior service cost	449	720	400
Net amount recognized	(9,799)	4,627	3,848
Amounts in accumulated other comprehensive loss expected to be recognized as components of periodic benefit cost in next fiscal year
Amortization of net loss				2,092
Amortization of prior service cost				391
Amount expected to be recognized in next fiscal year				2,483
Components of net periodic benefit cost:
Service cost	5,921	5,954	5,526
Interest cost	2,023	1,828	1,747
Expected return on plan assets	(2,366)	(2,610)	(2,409)
Amortization of net loss	1,444	1,716	1,895
Amortization of prior service cost	449	720	400
Net periodic benefit cost	7,471	7,608	7,159
Curtailment	(246)	(59)
Special termination benefit charge	65	62
Total net periodic benefit cost	$ 7,290	$ 7,611	$ 7,159
Accumulated benefit obligation				91,800	80,900
Projected benefit obligation ("PBO"), ABO, and fair value of plan assets for all pension plans with an ABO in excess of plan assets
Projected benefit obligation				92,561	93,029
Accumulated benefit obligation				65,062	68,981
Fair value of plan assets				46,371	56,611
PBO, ABO, and fair value of plan assets for all pension plans with a PBO in excess of plan assets
Projected benefit obligation				102,310	92,555
Accumulated benefit obligation				73,943	68,506
Fair value of plan assets				$ 55,260	$ 56,136
Weighted-average assumptions used to determine benefit obligations
Discount rate (as a percent)				1.04%	1.82%	1.62%
Rate of compensation increase (as a percent)				3.05%	3.01%	3.02%
Weighted-average assumptions used to determine net periodic benefit cost
Discount rate (as a percent)	1.84%	1.62%	1.65%
Expected long-term return on plan assets (as a percent)	3.69%	3.66%	3.66%
Rate of compensation increase (as a percent)	3.05%	3.02%	3.00%
Plan Assets:
Weighted-average asset allocations (as a percent)				100.00%	100.00%
Total Investments in Fair Value Hierarchy				$ 74,189	$ 68,992
Total Investments	$ 68,992	$ 68,992	$ 73,384	74,189	68,992	$ 73,384
Expected contribution in next fiscal year				700
Foreign Plans \| Cash and Short Term Securities
Plan Assets:
Total Investments in Fair Value Hierarchy				$ 2,030	$ 718
Foreign Plans \| Equity Securities
Plan Assets:
Weighted-average asset allocations (as a percent)				4.00%	4.00%
Total Investments in Fair Value Hierarchy				$ 2,995	$ 2,591
Foreign Plans \| Fixed Income Funds
Plan Assets:
Weighted-average asset allocations (as a percent)				1.00%	1.00%
Total Investments in Fair Value Hierarchy				$ 820	$ 717
Foreign Plans \| Corporate debts securities
Plan Assets:
Weighted-average asset allocations (as a percent)				3.00%	3.00%
Total Investments in Fair Value Hierarchy				$ 2,115	$ 2,097
Foreign Plans \| Investment Funds
Plan Assets:
Weighted-average asset allocations (as a percent)				89.00%	91.00%
Target allocation (as a percent)				100.00%
Total Investments in Fair Value Hierarchy				$ 66,229	$ 62,869
Foreign Plans \| Money market
Plan Assets:
Weighted-average asset allocations (as a percent)				3.00%	1.00%
Foreign Plans \| Level 1
Change in plan assets:
Fair value of plan assets at beginning of year	28,245
Fair value of plan assets at end of year	31,757	28,245
Plan Assets:
Total Investments in Fair Value Hierarchy				$ 31,757	$ 28,245
Total Investments	28,245	28,245		31,757	28,245
Foreign Plans \| Level 1 \| Cash and Short Term Securities
Plan Assets:
Total Investments in Fair Value Hierarchy				2,030	718
Foreign Plans \| Level 1 \| Cash and Short Term Securities \| EUR
Plan Assets:
Total Investments in Fair Value Hierarchy				2,012	718
Foreign Plans \| Level 1 \| Cash and Short Term Securities \| Others
Plan Assets:
Total Investments in Fair Value Hierarchy				18
Foreign Plans \| Level 1 \| Equity Securities
Plan Assets:
Total Investments in Fair Value Hierarchy				2,995	2,591
Foreign Plans \| Level 1 \| International Equities
Plan Assets:
Total Investments in Fair Value Hierarchy				2,995	2,591
Foreign Plans \| Level 1 \| Fixed Income Funds
Plan Assets:
Total Investments in Fair Value Hierarchy				820	717
Foreign Plans \| Level 1 \| Corporate debts securities
Plan Assets:
Total Investments in Fair Value Hierarchy				2,115	2,097
Foreign Plans \| Level 1 \| Euro Corporate Bonds
Plan Assets:
Total Investments in Fair Value Hierarchy				2,115	2,097
Foreign Plans \| Level 1 \| Investment Funds
Plan Assets:
Total Investments in Fair Value Hierarchy				23,797	22,122
Foreign Plans \| Level 1 \| Mutual Funds in Equities
Plan Assets:
Total Investments in Fair Value Hierarchy				4,025	3,339
Foreign Plans \| Level 1 \| Mutual Funds in Bonds
Plan Assets:
Total Investments in Fair Value Hierarchy				18,881	18,060
Foreign Plans \| Level 1 \| Mutual Funds Diversified
Plan Assets:
Total Investments in Fair Value Hierarchy				891	723
Foreign Plans \| Level 2
Change in plan assets:
Fair value of plan assets at beginning of year	40,747
Fair value of plan assets at end of year	42,432	40,747
Plan Assets:
Total Investments in Fair Value Hierarchy				42,432	40,747
Total Investments	$ 40,747	$ 40,747		42,432	40,747
Foreign Plans \| Level 2 \| Investment Funds
Plan Assets:
Total Investments in Fair Value Hierarchy				42,432	40,747
Foreign Plans \| Level 2 \| Mutual Funds Diversified
Plan Assets:
Total Investments in Fair Value Hierarchy				42,432	40,747
Non-qualified supplemental pension plan \| United States
Non-qualified supplemental pension plan information
Non funded liability				$ 12,600	$ 11,100

RETIREMENT AND DEFERRED COMPE_4

RETIREMENT AND DEFERRED COMPENSATION PLANS (Schedule of Estimated Benefit Payments to Defined Benefit Plans) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
United States
Defined contribution plan
Total contributions by Company	$ 4,100	$ 3,700	$ 3,300
Estimated benefit payments relating to defined benefit plans over the next ten years
2020	11,064
2021	11,134
2022	11,665
2023	12,467
2024	13,077
2025 - 2029	$ 74,584
United States \| Maximum
Defined contribution plan
Employer matching contribution as a percentage of salary	3.00%
Foreign Plans
Defined contribution plan
Total contributions by Company	$ 2,300	$ 2,400	$ 2,200
Estimated benefit payments relating to defined benefit plans over the next ten years
2020	5,382
2021	2,904
2022	3,155
2023	4,676
2024	6,537
2025 - 2029	$ 34,386

ACCUMULATED OTHER COMPREHENSI_3

ACCUMULATED OTHER COMPREHENSIVE INCOME (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Accumulated other comprehensive income activity
Balance at the beginning of the period	$ 1,422,556
Balance at the end of the period	1,571,916	$ 1,422,556
Foreign Currency
Accumulated other comprehensive income activity
Balance at the beginning of the period	(248,401)	(185,503)	$ (259,888)
Other comprehensive income (loss) before reclassifications	(8,723)	(62,898)	74,385
Net current-period other comprehensive income (loss)	(8,723)	(62,898)	74,385
Balance at the end of the period	(257,124)	(248,401)	(185,503)
Defined Benefit Pension Plans
Accumulated other comprehensive income activity
Balance at the beginning of the period	(60,463)	(64,595)	(59,775)
Other comprehensive income (loss) before reclassifications	(25,557)	5,266	(8,944)
Amounts reclassified from accumulated other comprehensive income	2,873	5,524	4,124
Net current-period other comprehensive income (loss)	(22,684)	10,790	(4,820)
Balance at the end of the period	(83,147)	(60,463)	(64,595)
Defined Benefit Pension Plans \| Accounting Standards Update 2018-02
Accumulated other comprehensive income activity
Adoption of accounting standards		(6,658)
Derivatives
Accumulated other comprehensive income activity
Balance at the beginning of the period	(1,640)	(3,204)	(46)
Other comprehensive income (loss) before reclassifications	8,026	16,624	(11,806)
Amounts reclassified from accumulated other comprehensive income	(8,063)	(15,060)	8,648
Net current-period other comprehensive income (loss)	(37)	1,564	(3,158)
Balance at the end of the period	(1,677)	(1,640)	(3,204)
Accumulated Other Comprehensive Income/(Loss)
Accumulated other comprehensive income activity
Balance at the beginning of the period	(310,504)	(253,302)	(319,709)
Other comprehensive income (loss) before reclassifications	(26,254)	(41,008)	53,635
Amounts reclassified from accumulated other comprehensive income	(5,190)	(9,536)	12,772
Net current-period other comprehensive income (loss)	(31,444)	(50,544)	66,407
Balance at the end of the period	$ (341,948)	(310,504)	$ (253,302)
Accumulated Other Comprehensive Income/(Loss) \| Accounting Standards Update 2018-02
Accumulated other comprehensive income activity
Adoption of accounting standards		$ (6,658)

ACCUMULATED OTHER COMPREHENSI_4

ACCUMULATED OTHER COMPREHENSIVE INCOME (Reclassifications From Accumulated Other Comprehensive Income) (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Amount Reclassified from Accumulated Other Comprehensive Income
Miscellaneous, net									$ 1,556	$ 5,550	$ 6,694
Interest expense									35,489	32,626	40,597
Total before tax									(342,069)	(266,020)	(294,825)
Tax benefit									99,842	71,254	74,796
Total reclassifications for the period	$ (48,533)	$ (56,750)	$ (73,915)	$ (63,004)	$ (40,674)	$ (38,996)	$ (55,775)	$ (59,300)	(242,202)	(194,745)	(220,030)
Amount Reclassified from Accumulated Other Comprehensive Income
Amount Reclassified from Accumulated Other Comprehensive Income
Total reclassifications for the period									(5,190)	(9,536)	12,772
Defined Benefit Pension Plans \| Amount Reclassified from Accumulated Other Comprehensive Income
Amount Reclassified from Accumulated Other Comprehensive Income
Amortization of net loss									3,401	6,589	5,100
Amortization of prior service cost									449	720	400
Total before tax									3,850	7,309	5,500
Tax benefit									(977)	(1,785)	(1,376)
Total reclassifications for the period									2,873	5,524	4,124
Derivatives \| Amount Reclassified from Accumulated Other Comprehensive Income
Amount Reclassified from Accumulated Other Comprehensive Income
Total before tax									(8,063)	(18,149)	10,427
Tax benefit										3,089	(1,779)
Total reclassifications for the period									(8,063)	(15,060)	8,648
Derivatives \| Treasury locks \| Amount Reclassified from Accumulated Other Comprehensive Income
Amount Reclassified from Accumulated Other Comprehensive Income
Interest expense										26	42
Derivatives \| Cross Currency Swap Contract: Interest Component \| Amount Reclassified from Accumulated Other Comprehensive Income
Amount Reclassified from Accumulated Other Comprehensive Income
Interest expense									(4,805)	(5,150)	(1,526)
Derivatives \| Cross Currency Swap Contract: Foreign Exchange Component \| Amount Reclassified from Accumulated Other Comprehensive Income
Amount Reclassified from Accumulated Other Comprehensive Income
Miscellaneous, net									$ (3,258)	$ (13,025)	$ 11,911

DERIVATIVE INSTRUMENTS AND HE_3

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Cash Flow Hedge) (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Sep. 30, 2017	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Jul. 20, 2017
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Net after-tax loss included in accumulated other comprehensive earnings		$ 37	$ (1,547)	$ 3,186
Derivatives in Cash Flow Hedging Relationships
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)		8,361	20,039
Cross Currency Swap Contract \| Derivatives in Cash Flow Hedging Relationships
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount hedged					$ 280,000
Net after-tax loss included in accumulated other comprehensive earnings		1,700	$ 1,600
Fair value of derivative asset		2,600
Cross Currency Swap Contract: Interest Component \| Derivatives in Cash Flow Hedging Relationships
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount expected to be recognized in earnings in next twelve months related to cross currency swap contract		$ 2,800
Notes payable
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Proceeds from debt	$ 280,000			$ 280,000
Interest rate on notes (as a percent)		1.36%	1.36%

DERIVATIVE INSTRUMENTS AND HE_4

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Fair Value of Derivative Instruments in the Consolidated Balance Sheets) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Fair Value of Derivative Instruments
Derivative Assets	$ 2,758	$ 259
Derivative Liabilities	401	1,371
Cash delivered on foreign currency forward contract			$ 66,155
Foreign Exchange Contract, Amount of Gain (Loss) Recognized in Income on Derivative, not designated as hedging instruments	(141)	652
Foreign Exchange Contracts
Fair Value of Derivative Instruments
Aggregate amount of forward exchange contracts	51,500
Foreign Exchange Contract, Amount of Gain (Loss) Recognized in Income on Derivative, not designated as hedging instruments	(141)	652
Derivative Contracts Not Designated as Hedging Instruments
Fair Value of Derivative Instruments
Derivative Assets	206	259
Derivative Liabilities	401	331
Derivative Contracts Not Designated as Hedging Instruments \| Foreign Exchange Contracts \| Prepaid and other
Fair Value of Derivative Instruments
Derivative Assets	206	259
Derivative Contracts Not Designated as Hedging Instruments \| Foreign Exchange Contracts \| Accounts payable and accrued liabilities
Fair Value of Derivative Instruments
Derivative Liabilities	401	331
Derivative Contracts Designated as Hedging Instruments
Fair Value of Derivative Instruments
Derivative Assets	2,552
Derivative Liabilities		1,040
Derivative Contracts Designated as Hedging Instruments \| Cross Currency Swap Contract \| Prepaid and other
Fair Value of Derivative Instruments
Derivative Assets	$ 2,552
Derivative Contracts Designated as Hedging Instruments \| Cross Currency Swap Contract \| Accounts payable and accrued liabilities
Fair Value of Derivative Instruments
Derivative Liabilities		$ 1,040

DERIVATIVE INSTRUMENTS AND HE_5

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Effect of Derivative Instruments on the Consolidated Statements of Income) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Derivative instruments, gain or (loss)
Foreign Exchange Contract, Amount of Gain (Loss) Recognized in Income on Derivative, not designated as hedging instruments	$ (141)	$ 652
Other Nonoperating Income (Expense)	1,556	5,550	$ 6,694
Interest Expense.	35,489	32,626	$ 40,597
Derivatives in Cash Flow Hedging Relationships
Derivative instruments, gain or (loss)
Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)	8,361	20,039
Amount of Gain (Loss) Reclassified from AOCI on Derivative	8,063	18,175
Foreign Exchange Contracts
Derivative instruments, gain or (loss)
Foreign Exchange Contract, Amount of Gain (Loss) Recognized in Income on Derivative, not designated as hedging instruments	(141)	652
Cross Currency Swap Contract: Interest Component \| Interest expense \| Derivatives in Cash Flow Hedging Relationships
Derivative instruments, gain or (loss)
Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)	5,103	7,014
Amount of Gain (Loss) Reclassified from AOCI on Derivative	4,805	5,150
Interest Expense.	35,489
Cross Currency Swap Contract: Foreign Exchange Component \| Other Income (Expense): Miscellaneous, net \| Derivatives in Cash Flow Hedging Relationships
Derivative instruments, gain or (loss)
Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)	3,258	13,025
Amount of Gain (Loss) Reclassified from AOCI on Derivative	3,258	$ 13,025
Other Nonoperating Income (Expense)	$ 1,556

DERIVATIVE INSTRUMENTS AND HE_6

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Schedule of Derivative Assets and Liabilities) (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Derivative Assets
Gross Amount	$ 2,758	$ 259
Net Amounts Presented in the Statement of Financial Position	2,758	259
Net Amount	2,758	259
Derivative Liabilities
Gross Amount	401	1,371
Net Amounts Presented in the Statement of Financial Position	401	1,371
Net Amount	$ 401	$ 1,371

FAIR VALUE (Details)

FAIR VALUE (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Oct. 31, 2019	May 31, 2019	Dec. 31, 2018
Liabilities
Fair value of long-term obligations	$ 1,100,000			$ 1,100,000
Reboul
Liabilities
Fair value of contingent consideration arrangement				0
Gateway Analytical
Liabilities
Fair value of contingent consideration arrangement	3,000		$ 3,000
Noble
Liabilities
Fair value of contingent consideration arrangement	2,900	$ 2,900
Assets and liabilities measured at fair value on recurring basis \| Total
Assets
Foreign exchange contracts, assets	206			259
Cross currency swap contract, asset	2,552
Total assets at fair value	2,758			259
Liabilities
Foreign exchange contracts, liabilities	401			331
Cross currency swap contract, liability				1,040
Fair value of contingent consideration arrangement	5,930
Total liabilities at fair value	6,331			1,371
Assets and liabilities measured at fair value on recurring basis \| Level 2
Assets
Foreign exchange contracts, assets	206			259
Cross currency swap contract, asset	2,552
Total assets at fair value	2,758			259
Liabilities
Foreign exchange contracts, liabilities	401			331
Cross currency swap contract, liability				1,040
Fair value of contingent consideration arrangement	0
Total liabilities at fair value	401			$ 1,371
Assets and liabilities measured at fair value on recurring basis \| Level 3
Liabilities
Fair value of contingent consideration arrangement	5,930
Total liabilities at fair value	$ 5,930

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details) - USD ($)	3 Months Ended	12 Months Ended
COMMITMENTS AND CONTINGENCIES (Details) - USD ($)	Mar. 31, 2017	Dec. 31, 2019	Mar. 31, 2019	Dec. 31, 2018
Commitments and contingencies
Environmental Remediation Expense	$ 1,500,000
Brazil
Commitments and contingencies
Accrual for Environmental Loss Contingencies	$ 1,500,000	$ 500,000
Payments to settle environmental loss contingency		600,000
Brazil \| Reduction of gross receipts tax
Commitments and contingencies
Recovery of part of claim			$ 2,700,000	$ 631,000
Brazil \| Reduction of gross receipts tax \| Cost of Sales
Commitments and contingencies
Recovery of part of claim			1,700,000
Brazil \| Reduction of gross receipts tax \| Interest Income
Commitments and contingencies
Recovery of part of claim			$ 1,000,000
Brazil \| Minimum \| Reduction of gross receipts tax
Commitments and contingencies
Estimated potential recoveries		3,000,000
Brazil \| Maximum \| Reduction of gross receipts tax
Commitments and contingencies
Estimated potential recoveries		10,000,000
Indemnification agreements
Commitments and contingencies
Liabilities recorded under indemnification agreements		0
Tax Assessment \| Brazil
Commitments and contingencies
Estimated loss contingency		7,900,000
Loss contingency liability recorded		0
Tax Assessment, Interest \| Brazil
Commitments and contingencies
Estimated loss contingency		3,000,000
Tax Assessment, Penalites \| Brazil
Commitments and contingencies
Estimated loss contingency		$ 1,000,000

STOCK REPURCHASE PROGRAM (Detai

STOCK REPURCHASE PROGRAM (Details) - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Apr. 18, 2019	Oct. 20, 2016
Stock repurchase program
Aggregate amount of share repurchases (in dollars)	$ 86,497	$ 3,905	$ 120,540
Common stock repurchased (retired and held in treasury) (in shares)	779	668
Common stock repurchased (retired and held in treasury)	$ 86,500	$ 61,700
Common stock repurchased and retired (in shares)		623
Common stock repurchased and retired		$ 57,786	$ 40,994
Remaining authorized repurchase amount	$ 278,500
Stock Repurchase Program October 20, 2016
Stock repurchase program
Share repurchases authorized amount					$ 350,000
Stock Repurchase Program April 18, 2019
Stock repurchase program
Share repurchases authorized amount				$ 350,000

CAPITAL STOCK (Details)

CAPITAL STOCK (Details) - USD ($) $ in Thousands	12 Months Ended
CAPITAL STOCK (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Common stock and treasury stock and the share activity
Authorized common stock (in shares)	199,000,000	199,000,000
Balance at the beginning of the year (in shares)	67,300,000
Common stock repurchased and retired		(623,000)
Balance at the end of the year (in shares)	68,600,000	67,300,000
Cash dividends paid on the common stock	$ 90,208	$ 82,346	$ 79,944
Common Stock Par Value
Common stock and treasury stock and the share activity
Balance at the beginning of the year (in shares)	67,341,316	66,742,490
Restricted stock vestings (in shares)	41,268	39,691
Common stock repurchased and retired		(623,412)
Balance at the end of the year (in shares)	68,608,508	67,341,316	66,742,490
Common Stock Par Value \| Stock Awards Plans
Common stock and treasury stock and the share activity
Stock option exercises (in shares)	1,079,841	1,182,547
Common Stock Par Value \| Director Stock Option Plans
Common stock and treasury stock and the share activity
Stock option exercises (in shares)	146,083
Treasury Stock
Common stock and treasury stock and the share activity
Balance at the beginning of the year (in shares)	4,424,884	4,881,889
Common stock repurchased (in shares)	778,848	45,000
Balance at the end of the year (in shares)	4,836,027	4,424,884	4,881,889
Treasury Stock \| Stock Awards Plans
Common stock and treasury stock and the share activity
Stock option exercises (in shares)	(367,705)	(502,005)

STOCK-BASED COMPENSATION (Detai

STOCK-BASED COMPENSATION (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
STOCK-BASED COMPENSATION
Proceeds from stock option exercises	$ 90,834	$ 88,156	$ 73,905
Stock options
STOCK-BASED COMPENSATION
Award vesting period	3 years
Expiration period	10 years
Compensation expense	$ 5,700	10,900	15,200
Compensation expense, net of tax	4,500	8,400	10,500
Fair value of shares vested	17,500	16,500	16,900
Proceeds from stock option exercises	90,200
Actual tax benefit realized for the tax deduction from option exercises	19,500
Unrecognized compensation cost expected to be recognized in future periods	$ 2,300
Weighted-average period over which compensation cost is expected to be recognized	1 year
Stock options \| Selling, research & development and administrative expenses
STOCK-BASED COMPENSATION
Compensation expense	$ 4,800	8,700	13,200
Restricted stock units
STOCK-BASED COMPENSATION
Compensation expense	18,200	8,700	3,700
Actual tax benefit realized for the tax deduction from option exercises	1,000
Unrecognized compensation cost expected to be recognized in future periods	$ 28,900
Weighted-average period over which compensation cost is expected to be recognized	2 years 10 months 24 days
Weighted-Average Grant-Date Fair Value
Fair value of units vested	$ 4,600	3,000	4,700
Intrinsic value of units vested	$ 5,400	$ 3,700	$ 5,200
Restricted stock units (time-based)
Restricted stock unit activity
Balance at the beginning of the period (in shares)	261,487
Granted (in shares)	295,412
Vested (in shares)	(51,433)
Forfeited (in shares)	(24,737)
Balance at the end of the period (in shares)	480,729	261,487
Weighted-Average Grant-Date Fair Value
Nonvested at the beginning of the period (in dollars per share)	$ 91.78
Granted (in dollars per share)	97.80
Vested (in dollars per share)	88.77
Forfeited (in dollars per share)	98.72
Nonvested at the end of the period (in dollars per share)	$ 95.45	$ 91.78
Stock Awards Plans \| Stock options
STOCK-BASED COMPENSATION
Weighted-average fair value of stock options granted (in dollars per share)		$ 14.82	$ 11.86
Assumptions used to estimate fair value of stock options granted
Dividend Yield (as a percent)		1.50%	1.70%
Expected Stock Price Volatility (as a percent)		14.20%	15.80%
Risk-free Interest Rate (as a percent)		2.80%	2.20%
Expected Life of Option (years)		6 years 7 months 6 days	6 years 8 months 12 days
Stock options activity
Outstanding at the beginning of the period (in shares)	6,761,055
Exercised (in shares)	(1,560,047)
Forfeited or expired (in shares)	(156,828)
Outstanding at the end of the period (in shares)	5,044,180	6,761,055
Exercisable at the end of the period (in shares)	4,288,542
Weighted Average Exercise Price
Outstanding at the beginning of the period (in dollars per share)	$ 65.76
Exercised (in dollars per share)	57.10
Forfeited or expired (in dollars per share)	73.15
Outstanding at the end of the period (in dollars per share)	68.32	$ 65.76
Exercisable at the end of the period (in dollars per share)	$ 66.01
Weighted-Average Remaining Contractual Term (Years):
Outstanding at the end of the period	5 years 4 months 24 days
Exercisable at the end of the period	5 years
Aggregate Intrinsic Value:
Outstanding at the end of the period	$ 239,033
Exercisable at the end of the period	212,745
Intrinsic Value of Options Exercised	$ 87,251	$ 72,951	$ 51,140
Assumptions used to estimate fair value of restricted stock units granted
Expected Stock Price Volatility (as a percent)		14.20%	15.80%
Risk-free Interest Rate (as a percent)		2.80%	2.20%
Dividend Yield (as a percent)		1.50%	1.70%
Stock Awards Plans \| Restricted stock units (time-based)
STOCK-BASED COMPENSATION
Award vesting period	3 years
Stock Awards Plans \| Restricted stock units (performance-based)
STOCK-BASED COMPENSATION
Award vesting period	3 years
Assumptions used to estimate fair value of stock options granted
Dividend Yield (as a percent)	1.30%	1.43%
Expected Stock Price Volatility (as a percent)	16.50%	12.30%
Risk-free Interest Rate (as a percent)	2.19%	2.42%
Assumptions used to estimate fair value of restricted stock units granted
Fair value per stock award (in dollars per share)	$ 134.97	$ 128.70
Grant date stock price (in dollars per share)	$ 104.51	$ 89.42
Expected Stock Price Volatility (as a percent)	16.50%	12.30%
Expected average volatility of peer companies (as a percent)	31.90%	27.50%
Correlation assumption (as a percent)	37.40%	20.20%
Risk-free Interest Rate (as a percent)	2.19%	2.42%
Dividend Yield (as a percent)	1.30%	1.43%
Restricted stock unit activity
Balance at the beginning of the period (in shares)	69,990
Granted (in shares)	123,246
Forfeited (in shares)	(11,556)
Balance at the end of the period (in shares)	181,680	69,990
Weighted-Average Grant-Date Fair Value
Nonvested at the beginning of the period (in dollars per share)	$ 111.55
Granted (in dollars per share)	119.35
Forfeited (in dollars per share)	117.04
Nonvested at the end of the period (in dollars per share)	$ 117.26	$ 111.55
Director Stock Option Plans \| Stock options
Stock options activity
Outstanding at the beginning of the period (in shares)	155,200
Exercised (in shares)	(19,949)
Outstanding at the end of the period (in shares)	135,251	155,200
Exercisable at the end of the period (in shares)	135,251
Weighted Average Exercise Price
Outstanding at the beginning of the period (in dollars per share)	$ 58.13
Exercised (in dollars per share)	55.99
Outstanding at the end of the period (in dollars per share)	58.45	$ 58.13
Exercisable at the end of the period (in dollars per share)	$ 58.45
Weighted-Average Remaining Contractual Term (Years):
Outstanding at the end of the period	3 years 2 months 12 days
Exercisable at the end of the period	3 years 2 months 12 days
Aggregate Intrinsic Value:
Outstanding at the end of the period	$ 7,732
Exercisable at the end of the period	7,732
Intrinsic Value of Options Exercised	$ 1,172	$ 2,286	$ 1,995
Director Stock Option Plans \| Restricted stock units
STOCK-BASED COMPENSATION
Award vesting period	1 year
Director Stock Option Plans \| Restricted stock units (time-based)
Restricted stock unit activity
Granted (in shares)	11,490
Vested (in shares)	(14,257)
New long-term incentive program
STOCK-BASED COMPENSATION
Compensation expense	$ 800	$ 1,200	$ (700)
Performance period used to measure cumulative total shareholder return of common stock	3 years
Expected total expense related to program over the performance period	$ 2,700

EARNINGS PER SHARE (Details)

EARNINGS PER SHARE (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Earning per share
Authorized common stock (in shares)	199,000				199,000				199,000	199,000
Common stock, par value (in dollars per share)	$ 0.01				$ 0.01				$ 0.01	$ 0.01
Income (Numerator)
Income available to common stockholders, basic (in dollars)	$ 48,533	$ 56,750	$ 73,915	$ 63,004	$ 40,674	$ 38,996	$ 55,775	$ 59,300	$ 242,202	$ 194,745	$ 220,030
Income available to common stockholders, diluted (in dollars)									$ 242,202	$ 194,745	$ 220,030
Shares (Denominator)
Basic (in shares)	63,835	64,010	63,471	62,964	62,834	62,378	62,402	62,128	63,574	62,437	62,435
Total average equivalent shares	66,192	66,702	66,232	65,349	65,344	65,129	64,850	64,414	66,150	64,958	64,596
Per Share Amount
Net income per share, basic (in dollars per share)	$ 0.76	$ 0.89	$ 1.16	$ 1	$ 0.65	$ 0.63	$ 0.89	$ 0.95	$ 3.81	$ 3.12	$ 3.52
Net income per share, diluted (in dollars per share)	$ 0.73	$ 0.85	$ 1.12	$ 0.96	$ 0.62	$ 0.60	$ 0.86	$ 0.92	$ 3.66	$ 3	$ 3.41
Stock options
Shares (Denominator)
Effect of dilutive stock based compensation (in shares)									2,344	2,440	2,106
Restricted stock units
Shares (Denominator)
Effect of dilutive stock based compensation (in shares)									232	81	55

SEGMENT INFORMATION (Summary of

SEGMENT INFORMATION (Summary of Reportable Segments) (Details) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2019USD ($)	Sep. 30, 2019USD ($)	Jun. 30, 2019USD ($)	Mar. 31, 2019USD ($)	Dec. 31, 2018USD ($)	Sep. 30, 2018USD ($)	Jun. 30, 2018USD ($)	Mar. 31, 2018USD ($)	Dec. 31, 2019USD ($)segment	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)
Financial information regarding the Company's reportable segments
Number of reportable segments \| segment									3
Net sales	$ 671,333	$ 701,278	$ 742,661	$ 744,460	$ 685,028	$ 665,775	$ 710,608	$ 703,350	$ 2,859,732	$ 2,764,761	$ 2,469,283
Acquisition related costs									3,927	23,770
Total Restructuring Initiatives									20,472	63,829	2,208
Gain on insurance recovery											10,648
Depreciation and amortization									194,552	171,747	153,094
Interest expense									(35,489)	(32,626)	(40,597)
Interest income									4,174	7,056	5,470
Income before Income Taxes									342,069	266,020	294,825
Capital Expenditures									242,276	211,252	156,624
Total Assets	3,562,119				3,377,735				3,562,119	3,377,735	3,137,823
Business Transformation
Financial information regarding the Company's reportable segments
Total Restructuring Initiatives									20,472	63,829	2,208
Capital Expenditures									38,000
Business Transformation \| Employee severance
Financial information regarding the Company's reportable segments
Total Restructuring Initiatives									8,104
Beauty + Home
Financial information regarding the Company's reportable segments
Net sales									1,352,714	1,426,382	1,313,786
Adjusted EBITDA									181,150	185,926	173,227
Total Restructuring Initiatives									17,682	52,244	529
Depreciation and amortization									82,778	83,546	79,422
Capital Expenditures									96,040	101,371	76,425
Total Assets	1,378,292				1,373,816				1,378,292	1,373,816	1,358,283
Pharma
Financial information regarding the Company's reportable segments
Net sales									1,091,051	954,652	805,880
Adjusted EBITDA									387,483	343,706	275,933
Total Restructuring Initiatives									632	3,589
Depreciation and amortization									65,590	51,495	41,143
Capital Expenditures									89,702	54,433	33,005
Total Assets	1,422,815				1,324,696				1,422,815	1,324,696	881,443
Food + Beverage
Financial information regarding the Company's reportable segments
Net sales									415,967	383,727	349,617
Adjusted EBITDA									68,108	57,589	62,903
Total Restructuring Initiatives									391	4,185	1,679
Depreciation and amortization									35,728	27,467	24,720
Capital Expenditures									45,130	41,236	38,730
Total Assets	534,527				501,700				534,527	501,700	296,271
Corporate & Other
Financial information regarding the Company's reportable segments
Adjusted EBITDA									(44,406)	(36,285)	(37,457)
Total Restructuring Initiatives									1,767	3,811
Depreciation and amortization									10,456	9,239	7,809
Capital Expenditures									13,933	25,739	18,924
Transfer of Corporate Technology Expenditures									(2,529)	(11,527)	(10,460)
Total Assets	$ 226,485				$ 177,523				226,485	177,523	601,826
Operating segment
Financial information regarding the Company's reportable segments
Net sales									2,894,507	2,787,989	2,491,444
Operating segment \| Beauty + Home
Financial information regarding the Company's reportable segments
Net sales									1,376,027	1,446,231	1,333,048
Operating segment \| Pharma
Financial information regarding the Company's reportable segments
Net sales									1,100,463	955,069	805,913
Operating segment \| Food + Beverage
Financial information regarding the Company's reportable segments
Net sales									418,017	386,689	352,483
Intersegment
Financial information regarding the Company's reportable segments
Net sales									(34,775)	(23,228)	(22,161)
Intersegment \| Beauty + Home
Financial information regarding the Company's reportable segments
Net sales									(23,313)	(19,849)	(19,262)
Intersegment \| Pharma
Financial information regarding the Company's reportable segments
Net sales									(9,412)	(417)	(33)
Intersegment \| Food + Beverage
Financial information regarding the Company's reportable segments
Net sales									$ (2,050)	$ (2,962)	$ (2,866)

SEGMENT INFORMATION (Summary _2

SEGMENT INFORMATION (Summary of Net Sales and Long-Lived Assets By Geographic Area) (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Jan. 01, 2019
Net sales and long-lived asset information by geographic area
Net sales	$ 671,333	$ 701,278	$ 742,661	$ 744,460	$ 685,028	$ 665,775	$ 710,608	$ 703,350	$ 2,859,732	$ 2,764,761	$ 2,469,283
Plant, Property & Equipment	1,087,678				991,613				$ 1,087,678	$ 991,613	$ 867,906	$ 997,489
Customer Concentration Risk \| Net sales
Net sales and long-lived asset information by geographic area
Concentration Risk, Percentage									6.00%	6.00%	6.00%
United States
Net sales and long-lived asset information by geographic area
Net sales									$ 836,768	$ 726,336	$ 642,164
Plant, Property & Equipment	300,820				265,004				300,820	265,004	182,434
Europe
Net sales and long-lived asset information by geographic area
Net sales									1,638,469	1,627,478	1,426,173
Plant, Property & Equipment	619,268				577,144				619,268	577,144	547,795
France
Net sales and long-lived asset information by geographic area
Net sales									895,110	862,364	744,856
Plant, Property & Equipment	338,288				308,250				338,288	308,250	266,804
Germany
Net sales and long-lived asset information by geographic area
Net sales									452,409	474,369	416,802
Plant, Property & Equipment	163,782				154,505				163,782	154,505	163,948
Italy
Net sales and long-lived asset information by geographic area
Net sales									141,867	144,044	131,523
Plant, Property & Equipment	53,562				54,978				53,562	54,978	57,080
Other Europe
Net sales and long-lived asset information by geographic area
Net sales									149,083	146,701	132,992
Plant, Property & Equipment	63,636				59,411				63,636	59,411	59,963
Other Foreign Countries
Net sales and long-lived asset information by geographic area
Net sales									384,495	410,947	400,946
Plant, Property & Equipment	$ 167,590				$ 149,465				$ 167,590	$ 149,465	$ 137,677

INSURANCE SETTLEMENT RECEIVAB_2

INSURANCE SETTLEMENT RECEIVABLE (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
INSURANCE SETTLEMENT RECEIVABLE
Gain on insurance recovery			$ 10,648
France \| Fire damage
INSURANCE SETTLEMENT RECEIVABLE
Insurance proceeds received	$ 3,400
Costs incurred related to fire		$ 18,900	20,300
Insurance receivable	$ 0
Expenses related to fire		5,800
Beauty + Home \| France \| Fire damage
INSURANCE SETTLEMENT RECEIVABLE
Expenses related to fire		3,800	5,600
Gain on insurance recovery			$ 10,600
Pharma \| France \| Fire damage
INSURANCE SETTLEMENT RECEIVABLE
Expenses related to fire		$ 2,000

ACQUISITIONS (Details)

ACQUISITIONS (Details) $ in Thousands	Oct. 31, 2019USD ($)	Oct. 01, 2019	Aug. 02, 2019USD ($)	Jun. 05, 2019USD ($)	May 31, 2019USD ($)	Aug. 27, 2018USD ($)	May 01, 2018USD ($)	Jan. 31, 2019USD ($)	Dec. 31, 2018USD ($)	Dec. 31, 2019USD ($)	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)	Feb. 13, 2020	Jan. 01, 2020USD ($)	Aug. 31, 2019USD ($)item	May 31, 2018USD ($)
Acquisitions
Investment in unconsolidated affiliate										$ 3,530	$ 10,000	$ 5,000
Acquisition of business, net of cash received										106,328	527,916
Proceeds from sale of investment in equity securities										16,487
Acquisition related costs										3,927	23,770
Restricted cash included in prepaid and other									$ 5,000	5,003	5,000
Assets
Goodwill									712,095	763,461	712,095	$ 443,887
Preferred equity stocks
Acquisitions
Cost method investments															$ 3,500
Number of preferred equity investments \| item															2
Investment in preferred equity stock																$ 10,000
Proceeds from sale of investment in equity securities								$ 16,500
Gain on sale of equity method investment									$ 6,500
Carrying amount adjustments related to fair value adjustments
Investment impairment											$ 0
Bapco
Acquisitions
Ownership interest previously held									20.00%		20.00%
Fusion Packaging \| Subsequent Events
Acquisitions
Percentage of interest acquired													100.00%
BTY \| Subsequent Events
Acquisitions
Ownership percentage of equity method investment														49.00%
Investment in preferred equity stock														$ 32,000
BTY \| Strategic Definitive Agreement
Acquisitions
Ownership percentage of equity method investment		49.00%
Initial lock-up period		5 years
Second lock-up period		3 years
BTY \| Strategic Definitive Agreement \| Call Option \| Minimum
Acquisitions
Ownership percentage of equity method investment		26.00%
BTY \| Strategic Definitive Agreement \| Call Option \| Maximum
Acquisitions
Ownership percentage of equity method investment		31.00%
2019 Acquisitions
Acquisitions
Acquisition related costs										3,400
Goodwill expected to be tax deductible										29,600
Assets
Cash and equivalents										3,427
Accounts receivable										3,504
Prepaid and other										2,478
Property, plant and equipment										4,267
Goodwill										59,143
Intangible assets										52,980
Other miscellaneous assets										430
Liabilities
Accounts payable, accrued and other liabilities										5,388
Deferred income taxes										2,592
Deferred and other non-current liabilities										1,598
Net assets acquired										116,651
2019 Acquisitions \| Pharma
Assets
Goodwill										59,100
Noble
Acquisitions
Percentage of interest acquired	100.00%
Acquisition of business, net of cash received	$ 62,300
Fair value of contingent consideration arrangement	2,900									2,900
Restricted cash included in prepaid and other										5,000
Assets
Cash and equivalents	$ 1,600
Gateway Analytical
Acquisitions
Cost of acquired entity					$ 7,000
Fair value of contingent consideration arrangement					$ 3,000					$ 3,000
Nanopharm
Acquisitions
Acquisition of business, net of cash received				$ 38,100
Assets
Cash and equivalents				$ 1,800
Reboul
Acquisitions
Percentage of interest acquired							100.00%
Cost of acquired entity							$ 3,500
Fair value of contingent consideration arrangement									$ 0		$ 0
Assets
Cash and equivalents							$ 112
Bapco
Acquisitions
Percentage of interest acquired			80.00%
Acquisition of business, net of cash received			$ 3,800
Assets
Cash and equivalents			$ 2,900
CSP Technologies
Acquisitions
Cost of acquired entity						$ 553,500
Sales of acquiree during the reporting period											48,900
Pretax income of acquiree during the reporting period											(10,200)
Acquisition related costs											9,000
Nonrecurring expense related to the fair value adjustment to acquisition-date inventory (before tax)											14,100
Restricted cash included in prepaid and other									5,000		5,000
Refund from working capital adjustment								$ 1,000
Assets
Cash and equivalents									24,053		24,053
Accounts receivable									20,847		20,847
Inventories									42,169		42,169
Prepaid and other									3,995		3,995
Property, plant and equipment									99,194		99,194
Goodwill									278,020		278,020
Intangible assets									177,120		177,120
Other miscellaneous assets									1,039		1,039
Liabilities
Current maturities of long-term obligations									129		129
Accounts payable, accrued and other liabilities									31,989		31,989
Long-term obligations									6,037		6,037
Deferred income taxes									38,442		38,442
Retirement and deferred compensation plans									1,038		1,038
Deferred and other non-current liabilities									15,344		15,344
Net assets acquired									553,458		553,458
CSP Technologies \| Pharma
Acquisitions
Sales of acquiree during the reporting period											33,900
Pretax income of acquiree during the reporting period											(10,300)
Assets
Goodwill									174,300		174,300
CSP Technologies \| Food + Beverage
Acquisitions
Sales of acquiree during the reporting period											15,000
Pretax income of acquiree during the reporting period											100
Assets
Goodwill									$ 103,700		$ 103,700

ACQUISITIONS (Acquired Intangib

ACQUISITIONS (Acquired Intangibles) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
CSP Technologies
Acquired finite-lived intangible assets
Estimated Fair Value of Asset		$ 177,120
CSP Technologies \| Acquired technology
Acquired finite-lived intangible assets
Weighted average useful life		12 years
Estimated Fair Value of Asset		$ 46,700
CSP Technologies \| Customer relationships
Acquired finite-lived intangible assets
Weighted average useful life		16 years
Estimated Fair Value of Asset		$ 113,300
CSP Technologies \| Trademarks and trade names
Acquired finite-lived intangible assets
Weighted average useful life		9 years
Estimated Fair Value of Asset		$ 14,600
CSP Technologies \| License agreements and other
Acquired finite-lived intangible assets
Weighted average useful life		11 years
Estimated Fair Value of Asset		$ 2,520
2019 Acquisitions
Acquired finite-lived intangible assets
Estimated Fair Value of Asset	$ 52,980
2019 Acquisitions \| Acquired technology
Acquired finite-lived intangible assets
Weighted average useful life	8 years
Estimated Fair Value of Asset	$ 9,160
2019 Acquisitions \| Customer relationships
Acquired finite-lived intangible assets
Weighted average useful life	11 years
Estimated Fair Value of Asset	$ 39,379
2019 Acquisitions \| Trademarks and trade names
Acquired finite-lived intangible assets
Weighted average useful life	4 years
Estimated Fair Value of Asset	$ 2,457
2019 Acquisitions \| License agreements and other
Acquired finite-lived intangible assets
Weighted average useful life	1 year
Estimated Fair Value of Asset	$ 1,984

ACQUISITIONS (Pro Forma) (Detai

ACQUISITIONS (Pro Forma) (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Unaudited pro forma financial information
Net Sales	$ 2,857,765	$ 2,605,095
Net Income Attributable to AptarGroup, Inc.	$ 208,717	$ 230,753
Net Income per common share - basic	$ 3.34	$ 3.70
Net Income per common share - diluted	$ 3.21	$ 3.57
CSP Technologies \| Acquisition Related Costs
Acquisitions
Transaction costs excluded from supplemental pro forma earnings (after tax)	$ 16,700
Transaction costs excluded from supplemental pro forma earnings (before tax)	22,000
CSP Technologies \| Fair Value Adjustment
Acquisitions
Nonrecurring expense related to the fair value adjustment to acquisition-date inventory excluded from supplemental pro forma earnings (after tax)	10,900
Nonrecurring expense related to the fair value adjustment to acquisition-date inventory excluded from supplemental pro form earnings (before tax)	$ 14,100

RESTRUCTURING INITIATIVE (Detai

RESTRUCTURING INITIATIVE (Details) - USD ($) $ in Thousands	12 Months Ended
RESTRUCTURING INITIATIVE (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Restructuring initiatives
Capital Expenditures	$ 242,276	$ 211,252	$ 156,624
Restructuring reserve
Expense recognized related to the plan	20,472	63,829	2,208
Business Transformation
Restructuring initiatives
Expected implementation costs	110,000
Expected capital investments related to transformation plan	55,000
Cumulative expense incurred	86,500
Capital Expenditures	38,000
Restructuring reserve
Restructuring reserve, balance at the beginning of the period	15,035
Expense recognized related to the plan	20,472	63,829	2,208
Cash paid	(24,608)
FX impact	(200)
Restructuring reserve, balance at the end of the period	10,699	15,035
Business Transformation \| Employee severance
Restructuring reserve
Restructuring reserve, balance at the beginning of the period	3,934
Expense recognized related to the plan	8,104
Cash paid	(4,813)
FX impact	(135)
Restructuring reserve, balance at the end of the period	7,090	3,934
Business Transformation \| Professional fees and other costs
Restructuring reserve
Restructuring reserve, balance at the beginning of the period	11,101
Expense recognized related to the plan	12,368
Cash paid	(19,795)
FX impact	(65)
Restructuring reserve, balance at the end of the period	3,609	11,101
Beauty + Home
Restructuring initiatives
Capital Expenditures	96,040	101,371	76,425
Restructuring reserve
Expense recognized related to the plan	17,682	52,244	529
Pharma
Restructuring initiatives
Capital Expenditures	89,702	54,433	33,005
Restructuring reserve
Expense recognized related to the plan	632	3,589
Food + Beverage
Restructuring initiatives
Capital Expenditures	45,130	41,236	38,730
Restructuring reserve
Expense recognized related to the plan	391	4,185	1,679
Corporate & Other
Restructuring initiatives
Capital Expenditures	13,933	25,739	$ 18,924
Restructuring reserve
Expense recognized related to the plan	$ 1,767	$ 3,811

QUARTERLY DATA (UNAUDITED) (Det

QUARTERLY DATA (UNAUDITED) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
QUARTERLY DATA (UNAUDITED)
Net sales	$ 671,333	$ 701,278	$ 742,661	$ 744,460	$ 685,028	$ 665,775	$ 710,608	$ 703,350	$ 2,859,732	$ 2,764,761	$ 2,469,283
Gross profit	193,588	215,222	231,739	233,841	184,775	192,544	209,018	209,171	874,390	795,508
Net Income	48,538	56,769	73,921	62,999	40,675	39,022	55,781	59,288	242,227	194,766	220,029
Net Income Attributable to AptarGroup, Inc.	$ 48,533	$ 56,750	$ 73,915	$ 63,004	$ 40,674	$ 38,996	$ 55,775	$ 59,300	$ 242,202	$ 194,745	$ 220,030
Net Income Attributable to AptarGroup, Inc. Per Common Share:
Basic (in dollars per share)	$ 0.76	$ 0.89	$ 1.16	$ 1	$ 0.65	$ 0.63	$ 0.89	$ 0.95	$ 3.81	$ 3.12	$ 3.52
Diluted (in dollars per share)	$ 0.73	$ 0.85	$ 1.12	$ 0.96	$ 0.62	$ 0.60	$ 0.86	$ 0.92	$ 3.66	$ 3	$ 3.41
Average number of shares outstanding:
Basic (in shares)	63,835	64,010	63,471	62,964	62,834	62,378	62,402	62,128	63,574	62,437	62,435
Diluted (in shares)	66,192	66,702	66,232	65,349	65,344	65,129	64,850	64,414	66,150	64,958	64,596

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details) - Subsequent Events - USD ($) $ in Millions	Feb. 13, 2020	Jan. 01, 2020
Fusion Packaging
Subsequent Event [Line Items]
Percentage of interest acquired	100.00%
BTY
Subsequent Event [Line Items]
Investment in preferred equity stock		$ 32
Ownership percentage of equity method investment		49.00%

SCHEDULE II - VALUATION AND Q_2

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Allowance for doubtful accounts
VALUATION AND QUALIFYING ACCOUNTS
Balance at the Beginning of the Period	$ 3,541	$ 3,161	$ 2,989
Charged to Costs and Expenses	782	923	235
Deductions from Reserve	(697)	(543)	(63)
Balance at the End of the Period	3,626	3,541	3,161
Deferred tax valuation allowance
VALUATION AND QUALIFYING ACCOUNTS
Balance at the Beginning of the Period	11,189	5,414	4,070
Charged to Costs and Expenses	12,058	4,230	3,640
Charged to Other Accounts	1,508	2,604
Deductions from Reserve	(1,435)	(1,059)	(2,296)
Balance at the End of the Period	$ 23,320	$ 11,189	$ 5,414